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Abstract of Dissertation

APPLICATIONS OF CELL-DERIVED VESICLES: FROM SINGLE MOLECULE
STUDIES TO DRUG DELIVERY
Single molecule studies can provide information of biological molecules which otherwise
is lost in ensemble studies. A wide variety of fluorescence-based techniques are utilized
for single molecule studies. While these tools have been widely applied for imaging soluble
proteins, single molecule studies of transmembrane proteins are much more complicated.
A primary reason for this is that, unlike membrane proteins, soluble proteins can be easily
isolated from the cellular environment. One approach to isolate membrane proteins into
single molecule level involves a very low label expression of the protein in cells. However,
cells generate background fluorescence leading to a very low signal to noise ratio. An
alternative approach involves isolating membrane proteins in artificial membrane derived
vesicles. This approach is limited to proteins which can be solubilized or stabilized in
detergent solution. This intermediate step endangers the structural integrity of proteins
with multiple subunits. Hence, we isolated transmembrane proteins into cell-derived
vesicles which maintain the proteins in their physiological membrane without
compromising their functional integrity. We studied the stoichiometric assembly of 34
nicotinic receptors which are pentameric receptor with possible stoichiometry of (3)2(4)3
and (3)3(4)2. We found that (3)2(4)3 is the predominant stoichiometry, and we have
verified our finding with both single and double color experiments. We have also
demonstrated that cell-derived vesicles can be utilized to study ligand receptor interactions.
Cell-derived vesicles generated from cellular preparations provide a method to study the
overall structural and functional properties of membrane proteins. However, organelle
specific information is not available in this approach. Alternatively, separating vesicles
based on their original organelle could provide information on the assembly and trafficking
of membrane proteins. For example, it has been hypothesized that nicotine actsas a
pharmacological chaperone of 42 nicotinic receptors and nicotine alters the assembly of
the nicotinic receptors towards the high sensitivity isoform in the ER. To validate this
hypothesis, we isolated 42 nicotinic receptors located on vesicles derived from the ER
and plasma membrane origins and utilized single molecule studies to determine the
stoichiometric assembly of the receptor. The data suggested that the ER has a higher ratio

of the low sensitivity isoform ((4)3(2)2) than the plasma membrane indicating that the
high sensitivity isoform trafficked more efficiently to the cell surface. When nicotine was
added, the distribution of nicotinic receptors changes in those compartments. In both the
ER and plasma membrane, the percentage of high sensitivity isoform was greater than the
sample without the presence of nicotine. The results suggested that nicotine altered the
assembly of nicotinic receptors to form the high sensitivity isoform in the ER and the
altered assembly trafficked to the plasma membrane efficiently increasing the ratio of this
isoform in the plasma membrane.
The cell derived vesicles we utilized to isolate single receptors are structurally similar to
liposomes, an FDA approved drug delivery system, which is spherical vesicles composed
of at least one lipid bilayer. Hence, cell-derived vesicles possess potential to be utilized as
drug delivery vehicles. I explored the applicability of cell-derived vesicles as general
delivery vehicles to cultured cells. Additionally, we implanted xenografts into immune
compromised nude mice and prepared cell derived vesicles labeled with dye molecules.
The vesicles were injected in a mouse containing a xenograft to monitor whether these
vesicles can reach to the xenograft. Our data suggested that cell-derived vesicles can
successfully reach the xenograft and thus have potential to be utilized as a drug delivery
vehicle.
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Introduction to Single Molecule Studies and Drug Delivery Systems
Copyright information: A part of this chapter was published on Acta Diabetologica.
Reprinted by permission from Springer Customer Service Centre GmbH: Springer Nature,
Acta Diabetologica, “Advances in micro- and nanotechnologies for the GLP-1-based
therapy and imaging of pancreatic beta-cells”, by Faruk H. Moonschi, Corey B. Hughes,
George M. Mussman, John L. Fowlkes, Chris I. Richards, Iuliana Popescu, COPYRIGHT
(2017) (https://doi.org/10.1007/s00592-017-1086-7)

1.1 Aims and Scopes of This Study
One of the primary aims of this work was to develop a method to isolate single
membrane proteins into a physiological relevant lipid bilayer to conduct single molecule
studies. One of the biggest challenges for single molecule studies of membrane proteins is
the concentration barrier resulting from high levels of proteins present in the native cellular
environment. The approaches detailed in this work provide the ability to isolate single
proteins in their physiological environment without compromising the structural integrity
of multimeric proteins.

Current approaches to studying membrane receptors often rely on biochemical
techniques that are unable to distinguish between receptors originating from different
organelles. Another aim of this work was to utilize cell derived vesicles to determine the
overall structure and assembly of a membrane protein from specific organelles. This
approach provided us with the capability to study the properties of multimeric proteins
originating from the endoplasmic reticulum and the plasma membrane in order to
understand their assembly before and after trafficking to the plasma membrane.

The final aim of my work was to utilize cell-derived vesicles to deliver therapeutics
into a targeted location. Lipid-based drug delivery vehicles including liposomes and
exosomes have been extensively studied to encapsulate therapeutics and to deliver them
into a targeted location in the body (1-3). Cell-derived vesicles those used to isolate single
receptors have many properties that make them ideal for the encapsulation and delivery of
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therapeutics. We validated that cell-derived vesicles can be used to deliver different types
of cargo both to cells and to tumors in a rodent model.

In Chapter 1, I describe background information related to my research including
(1) the challenges faced by researches who conduct single-molecule based studies of
biological systems, (2) the different approaches made by researchers to isolate single
molecules, (3) the different single molecule methods used in this work, (4) the membrane
proteins used in this study, and (5) the common approaches used by researchers to utilize
lipid based systems as a drug delivery system (DDS) and advantages of using cell-derived
vesicles as a DDS.

In Chapter 2, I describe a single molecule method which isolates single receptors
into cell-derived vesicles. I utilized HEK293T cells which expressed α3-GFP β4-wt or α3wt β4-GFP receptors. Nitrogen cavitation and differential ultracentrifugation were
employed to isolate cell-derived vesicles implanted with single receptors. These vesicles
were utilized to study the stoichiometry of the receptor at the single molecule level. The
data suggested that (α3)2(β4)3 is the predominate stoichiometry of the receptor. We verified
the result using two color experiments with α3-mCherry β4-GFP receptors. I also
demonstrated that cell-derived vesicles can be employed to study ligand receptor
interactions using fluorescence correlation spectroscopy (FCS) and immobilized molecules
on a glass substrate.

In Chapter 3, related to the second aim of this work, I included the studies showing
the effect of different types of nicotinic receptor ligands (agonists, partial agonists and
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antagonist) on the assembly and trafficking of α4β2 nicotinic receptors. Then, ER and
plasma membrane originated α4β2 nicotinic receptors were isolated to study the
stoichiometric assembly of the receptor in those organelles. The data suggested that all
types of nicotinic ligands increased the total number of receptors in the ER and the plasma
membrane and altered the distribution of receptors in those organelles. The single molecule
studies with whole cell samples suggested that all nicotinic ligands differentially shifted
the stoichiometry from the low sensitivity isoform ((α4)3(β2)2) to the high sensitivity
isoform ((α4)2(β2)3). The single molecule studies with the ER and plasma membrane
originated vesicles suggested that (–)-nicotine (hereafter, nicotine) altered the assembly of
nicotinic receptors in the ER and the high sensitivity isoform is preferentially trafficked
from the ER to the plasma membrane.

In Chapter 4, I included work related to the utilization of cell-derived vesicles as a
delivery vehicle in vitro and in vivo. These studies utilized fluorescent dyes and separately
chemotherapeutics for delivery to cells to demonstrate their capability as a drug delivery
vehicle. We characterized the vesicles, implanted xenografts, collected and purified cancer
cells, and injected the cancer-cell-derived vesicles into mouse models to monitor if vesicles
can reach to the tumor. Our preliminary data suggested that cancer cell-derived vesicles
can reach to the tumor selectively, but will need to be optimized to facilitate a robust
delivery of cargo into the tumor.
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1.2 Challenges of Single Molecule Studies in Biological Systems
Biological systems are very complex because of the thousands of processes
occurring simultaneously. A better understanding of these processes can provide critical
information for the development of cures to treat diseases. A common approach to
understand biological processes involves ensemble studies which can provide valuable
information about the system but can lose some other information as well. For example,
calcium sensing fluorescent dyes can be loaded into cells and the calcium induced
fluorescence signal can be monitored after activating calcium channels. This result can
provide information relating the amount of ligand added versus the degree of activation of
ion channel. However, the activity of individual calcium channels is lost due to averaging
over the entire ensemble. A single-molecule analysis of the channel can provide
information of channel activation, conformational changes, and gating dynamics (4-6).
Understanding these processes can provide key insights needed to design better
pharmaceuticals to manipulate the ion channel.

Biological phenomena including protein conformational changes, protein folding
and unfolding, ion channel gating, and oligomeric protein assembly have been studied with
single-molecule fluorescence microscopy (4,6-12). For example, single molecule Forester
resonance energy transfer (FRET) can be utilized to determine the distance between
specifically labeled dye molecules on two different positions of a biomolecule. The change
in distance can be utilized to determine the conformation change and the gating mechanism
of ion channels. Folding and unfolding of a protein can also be studied with single molecule
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FRET (11,12). Single molecule photobleaching step counting can provide information
about the stoichiometric assembly of an oligomeric protein (10,13).

One of the challenges of single molecule studies of biological samples with
fluorescence microscopy is that one molecule needs to be isolated in a relatively large area
defined by the diffraction limit of light. A diffraction limited spot is a theoretical limitation
of an optical lens due to the diffraction of light. If two fluorophores are located in a distance
less than or equal to the diffraction limit of the objective lens, their signal will display a
single diffraction limited fluorescent spot rather than two separate spots (Figure 1.1). The
size of a diffraction limited spot is determined by Abbe resolution, which, for microscopy,
can be expressed as,

𝑨𝒃𝒃𝒆 𝒓𝒆𝒔𝒐𝒍𝒖𝒕𝒊𝒐𝒏 =

𝝀

Eq. 1.1

𝟐𝑵𝑨

Where λ is the wavelength of the light and NA is the numerical aperture of the
objective lens. NA of an objective lens is the range of angle to which it can emit light or
from which it can accept light. Mathematically, NA can be expressed with the following
equation,

𝑵𝑨 = 𝜼 × 𝐬𝐢𝐧(𝜽)

Eq. 1.2

Where η is the refractive index of the media and θ is one-half of the maximum angle
of the objective lens.

The native concentration of proteins expressed in a cell is usually not suitable for
single molecule studies due to the presence of multiple proteins in a diffraction limited

6

Figure 1.1 Graphical representation of the consequence of the presence of two
fluorophores in a distance lower than or equal to the diffraction limit of a
microscope. (A) Two fluorophores are located at a distance lower than the diffraction
limit of the objective lens. (B) When an image of the fluorophores in “A” is taken with
a camera, the image will display a single spot due to the inability of the objective lens
to separate the emissions from the two fluorophores. (C) When two fluorophores are
separated by a distance more than the diffraction limit, (D) the image will provide two
distinct spots corresponding to the two fluorophores.
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spot. One approach researcher usually take to mitigate this challenge includes the
expression of protein at a very low concentration which can be achieved by transfecting
the cells with fewer plasmids and reduced time (13,14). However, cells generate
background fluorescence from a number of sources including NADH, riboflavin, flavin
coenzymes (15) as well as mitochondria (16), and this noise reduces the signal to noise
ratio.

Additionally, membrane proteins tend to move laterally along the membrane (17)
spreading the emitted photons across multiple pixels of the camera. This process limits
single molecule studies to the few applications that can take advantage of bright
fluorophores such as quantum dots. Another approach of isolating single proteins utilizes
artificial lipid bilayers (18-21). The general approach requires the expression of proteins in
a cellular system with subsequent isolation and purification of the protein of interest. This
method works well for soluble proteins but is more challenging for membrane proteins
because they need to be transferred into an artificial lipid bilayer. One issue with this
approach is that the protein needs to be temporarily solubilized outside of a membrane in
a detergent solution. The detergent solution can denature and sometime precipitate the
proteins (22,23). This can lead to an oligomeric protein or a protein with multiple subunits
to fall apart and to lose functional activity. Another issue with this approach is that artificial
lipid bilayers lack the same membrane components as the native cellular membrane.
Hence, a better approach is necessary which can isolate single oligomeric proteins into
their physiological membrane. Additionally, to study single molecules using fluorescent
tags, a fluorescence microscope needs to be selected which can enhance signal to noise
ratio and possesses ability of detecting signals from single fluorophores.
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1.3 Fluorescence Microscopy
Fluorescence microscopy is an integral part of the study of many biological systems
both at the single cell and single molecule level. Microscopy can be used to visualize
fluorescent proteins or organic dyes which are selectively incorporated into a specific part
of a biological system. For example, lipids, proteins or DNA of a cell can be labeled with
fluorescent probes which can be excited with a light source to visualize the labeled
molecules using a fluorescence microscope. Thus, a cell or its compartments can be
visualized and studied. Different types of fluorescence microscopy have been developed
and are commercially available. A brief description of the most common ones are as
follows:

1.3.1 Wide-Field Fluorescence Microscopy
In this microscopy technique, an excitation source is used to illuminate all parts of
a specimen and the resultant fluorescence emission is either visualized by eye or captured
as an image with a camera (Figure 1.2). A xenon or mercury lamp is used as an excitation
source which is passed through a filter to select a narrow band of light and is directed to
the specimen through an objective lens. The emission is passed through a dichroic mirror
and/or a filter to separate the emission from the excitation source, and the emission is
finally directed to a camera to capture image of the specimen. Since the whole sample is
illuminated and emission is generated from the entire specimen, the presence of out of
focus emission reduces the image contrast and resolution. One of the common approaches
to resolve this issue involves the use of very thin specimens (less than 10 μm) which reduce
the emission signal and thus improves the image contrast (24). The major advantages of
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Figure 1.2 A schematic representation of the different parts of a wide-field
microscope. Excitation source is usually generated from a lamp (a) which is directed to
an excitation filter (b). This filter usually passes a narrow band of wavelengths while
reflecting all other wavelengths. The selected band from excitation source is directed to
a dichroic mirror (c) which reflects the light toward the sample (e) through an objective
(d). The fluorescent molecules located in the sample become excited by the excitation
source and emit fluorescence. A part of the emission passes though the objective toward
the dichroic mirror which allows the emission to pass through. The emission is further
filtered using an emission filter (f) and directed to a camera for capturing an image of
the specimen.
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wide-field fluorescence microscopy include low cost, simple instrumentation, and
flexibility. The major drawback of this system arises from the technique of exciting the
entire specimen which causes photobleaching of the incorporated fluorescent probes and
photo-toxicity to the live cell under investigation. The other notable disadvantage is the
low resolution of the images.

1.3.2 Confocal Microscopy
In wide field microscopy technique, the emission originated from the out of focus
molecules causes blurriness in the image of a specimen. Confocal microscopy is a special
type of fluorescence microscopy which provides better image resolution. In this
microscopy technique, the excitation source is usually a laser which is brighter and smaller
in size than that obtained from the mercury lamp used in wide-field microscopy. The
excitation lights from the laser is usually directed towards a sample through a pinhole and
an objective to produce a confocal beam, and the emitted lights are collected through the
same objective. A pinhole aperture is placed on the path of the emitted light to exclude all
light except that generated from the fluorophores located at the focus of the confocal beam.
Thus, the out of focus emission cannot reach to the detector providing an image of better
resolution. The emission is usually detected by a photomultiplier tube (PMT) for every
single position on the sample or the region of interest. Therefore, either the stage holding
the sample on top of the objective lens needs to be moved in different positions in space
(25) or the laser source needs to be directed toward different parts of the specimen (26) in
order to record an image. In the former arrangement, usually the stage is physically moved
along the X and Y axis while in the later arrangement, the laser is directed toward different
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parts of the specimen by using two orthogonal-mirrors (24). The laser and pinhole apertures
stay unchanged in their positions in both types of set-ups. Laser scanning confocal
microscopy is much faster and thus more common.

1.3.3 Total Internal Reflection Fluorescence Microscopy
A confocal microscope can acquire images of better resolution than a traditional a
wide-field fluorescence microscope and can produce an image from optical sections of
about 1 μm. In contrast, total internal reflection fluorescence (TIRF) microscopy can
produce optical sections of about 100 nm. TIRF microscopy is a special type of
fluorescence microscopy which is used to illuminate a thin segment of a sample located
above a glass substrate. In this microscopy technique, the excitation light is directed
through a high refractive index medium (usually glass substrate) into a low refractive index
medium (solution) at an angle. When the incident angle increases, the refraction angle also
increases. When the incident angle becomes larger than a critical value, the light does not
transfer from high refractive medium to low refractive medium. Rather, the excitation
source undergoes total internal reflection producing an exponentially decaying light from
the interface of the two media into the low refractive index medium. This exponentially
decaying light is known as evanescent wave and has the same wavelength as the excitation
source. The evanescent wave is utilized to excite the fluorescent molecules mounted on a
glass substrate. The penetration depth of the evanescent wave depends on the wavelength
of excitation source, the refractive index of the media and the incident angle utilized to
obtain total internal reflection (24). Since a TIRF microscope excites only a narrow region
(100-200 nm) into the sample, the background fluorescence decreases. It was reported that
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Figure 1.3 A schematic representation of a prism-type and an objective-type total
internal reflection fluorescence (TIRF) microscope set-up. (A) In a prism-type TIRF
microscopy set-up, an excitation beam is directed through a prism to the sample present
on top of a coverslip, and the emission is collected through an objective present under
the coverslip. (B) In an objective type TIRF microscopy set-up, the excitation beam is
directed into the sample located on top of the objective and the emission is collected
through the same objective.
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background fluorescence is 2,000 time lower in a TIRF microscope image than that
obtained in a typical wide-field fluorescence microscopy (27).

Single molecule studies of immobilized molecules are usually conducted with TIRF
microscopy equipped with an objective of a very high magnification (60-120x) and a
camera capable of detecting very low signals (10,28,29). An electron multiplying CCD
camera can be utilized to collect images of single molecules. The cooling system within
the camera reduces shot noise.

There are two common types of set-ups available for TIRF microscopy – Objective
type, and Prism type (30). In prism type TIRF microscopy, a prism is placed on top of a
sample present on a coverslip, and an inverted objective is positioned on the bottom of the
coverslip (Figure 1.3A). The excitation light is directed through the prism to the sample,
and the emission light is collected through the objective. For this system, a sample is
usually prepared in a microfluidic device whose top and bottom are made of a glass slide
and a cover slip respectively (31). This device with the sample is mounted on top of the
objective and the prism is mounted on top of the sample. The sample is excited from the
top since the excitation signal passes through the prism, and the fluorescence signal is
collected from the other side of the device though the objective.

In an objective type TIRF microscope, the sample is placed on top of a coverslip
which is mounted on top of an inverted objective of high numerical aperture (>1.45)(Figure
1.3B) (29,32). To achieve total internal reflection, the excitation beam is focused at the
back aperture of the objective. Then, a stepper motor is used to laterally move the beam
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toward the edge of the objective. This approach increases the angle of the incident light at
the interface of the glass substrate and the sample. When the objective has a high enough
numerical aperture, the excitation beam can be directed at an incident angle greater than
the critical angle needed to produce a total internal reflection of the excitation source. The
fluorescence emission is collected through the same objective and is separated from the
excitation light using a dichroic mirror.

1.4 Novel Approaches in Single Molecule Studies
To conduct single molecule studies of biological molecules, a single molecule
needs to be isolated into a diffraction limited spot. The normal expression of membrane
proteins in cells is often not suitable to conduct single molecule studies. To overcome this
concentration barrier, researchers have employed a number of approaches including
encapsulation of proteins into an artificial membrane (18,19), employing a metal nanoaperture (10) or simply expressing the protein at a very low concentration (14). However,
each of these approaches has limitations as presented previously (section 1.2). Here we
utilize a novel approach where cell derived vesicles are employed to isolate single
receptors.

1.4.1 Cell-Derived Vesicles
Cell derived vesicles can be generated by homogenizing cells obtaining fractions
of a cell inserted with membrane proteins. Common approaches to prepare the vesicles
includes ultrasonic and other mechanical homogenization as well as nitrogen cavitation
(33,34). All these approaches are assumed to produce cell fragments containing a native
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lipid bilayer which spontaneously form spherical vesicles. The mechanism of the
spontaneous formation of spherical vesicles from lipid bilayers has been explained based
on thermodynamics (35) and validated using molecular dynamic simulations (36). The
basic mechanism involves the structural features of a lipid molecule which contain a
hydrophobic tail and a hydrophilic head group. The hydrophobic tails of lipid molecules
do not prefer to be associated with water molecules due to hydrophobic interaction. Rather,
the hydrophobic tails interact with each other via Van der Waals interactions. The process
of self-association of the hydrophobic tails is thermodynamically favorable over the
interaction of the hydrophobic tails with water molecules (35,36). The minimum
interaction of hydrophobic tails of a cell fragment with water molecules is achieved when
the ends of a cell fragment associate with each other forming a spherical vesicle. In this
process, the entropy of the water increases making the process of vesicle formation
thermodynamically favorable (36).

Another common method of vesicle formation is extrusion which is typically used
to decrease the size of liposomal vesicles (37,38). However, this method has also been
applied to prepare cell-derived vesicles from mammalian cell suspension. In this approach,
a cell slurry is usually forced through a series of polycarbonate membranes containing very
small pores to generate vesicles inserted with endogenous proteins (39,40). To explain the
mechanism of vesicles formation via extrusion, Clerc et al has proposed a mechanism
based on the study of soap bubbles (41). According to this theory, a pore in a polycarbonate
membrane can be considered as a cylindrical tube, and when a large vesicle is passed
through the tube, a cylindrical lipid bilayer is formed inside the tube. When this cylindrical
structure reaches the other side of the pore, the cylindrical lipid bilayer breaks and
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reorganizes to produce small vesicles. This theory is based on the experiments carried out
with soap bubbles which showed that at the end of the pore, the bubble breaks when the
length of the bubble reaches to a critical value equal to the circumference of the pore.

Spherical vesicles generated by homogenization of cells can vary in size and may
contain multiple transmembrane proteins. The size of these vesicles can be reduced by
passing them through a polycarbonate membrane used in extrusion. Although, different
types of homogenization can produce cell derived vesicles, nitrogen cavitation has several
advantages (33) over other methods including (i) no heat damage because of the lack of
shear stress and friction compared to lysis, (ii) minimal physical and chemical stress
compared to mechanical homogenization, (iii) reduction in temperature during sudden
release of the pressure (the adiabatic expansion), (iv) a better protection of the labile cell
compartments as nitrogen does not cause any oxidation of the compartments, (v) no change
in the pH of the solution, (vi) a fast and uniform process, and (vii) commercial availability
of instruments for variable sample sizes.

1.4.2 Isolation of ER and Plasma Membrane Specific Vesicles
Cell derived vesicles generated from whole cell lysate contain vesicles originated
from both the ER and the plasma membrane. These vesicles can be employed to study the
inserted proteins using single molecule techniques and can provide an overall picture of
the whole cell. However, the organelle specific information of the membrane proteins is
lost but the information can be obtained by isolating cell-derived vesicles originating from
the different organelles.
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To isolate the freshly synthesized receptors in the ER and the resident receptors in
the plasma membrane, we aim to fragment the membrane using nitrogen cavitation and to
isolate the vesicles based on their endogenous density difference. The ER of mammalian
cells contains low concentrations of cholesterol and sphingolipids which impart flexibility
to the ER membrane allowing it to form the flattened sacs-like structure of the membrane
(42). The plasma membrane of mammalian cells is composed of a higher percentage of
cholesterol and sphingolipids compared to that in the ER allowing for a compact assembly
of the lipids in the plasma membrane. Therefore, the density of the lipids becomes higher
in the plasma membrane than that in the ER and thus the plasma membrane is resistant to
external mechanical stress (42). However, the rough ER which houses the proteins under
investigation contains a plethora of ribosomes which makes the membrane of the rough ER
much denser than the plasma membrane housing transmembrane proteins for normal
cellular functions (43). Hence, a density gradient can be employed to isolate ER and plasma
membrane derived vesicles.

The most common method of isolating intracellular organelles or subcellular
vesicles is the application of sucrose gradient. This approach involves the placement of the
vesicle solution on top of the layers of sucrose of different densities and the centrifugation
of the sample to help the vesicle solution to penetrate into the sucrose gradient. The
separation process is dictated by Stoke’s law: V t=2R2a(ρp – ρf)/(9η), where Vt is the
terminal velocity of the particles falling throgh the gradient, R is the radius of the particle,
a is the applied acceleration force applied by the centrifugation, ρ p is the density of the
particles, ρf is the density of the fluid (sucrose gradient) and η is the viscosity of the medium
(44). When the terminal velocity of the vesicles is zero due to the resistance from the
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sucrose solution, the organelles do not penetrate further inside the solution. The terminal
velocity of the vesicles inside the solution depends on the density and size of the penetrant
(44). The particles with larger radius and higher density can penetrate deeper into the
gradient solution and settle into the higher density fraction.

However, one of the major disadvantages of using a sucrose gradient (45) is that it
cannot maintain isosmotic pressure in the different density gradients. The vesicles or
organelles being isolated suffer from hyperosmotic pressure lightly in the low density
regions and severely in the highest density fractions of the sucrose solution. Thus, the
vesicles continuously lose water to the medium during penetration through the sucrose
gradient solution. This process endangers the hydrated macromolecules of the vesicles.

Conversely, OptiPrep is an iodinated density gradient solution with 60% iodixanol
in water and can maintain isosmotic pressure up to the density of 1.32 g/ml corresponding
to the 60% (w/v) solution (45). This solution is nonreactive to the biological materials,
does not remove water from the vesicles allowing them to maintain their size, and has been
employed to isolate subcellular vesicles and organelles (46,47).

1.4.3 Step-wise Photobleaching of Single Fluorophores
A total internal reflection fluorescence microscope can help us to visualize single
fluorophores by exciting about 100-200 nm into the sample above the glass substrate and
by increasing the signal to noise ratio. However, under continuous excitation, fluorophores
ultimately undergo an irreversible transition into a dark state. This process is known as the
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photobleaching of the molecule. Photobleaching is usually considered undesirable and a
limitation of fluorescence microscopy.

The mechanism of photobleaching is primarily believed to be the result of a
chemical reaction of the fluorophore with the reactive molecules in the local environment.
Fluorescent molecules transition to an excited singlet state and these molecules normally
go back to the ground electronic state from the first excited electronic state releasing the
energy as photons. But sometimes an excited molecule transitions from the excited singlet
state to an excited triplet state. Molecules are highly energetic in the excited triplet state
and can react with the ground electronic state of molecular oxygen. This process not only
helps the fluorescent molecules to return from the temporary dark state (triplet state) to
ground electronic state but also generates highly reactive excited singlet oxygen molecules.
An excited singlet oxygen molecule can react with the exposed functional groups of
organic dye molecules (e.g. amines) and exposed amino acid side chains of fluorescent
proteins (e.g. cysteine, histidine, tryptophan, and tyrosine) (48,49). The reaction between
exposed groups of dye molecules and excited singlet oxygen molecules changes the
structure of dye molecules transferring them to a permanent dark state, called
photobleaching. The reaction between excited singlet oxygen and dye molecules depends
on (i) the excitation intensity, (ii) the concentration of molecular oxygen, (iii) temperature,
and (iv) the rigidity of the medium (50). Jouonang et. al. have shown that photobleaching
survival time probability distribution, by measuring thousands of molecules, follows a
monoexponential decay curve (50). Hence, photobleaching survival time (simply
photobleaching time) of dye molecules is a stochastic event. A number of approaches have
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been used to reduce photobleaching of molecules including enzymatic reactions to remove
the oxygen from the solution (51,52).

However, careful study of the photobleaching nature of single molecules has
provided an opportunity to understand the assembly of biological complexes (10,13,28).
When temperature, buffer and the nature of fluorescent molecules are constant, the
photobleaching time is a stochastic event and is dependent on the intensity of the excitation
source. At a low excitation intensity, the probability of photobleaching of two fluorophores
at a given time is minimal. Hence, a low excitation intensity allows different fluorophores
to bleach at different time points. As the total fluorescence intensity arises from all the
fluorescent molecules present, the fluorescence intensity is reduced by one step when a
fluorophore is photobleached. Therefore, the number of photobleaching steps indicates the
number of fluorescent molecules present. If a subunit of a multimeric protein is genetically
tagged with a fluorescent protein, counting the number of photobleaching steps in the
expressed protein can provide the number of fluorophores present in the protein. Hence,
the number of subunits presents in a multimeric protein can be determined as well.

1.4.4 Fluorescence Correlation Spectroscopy
Fluorescence correlation spectroscopy (FCS) is another single molecule
fluorescence intensity based technique and can be employed to analyze biomolecules in a
very low concentration (about 1 μM to 1 nM ) with high spatial and temporal resolution
(53). When a fluorescent molecule diffuses through a confocal laser beam, the fluorescence
intensity of the molecule spontaneously fluctuates (54-56). This property of fluorescence
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intensity fluctuation is utilized in FCS to determine the parameters responsible for the
fluctuation (53).

In this method, a fluorescent molecule is allowed to diffuse through a confocal
beam to produce fluorescence signal and the fluorescence intensity obtained from the focal
plane of the confocal beam is recorded over time. Then, an autocorrelation function of the
signal is determined. In principle, the autocorrelation function, G(τ), is a measurement of
the similarity of the signal with itself after a certain lag time (τ) and can be express as
follows:

𝐆(𝛕) =
=

<𝜹𝑭(𝒕)𝜹𝑭(𝒕+ 𝛕)>

Eq. 1.3
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Eq. 1.4

Where, F(t) = fluorescence intensity at time t
F(t + τ) = fluorescence intensity at time t + τ
δF (t) = F(t) - <F(t)>
δF (t + τ) = F(t + τ) - <F(t)>
The y-intercept of the normalized autocorrelation function, G(0), can provide
information of the average number of molecules (<N>) present in the focal volume. The
average number of molecules in the focal volume can be obtained with following equation:
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Eq. 1.5
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Figure 1.4 Typical autocorrelation curves obtained from fluorescence correlation
spectroscopy (FCS). (A) The y-intercept of an autocorrelation curve inversely
represents the number of molecules present in the focal volume. Thus, with the increase
in the concentration of molecules, the y-intercept decreases. (B) The half-value decay
time is a good approximation of diffusion time which is related with the size of the
molecule. Hence, as the size of the molecule increases, the diffusion time also increases.
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Where, <C> = average concentration
Veff= Effective focal volume

Hence, if the concentration of molecules increases, the y-intercept of the
autocorrelation function G(0) decreases (Figure 1.4A). The half-value decay time provides
a good estimate of the average diffusion time, and when the diffusion time increases due
to the increase in size of the molecule, the half value decay time also increases (Figure
1.4B). The diffusion time (𝜏𝐷 ) can be used to determine the diffusion coefficient (D) of the
fluorescent molecule using the following equation:

𝐃𝐢𝐟𝐟𝐮𝐬𝐢𝐨𝐧 𝐜𝐨𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭, 𝐃 =

𝑾𝟐𝒙𝒚

Eq. 1.6

𝟒𝛕𝑫

Where, Wxy is the radial radius of the confocal beam and 𝜏𝐷 is the diffusion time.
The diffusion coefficient can be employed to deduce the size of vesicles using Stokes–
Einstein equation. The Stokes–Einstein equation can be expressed as:

𝐑𝐚𝐝𝐢𝐮𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐚𝐫𝐭𝐢𝐜𝐥𝐞, 𝐫 =

𝒌𝑩 𝑻

Eq. 1.7

𝟔𝝅𝜼𝑫

Where, kB is the Boltzmann constant, T is the temperature in Kelvin, 𝜂 is the
viscosity of the solution, and D is the diffusion coefficient.

1.5 Nicotinic Acetylcholine Receptors
I have conducted single molecules studies with nicotinic acetylcholine receptors
(nAChRs) because of their physiological importance and their association with different
diseases and nicotine addiction. nAChRs are ligand gated ion channels belong to the Cys-
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loop super family of proteins. These proteins are expressed throughout the central and
peripheral nervous systems and can be activated by both acetylcholine, an endogenous
agonist, and nicotine, a compound found in tobacco (57). Nicotinic receptors can be
divided into muscle-type and neuronal-type. Muscle-type nAChRs are found in the
neuromuscular junction while neuronal-type nAChRs are expressed throughout the central
and peripheral nervous system. These receptors are very important to normal physiological
function but are also associated with different diseases.

1.5.1 Physiology and Pathology of Nicotinic Receptors
Nicotinic receptors are located both in the presynaptic and postsynaptic junction
(58). In postsynaptic regions, these receptors upon binding with the endogenous
neurotransmitter, acetylcholine, lead to the depolarization of the neuron which initiates
action potentials (59,60). In presynaptic regions, these receptors are believed to affect their
local environment and thus help to release neurotransmitters into the synaptic cleft (61)
This is done by the flow of sodium ions into the cells activating voltage gated calcium
channels which helps the neurotransmitter containing vesicles to fuse to the cell membrane
releasing the cargo into the synaptic cleft (62). Some researchers believe that a nicotinic
receptor’s ability to flux calcium ions into the cell is sufficient to elicit the release of the
neurotransmitter (63-65).

Nicotinic receptors located in the brain are believed to be involved in learning and
memory formation, neuronal development, consciousness and reward (59,66). Since these
receptors plays a very important physiological role, dysfunction in the channel opening and
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closing or their relative expression level in the brain can be involved with diseases. For
example, Parkinson’s disease (PD), and Alzheimer disease (AD are the most common
diseases which has been associated with low level of nicotinic receptors (67-72).
Postmortem brain analysis of AD and PD patients exhibited a significant decrease in the
quantity of nicotinic receptors in the frontal cortex, temporal cortex, hippocampus and
caudate nucleus (67).

A similar study with the brains of patients suffering from

Schizophrenia displayed a significant decrease in nicotinic receptors in the hippocampus
(73). These receptors are involved in nicotine dependency as well.

1.5.2 Structure of Nicotinic Receptors
In the brain, nine alpha subunits (α2-α10) and three beta subunits (β2-β4) of
nAChRs have been isolated. Some of the common structural properties of a nAChR subunit
include the following (Figure 1.5) (57,74,75):
i.

Four transmembrane domains (M1-M4) where M2 forms the line of the central pore
and M4 is located towards the outside of the receptor,

ii.

A long extracellular N-terminal domain providing glycosylation sites consisting of
ten beta stands (β1- β10) and two alpha helices (α1- α2).

iii.

A conserved disulfide bond formed between two cysteines of 13 amino acids apart
and by joining the beta stands β6 and β7

iv.

A large intracellular domain between transmembrane domains M3 and M4
presenting phosphorylation sites,

v.

A short C-terminal domain (4-28 amino acids residues),
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Five subunits of nAChRs arrange symmetrically to generate a central ion pore
which non-selectively transports cations (Figure 1.5B). Heteromeric nAChRs consist of
two or more different types of subunits; homomeric ones are composed of all the same
subunits (α7-α9). The two main nAChRs found in the brain are α4β2 and α7 where these
receptors are heteromeric and homomeric, respectively (Figure 1.5C and D). Each
heteromeric nAChR contains at least two agonist binding sites that are located on the Nterminal domain between an alpha and a non-alpha subunit (57,74). On the other hand,
homomeric nAChRs contain five agonist binding sites (76). In heteromeric nAChRs, alpha
subunits containing a cysteine doublet make the positive side, but the non-alpha subunits
make the negative side of the agonist binding pocket. In contrast, the agonist binding sites
in homomeric nAChRs are formed by two adjacent alpha subunits.

Until recently, structural features of nicotinic receptor have been studied based on
computational simulations of homologous proteins (77-80). However, a crystal structure
of (α4)2(β2)3 nicotinic receptor has been recently reported which details the ligand binding
pockets along with the structure of the receptor (75). Two agonist binding sites have been
located between alpha and beta subunits and a binding pocket is contributed by six loops
of amino acids residues, namely loops A, B, C, D, E and F. Although, each subunit contains
these six loops in its N-terminus, the positive side of the binding pockets is formed by the
loops A-C of the alpha subunit and the negative side is contributed by the loops D-F of the
beta subunit. Although loop F does not directly form the nicotine binding pocket, it might
stabilize loop C though a hydrogen bond of D170 of loop F to the backbone nitrogen of
C199 of loop C. The remaining loops (A-E) form a tight hydrophobic box to encapsulate a
nicotine molecule where the different walls are formed as follows:
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i.

back wall: W156 (of loop B) and L121 (of loop E)

ii.

front wall: C199, C200, Y197 and Y204 (loop C)

iii.

floor wall: Y100 (loop A) and L121 (loop D)

iv.

top wall: V111 and V119 (loop E)
Nicotine forms a cation- π interaction and a hydrogen bond inside the binding

pocket. The hydrogen bond is formed between the pyrrolidine nitrogen of nicotine and
backbone carbonyl oxygen of W156 of loop B, and the cation-π occurs between the same
pyrrolidine nitrogen and the indole ring of W156. The conserved aromatic amino acid
residues located in the beta-alpha and beta-beta interfaces undergo reorganization
prohibiting the binding of nicotine in those interfaces. Nicotinic receptors are mainly
cationic channels and flux Na+, K+, and Ca2+ ions. However, heteromeric receptors are less
permeable to calcium ions than homomeric ones (57).

1.5.3 Nicotinic Receptor Subtypes
In the brain, twelve nicotinic receptor subunits (nine alpha subunits (α2-α10) and
three beta subunits (β2-β4)) have been discovered (81,82). Since an alpha subunit, itself
and in combination with one or more beta subunits, can form fully functional receptors, a
vast variety of the assembled receptors is possible. In homomeric receptors, the principle
and complementary side of a ligand binding pocket is composed of two adjacent identical
subunits (83). In heteromeric receptors, the principle component can be made of α2 to α4
and α6 subunits, and the complementary component can be either a β2 or β4 subunit. The
α5 and β3 subunits do not participate in the formation of a binding pocket, and hence, these
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Figure 1.5 The structural features of nicotinic acetyl choline receptors (nAChRs).
(A) Each subunit contains four transmembrane domains (M1-M4), a long extracellular
N- terminal domain (~200 amino acids), a variable size intracellular domain between
transmembrane domains M3 and M4, and a small C-terminal domain (4-28 amino
acids). (B) A nAChR consists of five subunits which symmetrically arrange to generate
a central ion pore that can transfer cations (Na+, K+, and Ca2+). (C) An example of a
heteromeric nicotinic receptor is an α4β2 receptor which can have one of the two
different stoichiometric assembles: (α4)2(β2)3 or (α4)3(β2)2. (D) An example of
homomeric nicotinic receptors is α7 whose all five subunits are identical.
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subunits are called auxiliary subunits (84). The three most common subtypes of nicotinic
receptors found in the brain are α4β2, α3β4 and α7.

1.5.3.1 α4β2* Nicotinic Acetylcholine Receptor
α4β2* (* means one or multiple other nicotinic receptor subunits might present in
the structure) nicotinic receptor subtypes are the most abundant nicotinic receptors in the
brain and display the highest affinity to nicotine (85). These receptors contain two α4, two
β2 and an α4 or β2 subunit in the fifth position leading to the possibility of two
stoichiometries of the receptor. The stoichiometric isoform with three alpha and two beta
subunits has an EC50 (half maximal effective concentration) of about 100 μM for
acetylcholine and is termed as a low sensitivity isoform (75). The other possible isoform
exhibited an EC50 value of 1 μM for acetylcholine and is called a high sensitivity isoform
(86). It has been reported that the α4 subunit is associated with calcium permeability and a
higher proportion of α4 subunits in a stoichiometry leads to higher calcium permeability
(87). Hence, the low sensitivity isoform possessing three α4 subunits per receptor has
higher calcium ion permeability and higher single channel conductance. Over all, α4β2 has
lower calcium ion conductivity than α7 and α3β4 receptors (88). The α4β2 nicotinic
receptor is the most abundant nicotinic receptor in the brain, has a very high affinity for
nicotine and was reported to be upregulated with chronic treatment of nicotine (89,90). An
alpha subunit makes the positive side of an agonist binding pocket while a beta subunit
makes the negative side. No binding pocket was reported at the β2-α4 and β2-β2 interfaces.
This finding was attributed to the fact that the beta subunits reorganize in the possible
binding sites making impossible for ligands to bind (75).
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α4β2 nicotinic receptors are expressed in different parts of a brain including the
cortex, hippocampus, thalamus, hypothalamus, striatum, cerebellum, ventral tegmental
area, substantia nigra, medial habenula, amygdala and interpeduncular nucleus (IPN) (80).
These receptors have been associated with nicotine addiction which was validated
employing α4 and β2 knock-out rodent models (91,92). β2 knock-out mice have been
reported to self-administer cocaine solution but not nicotine solution when cocaine was
replaced with nicotine, which indicated β2 subunit containing receptors are necessary for
nicotine self-administration (91). Nicotine induces dopamine release in the brain (93), but
when α4 knock-out mice was treated with nicotine, striatal dopamine level was found to
be unchanged (92). This result indicated that α4 subunit containing receptors are necessary
for nicotine induced dopamine release. Together, these studies implied that α4 and β2
containing nicotinic receptors might be involved in the nicotine dependency (94).

1.5.3.2 α7* Nicotinic Acetylcholine Receptor
The α7* nicotinic receptor is the second most abundant nicotinic receptor in the
brain and is generally considered to be a homo-pentameric receptors with 5 identical alpha
subunits (95,96). This receptor has higher α-Bungarotoxin binding affinity compared to
other nicotinic receptors and has 5 ligand binding pockets located in the interfaces between
adjacent α7 subunits (97-99). The functional and structural properties of this receptor are
usually conducted in in vitro cellular models with an α7 DNA only (77,95,100,101). In the
brain, since other types of nicotinic receptor subunits are accessible, the structure of an α7
nicotinic receptor may contain one or more other types of nicotinic receptor subunits.
Recent studies have demonstrated the presence of β2 subunits with α7 subunits in the brains
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of rodent models (102,103). The ratio of these subunits in a functional receptor was
determined in vitro by forming concatemers of α7 subunits with β2 subunits (104). The
results demonstrated that an α7 receptor can have up to three β2 subunits in a functional
receptor and with the increase in the number of β2 subunits, the duration of channel
opening increases. These authors have hypothesized that with the increase in the number
of β2 subunits, the desensitization decreases which leaded to the increased channel opening
time (104). The α7 nicotinic receptor has been reported to possess fast activation, fast
desensitization and high calcium permeability (76,88,105). This receptor has been reported
to be expressed in cortex, hippocampus, hypothalamus, medial habenula, cerebellum,
interpeduncular nucleus, ventral tegmental area and amygdala (80).

1.5.3.3 α3β4* Nicotinic Acetylcholine Receptor
α3β4* nicotinic receptors are expressed in the central and peripheral nervous
system. In the central nervous system, most of the α3β4* nicotinic receptors are expressed
in the interpeduncular nucleus and medial habenula but a moderate to high expression was
reported in thalamus, cerebellum and substantia nigra (106). α3β4 nicotinic receptors are
hetero-pentameric receptors and can be assembled into two different stoichiometric
isoforms. One isoform can have two α3 subunits and three β4 subunits while other isoform
can have three α3 subunits and two β4 subunits. This receptor has displayed moderate
upregulation with 10 μM nicotine treatment and a 5-fold upregulation with 1 mM nicotine
treatment (107). It is relevant to mention that the physiological concentration of nicotine
was reported to be 25-444 nM (108) and no upregulation of this receptor was reported with
the presence of the physiological relevant concentrations of nicotine. Due to their possible
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contribution in nicotine dependency, in recent years, more attention has been devoted to
study the effect of nicotine into α3β4* nicotinic receptors (72,109-113). Studies with β4
knock-out animal displayed that this subunit is necessary for nicotine induced
hypolocomotion, antinociception and hypothermic response (114,115). The absence of β4
subunits in mice led to reduced nicotine withdrawal somatic signs which are measured in
mice with the presence of shaking of body or head, scratching, and grooming (106).

1.5.4 Upregulation of Nicotinic Receptors
Cellular function is regulated by a large number of factors including response to
external stimuli often through membrane receptor activity. One way cells control activity
is through the modulation of the numbers of membrane receptors on the cell surface. In the
presence of high concentrations of agonist, some membrane receptors are often down
regulated, and , in contrast, in the presence of antagonist, the target receptors are
upregulated (116,117). An opposite result has been reported when α4β2 nicotinic receptors
were chronically treated with a nicotinic receptor agonist such as nicotine (81,117).
Upregulation of receptors is defined as an increase in the total number of receptors in the
cell surface while down-regulation is the opposite of upregulation (81). An agonist binds
and activates a receptor while an antagonist blocks the effect induced by an agonist. Both
agonist and antagonist have been reported to upregulate nicotinic receptors in brains (118).
The following subsections describe the effect of nicotine and other nicotinic receptor
ligands in the upregulation of nicotinic receptors along with the possible mechanisms of
upregulation.
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1.5.4.1 Ligand-Induced Upregulation
Nicotine induced upregulation was discovered in 1988 by postmortem analysis of
the brains of smokers in comparison with that of non-smokers (119). The result indicated
a significant increase in the number of nicotinic receptors in the smoker’s brain compared
to the non-smoker’s brain. (119). This result indicated that the nicotine causes upregulation
of the receptors in the brain. When rodents were repeatedly treated with nicotine, the
binding of the radio labeled agonists of α4β2 nicotinic receptors, nicotine and
acetylcholine, were significantly increased indicating nicotine induced upregulation of the
receptors (120,121). Nicotine induced upregulation is not uniform over the different
regions of the brain. In rodent models, nicotine induced upregulation was reported in
several brain regions including the cortex, midbrain, hindbrain, hypothalamus, and
cerebellum (121) while some other regions displayed resistance to nicotine induced
upregulation including the striatum (121) and thalamus (122).

Nicotine induced

upregulation has been reported to be dose dependent. In clonal cell culture, as low as 100
nM nicotine has been reported to cause upregulation and 10 M nicotine caused a 15-fold
increase in the α4β2 nicotinic receptor level (123). Nicotine induced upregulation is a
transient event and the upregulated receptors usually relapse back to the basal level with
varying time frame depending on the model being studied . For example, mice took 7-10
days to reach the basal level of nicotinic receptors upon cessation of nicotine treatment
while rat and human have been reported to take 10-15 and 21-60 days to reach the basal
levels of nicotinic receptors (81).
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In addition to nicotine, some other nicotinic receptor ligands including (–)-Cytisine
(here after Cytisine), Varenicline and Bupropion have been reported to alter the expression
level of nicotinic receptors. Cytisine is a natural product extracted from the seed of the
plant Cytisus laborinum (124). Cytisine acts as a partial agonist for 42 nicotinic
receptors (125), and this ligand has been reported to upregulate as well as alter the
stoichiometry of 42 nicotinic receptors. This ligand has also been used as a smoking
cessation agent in Central and Eastern Europe for over 40 years (125). Varenicline is a
synthetic analog of Cytisine and was developed and marketed as a smoking cessation agent
by Pfizer (126). Varenicline is also a partial agonist for 42 and agonist for 7 nicotinic
receptors (127). This ligand has been reported to upregulate 42 nicotinic receptors (128).
Bupropion was originally approved by the FDA as an antidepressant agent but it has
recently been approved by the FDA as a smoking cessation agent (129,130). Bupropion is
an antagonist of 42 and 7 nicotinic receptor and displayed 12-times more efficacy for
blocking 42 than 7 (115).

1.5.4.2 Upregulation Mechanisms
Understanding the mechanism of ligand induced upregulation is currently an area
of active research, and a number of models have been proposed to explain the mechanism
of upregulation. One such mechanism involves desensitization of nicotinic receptors
(131,132). This model assumes that the desensitized state of a nicotinic receptor induced
by repeated exposure to nicotine somehow causes the upregulation of the receptors (118).
Recent reports have discounted this mechanism because nicotinic receptors have been
reported to be upregulated at a very low concentrations of nicotine which activate and
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desensitize an insignificant proportion of receptors. For example, 42 nicotinic receptors
have been reported to be upregulated by 100 nM nicotine (123). Under these conditions,
only 4 % of the high sensitivity isoform and 0 % of the low sensitivity isoform of 42 are
activated and desensitized (118). However, when amino acids located in the binding pocket
of nicotinic receptors were mutated to diminish ligand binding, nicotine induced
upregulation disappeared indicating that ligand binding is necessary for upregulation of
nicotinic receptors (133) regardless of the need for desensitization of the channel.

Another model describes the upregulation based on nicotine induced reduction in
the turnover rate of nicotinic receptors (134). This model assumes that nicotine interacts
with the cell surface nicotinic receptors to increase their stability, thus, reducing their
internalization and degradation. An initial study with physiological relevant nicotine
concentrations (500 nM) and cell surface receptor biotinylation reported a half-life for
nicotinic receptors on the plasma membrane of 62.8 and 12.6 hours with and without the
presence of nicotine, respectively (134). This study clearly validated this model of
upregulation. However, subsequent studies were not in agreement with this study (135137). Hence, further experimentation is necessary to deduce if reduced turnover rates are
associated with nicotine induced upregulation.

One of the prominent models of nicotine induced upregulation of nicotinic
receptors is known as “Inside-out Pharmacology” (118). According to this model, first,
nicotine crosses the plasma membrane to enter intracellular organelles (ER and Golgi)
(134,138). In these organelles, nicotine acts as a maturation enhancer or pharmaceutical
matchmaker by helping the dimers and trimers of nicotinic receptor subunits to assemble
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into pentamers (138). Second, the assembled receptor remains stabilized in the ER through
interaction with the nicotine. Nicotine also helps the nicotinic receptors to be packed into
COPII vesicles in the ER and thus assists the receptors to be transported to the Golgi (139).
Third, in the Golgi, some upregulated receptors exit to reach to the plasma membrane while
some other upregulated receptors are assumed to fail the quality control check and go back
to ER through COPI vesicles (140). This retrograded transportation from the Golgi to the
ER is necessary for upregulation. It is believed that nicotine stays bound with the nicotinic
receptors when located in the COPI or COPII vesicles to keep the receptors desensitized
(118). Thus, nicotine increases the density of stable nicotinic receptors in the secretory
pathway leading to an increase in the delivery of COPII vesicles loaded with receptors from
the ER to the plasma membrane (141). Finally, nicotine might stabilize the receptors
present on the plasma membrane reducing the turnover rate of the receptor and increasing
the total number of receptors on the plasma membrane (142).

Regardless of the mechanism of ligand induced upregulation, nicotine can increase
the total number of receptors in the plasma membrane, can alter the assembly of the 42
nicotinic receptors, can increase the rate of delivery of receptors through COPII vesicles to
the plasma membrane. Therefore, it is necessary to understand the mechanism of nicotinic
induced upregulation and the change in stoichiometric assembly to understand nicotine
dependency.
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1.6 Drug Delivery Vehicles
1.6.1 Concept of Drug Delivery Vehicles
When therapeutics are administered to a human body, those compounds typically
reach to all parts of the body and interact with both the diseased and healthy tissue causing
undesirable side effects. Researchers are trying to develop drug delivery vehicles which
can remedy these issues associated with the side effects. An ideal drug delivery vehicle
should be loadable with virtually any kind of drug molecule, should be able to avoid
confiscation by the body’s immune system, should reach the targeted site selectively,
should stay and continuously deliver drugs in the targeted site for a prolonged period of
time, and should be biocompatible and biodegradable. A number of approaches has been
used to develop ideal drug delivery vehicles including lipid-based systems (liposomes,
exosomes and cell-derived vesicles), polymer-based systems (pegylation, Chitosan,
PLGA), nanoparticles formation, and absorption in carbon nanotubes or mesoporous silica
(143-150). A brief description of the most common approaches is as follows:

1.6.2 Liposomes
Liposomes are defined as spherical nanovesicles consisting of at least one lipid
bilayer encapsulating an aqueous medium in the center (Figure 1.6) (151,152). The bilayer
can be made of either natural lipids or synthetic amphiphiles in conjugation with
cholesterol which provide stability and membrane permeability (152-154). These vesicles
are the most widely studied nano carrier for delivering therapeutics to a targeted location

38

Figure 1.6 Loading of hydrophilic and lipophilic drug molecules into liposomes.
Liposomes are spherical vesicles consisting of at least one lipid bilayer with an aqueous
center. Hydrophilic drug molecules can be loaded into the aqueous layer and lipophilic
drug molecules can be incorporated into the lipid bilayer.
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Figure 1.7 The thin film dehydration method of the preparation of liposomes. At
first, lipids are dissolved in an organic solvent and the solvent is evaporated using rotary
evaporation producing a thin film of lipids on the surface of the container. A buffer is
added to the flask under vigorous shaking to rehydrate the lipid film generating large
mulilamellar vesicles (LMVs). Extrusion or sonication is applied to reduce the size of
the vesicles and these new vesicles are termed as small unilameller vesicles (SUVs).
Both LMVs and SUVs are called liposomes.
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and can encapsulate both lipophilic and hydrophilic therapeutic molecules making them
ideal vehicles for a wide variety of molecules (151). The hydrophobic molecules are
solubilized in the lipids of the bilayer while hydrophilic molecules are encapsulated in the
aqueous phase located in the center of the liposomes (155,156). These vesicles can enhance
the therapeutic indices of different drug molecules by altering their pharmacokinetic and
pharmacodynamics properties (157). Liposomes can protect the encapsulated molecules
from fast degradation, inactivation, and dilution during circulating in the body fluid (158).
These vesicles can be produced with varying charge, size and lipid content. The charge of
the vesicles is an important determinant of the function of the liposomes. For example,
negatively charged liposomes repulse each other prohibiting them from aggregating while
positively charged liposomes attract negatively charged lipids of the cell membrane
providing better internalization (159,160). The most common method of liposome
preparation is the Bangham method (Figure 1.7) (161). In this methods, the lipids with or
without drug molecules are dissolved into an organic solvent and the resultant mixture is
dried on the surface of a round-bottom flask by evaporating the solvent using a rotary
evaporator. This process leaves a film on the surface of the flask and this film is rehydrated
with vigorous shaking. The shaking process is considered as a critical determinant of the
size of the liposomes; mild shaking generates larger vesicles while vigorous shaking
produces smaller vesicles of non-uniform size (162,163). Sonication in a water bath and
extrusion through polycarbonate membranes are the most common methods applied to
reduce the size of liposomes. The size of these vesicles depends on the size of the
membrane pore and the number of extrusion cycles through the membrane (164,165).
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Figure 1.8 Mechanism of exosome formation in a cell. An endosome is formed by
inward budding of the cell membrane. The early endosome is matured and intraluminal
vesicles are generated by budding in the membrane of the endosome. Matured
endosomes containing intraluminal vesicles are called multivesicular bodies which are
either degraded by fusing with lysosomes or excretes exosomes by fusing with the
plasma membrane. The other extracellular vesicles are produced by budding out from
the plasma membrane.
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Based on the choice of phospholipids, liposomes can be cationic, anionic or neutral and the
drugs can be loaded into the liposome during or after the preparation of the vesicles.

1.6.3 Exosomes and Other Extracellular Vesicles
Exosomes are spherical vesicles that are excreted by a cell to the extracellular
region and which encapsulate cytosol in their centers (1). These vesicles are considered to
be a second means of communication between cells located at a distance while the first
means of communication is the secretion of hormones. Exosomes deliver DNA, RNA,
proteins and/or lipids from the donor to the acceptor cells. These vesicles are nano scale in
size (30-100 nm) and are produced with the following mechanism (Figure 1.8) (1,166-168).
At first, an endocytic vesicle is generated from the plasma membrane of the cell and the
endocytic vesicles are matured which then produce inward budding to make small vesicles
inside the lumen. The matured endosomes containing intraluminal vesicles are called
multivesicular bodies (MVBs). The MVBs either fuse with the lysosomes for degradation
or fuse into the plasma membrane of the cell releasing all the intraluminal vesicles into the
extracellular environment (169,170). The intraluminal vesicles released outside of the body
are termed as exosomes. Exosomes differ from the other types of extracellular vesicle –
microvesicles, microparticles, ectosomes, oncosomes– according to the origin and size of
the vesicles. While exosomes are produced through the generation of multivesicular bodies
and have size of 30-100 nm in diameter, the other extracellular vesicles are generated by
budding out from the cell membrane and are usually larger in size than exosomes (1) Since
exosomes and other extracellular vesicles are naturally present in the body, they are being
studied to employ as a drug delivery vehicle (171). The characteristic size and content of
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exosomes are being extensively studied to utilize them for drug delivery or diagnosis
purposes (3,172-174). These exosomes possess the potential of being loaded with drug
molecules to selectively deliver them to a targeted location. However, the production of
exosomes is a very slow and time consuming, and thus an expensive process.

1.6.4 Polymeric Nanoparticles
Drug molecules can be incorporated into polymers to produce nanoparticles. One
such approach is the conjugation of therapeutics into linear or branched polyethylene
glycol (PEG) polymers. The process of conjugating PEG into a molecule of interest is
called pegylation; this process increases the size of the molecules and thus reduces the renal
clearance as the kidney eliminates molecules by filtering according to their size. This
formulation has been reported to possess low immunogenicity, toxicity and antigenicity
(175,176).

PEG

polymers

have

displayed

improved

pharmacokinetics

and

pharmacodynamics of drugs (175-177). This polymer is removed from the body though
renal excretion when the molecular weight of PEG is less than 30 kDa and via fecal when
the size of the PEG is greater than 20 kDa.

Another approach of polymeric nanoparticle formation involves conjugation of
therapeutics with a poly lactic-co-glycolic acid (PLGA) consisting of repeating units of
lactic acid and glycolic acid. Hydrolysis of PLGA generates the monomers- lactic acid and
glycolic acid- which being endogenous in the body easily become digested exhibiting
minimal toxicity. The FDA has approved PLGA as a drug carrier because of its
biocompatibility and biodegradability. The rate of PLGA elimination from the body
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depends on both the molecular weight of the polymer and ratio of the two monomers (178).
The most common methods to form PLGA nanoparticles loaded with drug molecules are
single or double emulsion solvent evaporation techniques (179,180). In single emulsion
techniques, PLGA is dissolved in an organic solvent and drug molecules are dissolved in
the PLGA solution if the drug is hydrophobic. This organic solution (suspended phase) is
added into water (continuous phase, higher in volume than the suspended phase) and
sonication or another homogenization method is applied to make droplets of the organic
phase (called oil phase, o) in water (w) in the presence of an emulsifier (a surface acting
agent containing hydrophilic head and hydrophobic tail group). The emulsifier helps to
stabilize the droplet in the water. The solvent of the emulsion is allowed to evaporate,
leaving behind the oil-in-water (o/w) emulsion. Similarly, hydrophilic drug molecules can
be encapsulated into a water-in-oil (w/o) emulsion by dissolving the drug into the water
phase and making the water a suspended phase and the organic solvent a continuous phase.
In double emulsion techniques, the emulsion generated in single emulsification techniques
is emulsified into another solvent, water or oil, based on the outer layer of the previous
emulsification. For example, water-in-oil can be emulsified into water or organic solvent
to produce water-in-oil-water or water-in-oil-in-oil emulsions respectively. Water-in-oilin-water (181,182) and solid-in-oil-in-oil (183-185) double emulsion techniques have been
reported to encapsulate therapeutic peptides into nano- or micro-particles for targeted
delivery or extended release of the cargo.

The most frequently employed polymer to encapsulate therapeutic peptides or to
coat other types of drug delivery vehicles is chitosan obtained from a naturally occurring
polysaccharide, chitin, by deacetylation. This polymer is biodegradable, biocompatible and
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nontoxic making them suitable as drug delivery vehicles (186-189). Chitosan nanoparticles
are insoluble in aqueous solution of neutral pH but soluble in acidic solutions of pH less
than 5. At low pH, a chitosan polymer become positively changed due to the protonation
of an amino group, and this protonated chitosan can bind with the mucosa of the epithelial
cells of lungs allowing extended release of the incorporated drug molecules (190-192).
Therapeutics are usually loaded into chitosan particles during preparation of the particles.
There are a number of methods available to prepare chitosan nanoparticles loaded with
drug molecules including ionic cross-linking, covalent cross-linking, precipitation,
polymerization, self-assembly, and spray drying (189).

The entrapped therapeutics

become available in the body when the particles become depolymerized in the presence of
lysozyme. This characteristic degradation of the particles depends on the molecular weight,
degree of deacetylation, hydrolysis time and availability of amino groups of the chitosan
(193). A higher degree of deacetylation leads to faster degradation (194).

However, conjugation of therapeutics with polymer has been reported to elicit
immune response which leads to a rapid clearance of the pharmaceuticals (195).
Additionally, this approach can cause therapeutics to bind with serum proteins and to
reduce uptake by the target tissue.

1.6.5 Absorption in Nanoparticles
Mesoporous silica nanoparticles can also be used as a drug delivery system. These
particles contain honeycomb-like pores providing high surface area and pore area. Drug
molecules are absorbed inside the pores of the mesoporous particles. A number of
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modifications have been introduced to alter their surface properties including coating with
positively charged amines (196), cell permeable chitosan polymers (181), and pH sensitive
polymers (197,198) to load and deliver therapeutics.

1.6.6 Advantages and Applicability of Cell-Derived Vesicles
Some researchers used the term cell-derived vesicles as a synonym for extracellular
vesicles (199-201). For our discussion in this work, I define cell-derived vesicles as
spherical vesicles generated form the ER and plasma membrane through homogenization
or extrusion of cells. Since the human body has a natural tolerance for exosomes which are
present in the body and used by cells to communicate with non-adjacent cells, some
researchers are utilizing cell derived vesicles, which are structurally similar to exosomes,
to deliver therapeutics into targeted locations (39,40). These studies produce cancer cellderived vesicles by extrusion or spinning cups which were labeled with lipophilic dye
molecules. These dye labeled vesicles were then injected into the tail vein of a mouse model
containing a tumor, and the injected vesicles reached the tumor. This approach validates
the concept that cell derived vesicles can be employed to deliver chemotherapeutics
selectively to a tumor. However, the traditional extrusion or spin cup approach cannot
simultaneously prepare and load vesicles with drug molecules. Thus, a secondary
approach, (for example, remote loading) is necessary to accomplish the loading (202). We
prepare cell-derived vesicles with nitrogen cavitation where the cells are fragmented and
the cell fragments spontaneously reorganize to produce vesicles encapsulating the cell
suspension solution. Therefore, by maintaining the drug molecules in the suspension
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solution, we can simultaneously generate and load vesicles which is more efficient, faster
and cheaper process.
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Cell Derived Vesicles for Single Molecule Imaging of Membrane Proteins
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2.1 Introduction
Complex protein structures, such as membrane receptors, regulate many aspects of
cellular function including the initiation of signal transduction pathways (203,204).
Transient interactions between proteins often complicate efforts to fully understand the
function of specific biomolecules (205). The primary challenge is that a single species can
exist in multiple conformational or functional states. Single molecule approaches are often
employed to resolve these dynamics as they avoid ensemble averaging across multiple
states (206), but the physiological concentration of receptors is often too high for single
molecule measurements. Additionally, isolating individual proteins poses a challenge for
receptors as they tend to aggregate on the cell surface. A common approach to overcome
this concentration barrier (207,208) is to isolate biomolecules by purification from the cell
(28,209). This approach only works for proteins that can either be solubilized or stabilized
in a detergent solution. As a result, a variety of approaches have been employed to isolate
receptors or to apply single molecule techniques in cells (10,207,208,210). For example,
sub-micron liposomal vesicles composed of artificial bilayers have been utilized as
nanocontainers for the isolation of proteins (18). This approach requires receptors to be
temporarily supported in a detergent solution. This induces a major disadvantage in the
receptors which are completely removed from their physiological environment.

Here we introduce a single molecule approach that isolates receptors in vesicles
generated from cell membranes. Microsomes and other cell derived vesicles are widely
used for biochemical applications to study membrane receptors and other proteins
(211,212). We utilize a similar strategy by generating vesicles from cells expressing a
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Figure 2.1 A simplified representation of the different domains of a nicotinic receptor
subunit. A fluorescent protein (e.g. GFP, mCherry, etc.) has been incorporated into the
intracellular region between transmembrane domain 3 (M3) and 4 (M4). A super ecliptic
pHluorin (SEP) was incorporated at the C-terminus of the nicotinic receptor subunit.
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protein of interest in order to perform single molecule imaging. This approach leaves
membrane proteins inserted in the same physiological membrane in which they resided
within the cell. The use of these vesicles eliminates the need to support proteins in a
detergent environment or to encapsulate them in vesicles composed of artificial
membranes. We demonstrate the versatility of this method using several classes of
membrane receptors, and expand this technique to determine the stoichiometry of α3β4
nicotinic receptors.

2.2 Experimental Procedures
2.2.1 DNA Construct Preparations
In the nicotinic receptor subunits, fluorescent proteins were incorporated in the
intracellular region between 3rd and 4th transmembrane domains (Figure 2.1). Epitope tags
(Flag, HA, etc.) were added in the C-terminus of the amino acid sequence. EGFP (hereafter,
GFP) was added to the C-terminus of CFTR and EGFR proteins separately

2.2.2 Cell Culture
The human embryonic kidney 293T (HEK293T) cell line was obtained from Prof.
Louis B Hersh, Department of Biochemistry, University of Kentucky and was maintained
in a matrigel (Invitrogen) coated T75 flask with Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 1 % penicillin streptomycin (Invitrogen) and 10 % fetal
bovine serum (Invitrogen). Approximately 3 million HEK293T cells were plated in a
matrigel coated T75 flask 24 hours before transfection. Cells were transfected at 60-70 %
confluency with lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol
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with slight modification. 14 µl lipofectamine 2000 was added to transfect a flask of cells.
In order to lower the expression level of proteins, to facilitate single receptor isolation, we
have lowered the amount of DNA plasmid of all alpha, beta and CFTR to 3.5 µg. During
co-transfection of two different types of DNA plasmids, 3.5 µg of each DNA plasmid was
used, except Seq61-mCherry and plasma membrane-mCherry (PM-mCherry). The plasma
membrane and ER markers (i.e. PM-mCherry and Seq61-mCherry) were cotransfected
with 500 ng of each plasmid. EGFR-GFP was expressed with 2 µg DNA plasmid per flask.
Transfected cells were allowed to grow by incubating at 37 °C with 5 % CO2 flow for 2224 hours. Then, these cells were used to prepare vesicles.

2.2.3 Vesicle Preparation
At first, cells were visualized under a microscope to ensure that they were alive and
healthy, and the desired fluorescent protein conjugated receptors had been expressed. Then,
the transfection media was removed from the flask, and 5 ml Versene (Invitrogen) was
added and incubated at 37 °C for 5 minutes. Versene is an EDTA based chelating agent
which is used to dissociate cells from flasks. Afterward, the cell slurry was collected in a
15 ml tube and centrifuged at 400 ×g for 5 minutes. The obtained pellet was resuspended
in 5ml Sucrose-Protease inhibitor buffer (10mM HEPES pH 7.5, 250mM Sucrose, protease
inhibitor cocktail tablet (1 tablet per 10 ml buffer)) and placed into a precooled nitrogen
cavitation chamber (Figure 2.2) (Parr Instruments Company, IL, USA). Nitrogen gas was
flowed to the chamber for 250 psi, and the pressure was kept constant for 5 minutes. Then,
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Figure 2.2 A nitrogen cavitation chamber employed to generate vesicles from
mammalian cells. Cells were placed inside the chamber, the lid was closed and
nitrogen gas was flowed into the chamber. The valve was opened to release the gas
and to collect the cell lysate which contains spherical vesicles. This vesicles solution
was purified with differential centrifugation.

54

the pressure was suddenly released, and the resulting cell lysate was collected in a 15 ml
tube that was subjected to centrifugation at 4000×g, at 4 °C for 20 minutes. The pellet was
discarded, and the supernatant was centrifuged at 10,000 rpm (9,800 × g), at 4 °C for 20
minutes. Once again, the pellet was discarded; the supernatant was centrifuged at 30,000
rpm (100,000 × g), at 4 °C for 1 or 2 hour(s). The pellet was rinsed with 400 µl of sucrose
buffer (10 mM HEPES, 250 mM Sucrose pH 7.5) and resuspended in 400 to 800 µl of the
same buffer. The solution containing vesicles was aliquoted and stored at -80 °C.

2.2.4 Glass Bottom Dishes Cleaning
Glass bottom dishes (GBDs) were placed into 200 ml freshly prepared 5 M NaOH
solution. This was incubated at room temperature for 1 hour or sonicated at 45 °C for 30
minutes. Then, NaOH was removed by washing with very high-velocity-flowing tap water
for 30 seconds. About 1 ml ethanol (denatured) was placed into the dish, and was allowed
to sit for 30 seconds and rinsed with tap water in the same way. This ethanol incubation
and water-rinsing cycle was carried out for a total of three times. Then, GBDs were rinsed
with DI water, and ethanol was sprayed on the top and bottom of coverslips of GBDs.
Afterward, GBDs were dried with compressed air and subjected to the oxygen plasma clean
for 5 minutes at the maximum level. The presence of background fluorescence in the GBD
was checked under a microscope; if no background was detected, then the GBD was
utilized to develop the immobilization system on it.
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Figure 2.3 A schematic representation of different layers on top of a glass substrate to
immobilize receptor inserted in vesicles. On the top of a glass substrate, first, a SilanePEG-Biotin layer was placed, then NeutrAvidin, followed by biotinylated antibody and
finally vesicles were immobilized.
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2.2.5 Preparation of Immobilization System
Approximately 200 µl of 1 mg/ml of Biotin-PEG- Silane (MW 3500, Lysane Bio,
Inc.) in a solution of 95% ethanol and 5 % water was added on top of the coverslip of a
clean GBD. Then, it was incubated at room temperature for 30 minutes (Figure 2.3).
Afterward, the unreacted reagent was removed by rinsing with denatured ethanol and DI
water separately. Followed by, 200 µl of 0.10 mg/ml NeutrAvidin (Thermo Scientific)
solution in PBS buffer was added on top of the GBD; it was incubated for 5 minutes at
room temperature before rinsing (three times) with PBS buffer. Next, ~200 µl appropriate
biotinylated antibody (1 µg/ml) was added on top of the GBD and incubated at room
temperature for 15 minutes. The unbound antibody was removed by rinsing (three times)
with PBS buffer, and about 1 ml PBS buffer was added into the GBD to keep the antibody
in the solution. The antibody coated GBDs were examined under a microscope to verify
no background fluorescence was present. GBDs with non-significant background
fluorescent spots were used to immobilize vesicles.
2.2.6 Vesicle Immobilization
The freshly prepared Silane-PEG-Biotin-NeutrAvidin-biotinylated antibody coated
glass bottom dishes (GBDs) (hereafter, termed as antibody coated GBDs) were employed
to immobilize vesicles. About 100 times diluted vesicles were placed on top of the
appropriate antibody coated GBD; it was incubated for 30 minutes at room temperature
(Figure 2.3). Then, unbound vesicles were removed by rinsing (three times) with PBS
buffer. These immobilized vesicles were imaged under ~1 ml PBS buffer.
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2.2.7 Single Molecule TIRF Microscopy
488 nm and 561 nm laser lines were used to excite green fluorescent proteins
(GFPs) and mCherry proteins respectively. The laser beam was directed through an oilimmersion type 1.49 NA Olympus ApoN 60X or 100X objective (Olympus America,
Center Valley, PA, USA) mounted on an Olympus IX 81- inverted microscope (Olympus
America) through corresponding excitation filter and dichroic. Intensities of the 488nm and
561nm lasers were adjusted to be ~20 W/cm 2 and ~40 W/cm 2 respectively. Low autofluorescence emitting immersion oil (Thorlabs, Inc.) was placed on top of the objective. A
sample immobilized on a glass bottom dish was placed on top of the oil. An auto focus
module (Model: IX2-ZDC2, Olympus America) was used in order to limit focal drift, and
a stage control module (Olympus America,) was employed to remember the position of the
field of view. The objective used is capable of TIRF microscopy; TIRF was achieved by
translating the beam laterally across the objective lens. This was done by adjusting the
angle of the excitation beam using a stepper motor. The emitted fluorescence was collected
through the objective and dichroic, and directed to an electron multiplying CCD (Andor)
camera through an appropriate emission filter. For each of the samples, 10 to 15 movies
with 500 to 1000 frames (200 ms per frame) were taken. For dual color experiments of α3mCherry β4-GFP, at first, movies were taken with the 561 nm laser and then with the 488
nm laser on the same field of view using the stage control module.

2.2.8 Photobleaching Step Analysis
The tiff files of single frames or multiple frames (also termed as movies) were
analyzed with an open source software, ImageJ (NIH, USA). The background of an image
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was subtracted using rolling ball background subtraction with 20 pixels radius. Circular
region of interests (ROIs) with 4 pixels radius were selected manually, and Time Trace
Analysis V2.0 (or V3.0) plugin was used to generate time traces. During the dual color
experiments with GFP and mCherry conjugated proteins, ROIs were first selected on the
movies corresponding to the mCherry channel, and then, translated to the movies
corresponding to the GFP channels. A Matlab (Mathwork) script was written to
automatically plot graphs corresponding to individual punctate on the movie, and the
number of photobleaching steps were then determined manually (13,29). Time traces
showing clear photobleaching steps were counted and those showing indistinct bleaching
steps or exponential decay were discarded. Heteromeric nicotinic acetylcholine receptors
form a pentameric structure composed of either 2 or 3 of each subunit. Identification of
more than 3 bleaching steps was used as an indication of multiple receptors within a single
vesicle or within the diffraction limit. For dual color experiments (of α3-mCherry β4-GFP),
stoichiometry was assigned only to vesicles that showed a total of 5 bleaching steps (2mCherry & 3-GFP) or (3-mCherry & 2-GFP).

2.2.9 Study the Ligand-Receptor Interaction via FCS
Epidermal growth factor receptor conjugated with GFP (EGFR-GFP) containing
vesicles were generated by expressing HEK293T cells. Vesicles were diluted 20 times in
the sucrose buffer from original preparation prior to the experiment (see section 2.2.3). .
About100 µl of the sample was placed on the top of water immersion objective
(LUMPlanFL N, 60X, Olympus), and the confocal laser beam was focused 50 microns into
the sample solution. The laser power was held constant at 10 microwatts. The emitted light
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was directed through the appropriate filter to a 50 µm fiber acting as a pin hole. The light
was then directed to an APD (Avalanche Photodiode) τ-SPAD single photon counting
module (PicoQuant GmBh, Berlin, Germany). A PicoHarp-300 time correlated single
photon counting module was used to record the photon arrival time. Fluorescence
correlation was determined using Symphotime 64 Software (PicoQuant GmBh). FCS data
were recorded with (i) vesicles only, (ii) 0.3 nM epidermal growth factor conjugated with
tetramethylrhodamine (EGF-TMR) (Life technology) only, and (iii) EGFR-GFP
containing vesicles mixed with 0.3 nM EGF-TMR. 488 nm and 561 nm laser sources were
employed to determine the diffusion times with GFP and TMR respectively.

2.2.10 Ligand-Receptor Interaction on the Surface
HEK293T cells were cotransfected with EGFR- GFP and CFTR-HA plasmids and
vesicles were generated from them. 100 μl vesicles from our preparation was mixed with
EGF-TMR (EGF conjugated with tetramethylrhodamine) so that the final concentration of
the EGF was 1 μM. This mixture was subjected to dialysis to remove unbound EGF-TMR
with a Slide-A-Layer MINI Dialysis Devices, 10K molecular weight cut-off (Thermo
Scientific) for 4 hours at room temperature under stirring in 200 ml PBS buffer and buffer
was changed in every 30 minutes. The purified mixture was diluted 100 times and added
to a Biotin-NeutrAvidin- Anti HA antibody coated coverslip. A 488 nm laser in TIRF with
the corresponding excitation and emission filters was used to visualize vesicles (by locating
GFP) and a 561 nm laser with corresponding setup was used to locate the positions of
TMR. Overlap of the images of the two channels indicates the binding of ligand (i.e. EFG)
with the receptor (EGFR).
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2.2.11 Determination of the Percentage of Vesicles Inserted with Receptors
Since the expression of receptors was kept very low to facilitate single receptors
per vesicles, some of the vesicles might not contain a receptor. Determining proportion of
vesicles containing receptors in them can be used to determine probability of isolating
single receptor per vesicle. To do so, we have expressed HEK293T cells with (i) plasma
membrane marker –plasma membrane mCherry (PM-mCherry), (ii) ER marker– Seq61
mCherry, and (ii) α3-GFP, β4-wt nicotinic receptor. Membrane markers were employed to
locate vesicles, and receptors were incorporated to detect the positions of the receptors in
vesicles. We have generated vesicles from the HEK293T cells, and then those vesicles
were immobilized on an anti-mCherry antibody coated coverslip. Images were taken
exciting mCherry (561 nm) and GFP (488 nm) separately on the same field of view. The
number of particles were determined in both images to find the number of vesicles and
receptors present in them.

2.2.12 Determination of the Size of Vesicles
To determine the size, α3-GFP β4-GFP containing vesicles were generated. An ISS
Alba confocal fluctuation system coupled with a Nikon Ti-U inverse microscope with a
water objective (60x, 1.2 NA) was used to find the size of the vesicle through FCS. A 488
nm laser was employed to illuminate the sample. The emitted light was directed to two
photomultiplier tube (PMT) detectors through a 514 long pass filter. The focal volume of
the objective was calibrated with a solution of a known concentration of Rhodamine 110
(Diffusion coefficient = 440 μm2 s-1). The laser was focused at 100 µm into the solution.
FCS data were recorded for 1 minute and 10 measurements were performed to determine
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the mean and standard deviation of the measurements. FCS data was analyzed with
VistaVision 4.0.120 (ISS Alba). The Stokes-Einstein equation was employed to determine
the diameter of vesicles assuming the viscosity of the aqueous sample was the same as that
of water.

2.2.13 Determination of the Functional Assembly of Receptors in Vesicles
Functional assembly of receptors was examined though characteristic calcium flux
of α7 nicotinic receptor. The protocol to prepare vesicles in order to carry out calcium flux
experiment was adapted from Smith et. al. (213) with required modification. Briefly,
vesicles were generated by expressing α7-GFP and β2-Flag into HEK293T cells. 200 µl
vesicles was mixed with Fluo-8 AM (Assay Biotechnology Company, Inc., CA, USA) with
a final concentration of 10 pM and then incubated at 35 °C for 30 minutes to facilitate the
loading of Fluo-8 AM dyes inside the vesicles. Then, buffer-A (5 mM HEPES pH 7.4, 144
mM NaCl, 5 mM KCl, 1.2 mM MgSO4 and 5 mM glucose) was employed to dilute the
vesicles to 10 ml. Free Fluo-8 AM dye molecules were removed by centrifuging the diluted
vesicles (22,000 × g for 1 hour). The pellet was rinsed with 1ml buffer-A and resuspended
to 400 µl Buffer-A. 200 µl of this solution was added on top of an anti-Flag antibody coated
glass bottom dish to immobilize the vesicles. An image was taken exciting GFP (488nm).
Since activated Fluo-8 and GFPs have the same excitation and emission spectra, a
continuous excitation was made, before activating Fluo-8, to bleach all GFPs. Then, 1ml
solution containing 2mM CaCl2 and 200 µM Acetylcholine (ACh) chloride (SigmaAldrich) was added on top of the immobilized vesicles maintaining the same field of view.
An image was taken when exciting Fluo-8 at 488nm.
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2.2.14 Statistical Analysis of the bleaching steps
The probability of observing photobleaching steps from the time traces were
calculated fitting the data based on a binomial distribution(214). The probability of
observing a specific number of photobleaching steps, for a receptor with fixed number of
subunits is calculated using:

𝐧!

𝐅(𝐤, 𝐧, 𝐩) = 𝐤!(𝐧−𝐤)! 𝐩𝐤 (𝟏 − 𝐩)𝐧−𝐤

Eq. 2.1

Where, n is the total number of subunits, k is the number of observed units, p is the
probability of GFP being in an observable state, and F is the probability of observing k
number of photobleaching steps from n number of subunits. The reported fraction of GFP
that is in a visible state varies widely (0.64 to 0.9) across publications (215-217). Recent
publications have shown that at least 90% of GFP matures fully and remains in a
fluorescent state corresponding to p = 0.9 (216). nAChRs can potentially form multiple
stoichiometries. Thus, α3β4 can form a pentamer with either two or three α3 subunits. This
leads to a combination of (α3)2(β4)3 and (α3)3(β4)2 stoichiometries. Modeling the
probability of observing a specific number (m) of photobleaching steps for the mixed
stoichiometry case requires a combination of two binomial distributions for k=1, 2, and 3
for both F1 and F2. F1 corresponds to the case when n1 GFP labeled subunits are in a
receptor and F2 when there are n2.

Ftot= a1 · F1 + a2 · F2

Eq. 2.2
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Stoichiometry can exist in equal distributions or be biased toward one
stoichiometry. The fraction of the stoichiometry, ai, is used to weight the distribution based
on a mixed stoichiometry (ni). For example, the probability of observing 2 bleaching steps
(i.e. k=2) of α3 subunits from (α3)2 (β4)3 (i.e. n = 2) and (α3)3 (β4)2 (i.e. n = 3) can be
calculated with:

F= a1 · F (2, 2, p) + a2 · F (2, 3, p)

Eq. 2.3

A custom Matlab script was used to fit our data to a binomial distribution with
mixed stoichiometry using p=0.90. The data fit well with a distribution of 75 % (α3)2 (β4)3
and 25 % (α3)3 (β4)2 subunits. The error bars for subunit distribution are based on counting
events and are calculated as the square root of the counts (218).

2.3 Results and Discussion
2.3.1 Vesicle Characterization
Cell-derived vesicles can be utilized to isolate single receptors to conduct single
molecule experiments using total internal reflection fluorescence (TIRF) microscopy and
fluorescence correlation spectroscopy (FCS). It is necessary to characterize cell-derived
vesicles before using them for single molecule studies. Hence, we characterized the size of
the vesicles, specificity of the immobilization of the vesicles, the probability of having
single receptors on the vesicles, and the applicability of the vesicles to study protein
oligomerization.
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First, to determine size, we made vesicles from HEK293T cells transfected with
α3-GFP β4-GFP nicotinic receptors. Both subunits were labeled with GFP to maximize the
fluorescence signal. Then, these vesicles were used to determine the diffusion times in
solution by means of FCS. The mean diffusion time was employed to determine the
diffusion coefficient and radius through the Stokes– Einstein equation. Ten measurements
were made to get an average and standard deviation of the vesicle size. The diameter of the
vesicles was found to be 180 ± 20 nm, where error indicates the standard deviation (Figure
2.4).

In order to determine the probability obtaining a single receptor in a vesicle, we can
determine the percentage of vesicles that contains receptors. This was done by preparing
vesicles with α3-GFP and β4-wt along with membrane markers (sec61-mCherry as an ER
and plasma membrane-mCherry as a plasma membrane marker). The vesicles were
immobilized on the surface of a glass substrate though anti-mCherry antibodies. Then, the
number of vesicles were determined by taking an image by exciting mCherry, which
represented the positions of vesicles (Figure 2.5A). Followed by, another image was
captured on the same field of view by exciting GFPs which indicated locations of the
receptors (Figure 2.5B). The overlay of the positions of vesicles and receptors indicates
that some of the receptors presents into the vesicles. Afterward, the number of particles
present on the images were counted using ImageJ (NIH, USA) and it was found that about
15 % of the vesicles contained receptors in them. Therefore, it can be deduced that there
was 15 % probability of obtaining a receptor in a vesicle, and thus only 2 % vesicles will
contain two receptors. This indicated that there is about 98 % probability of having a single
receptor in a vesicle.
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Figure 2.4 Determination of the size of vesicles using FCS. Vesicles inserted with α3GFP β4-GFP nicotinic receptors were allowed to pass through the confocal beam of an
FCS, and an auto correlation curve of the signal was obtained. The diffusion time
extracted from the autocorrelation curve corresponded to a diameter of 180 nm.
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Figure 2.5 Determination of the number of vesicles inserted with receptors. Vesicles
were generated with membrane markers conjugated with mCherry (to locate and count the
number of vesicles) along with α3-GFP β4-wt nicotinic receptors (to find and count the
number of receptors in the vesicles). (A) An image taken by exciting mCherry which
indicating the positions of vesicles and (B) the position of receptors on the same field of view
as this image was captured by exciting GFPs. The overlay (C) indicates some of the vesicles
contain receptors in them. Counting the number of particles in image A and B, we found that
~15 % of vesicles contained receptors in them.
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We also carried out a series of experiments to demonstrate that our observation was limited
to the specific binding of receptors with the corresponding antibodies (Figure 2.6). We
have prepared vesicles by transfecting CFTR-GFP and by co-transfecting CFTR-HA with
EGFR-GFP. The surface tethered anti-GFP and anti-HA separately bound with CFTR-GFP
and CFTR-HA respectively and this binding was verified by imaging the GFP tag with a
TIRF microscope. However, HA tags did not attach with the anti-GFP antibody coated
coverslip which indicated that vesicles were bound specifically on the surface.

We validated that we could isolate single receptors into the vesicles and the
immobilization of vesicles are specific to the corresponding antibody. Next, to validate that
cell-derived vesicles can be utilized to studying stoichiometric assembly of membrane
proteins, we prepared vesicles with a membrane protein – CFTR– coupled with GFP
(CFTR-GFP). A glass substrate was tethered with the anti-GFP antibody, and CFTR-GFP
containing vesicles were immobilized on top of it (Figure 2.7). Movies were taken by
exciting GFPs with 488 nm laser souce under a TIRF microscope. The obtained movies
were analyzed to collect time traces from each peaks corresponding to single molecules.
When time traces were plotted, it displayed mainly single or double steps photobleaching
events. After analysis of photobleaching steps from about 10 movies, the data indicates the
presence of 80 % single CFTR. Although, CFTR is primarily considered as a monomeric
ion channel (219), it has been reported to present as a dimer as well (220). The presence of
about 20 % two photobleaching steps might arise from the dimers of CFTR.
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2.3.2 Analysis the Functional Assembly of Receptors in Vesicles
We have demonstrated that cell-derived vesicles have a size of about 200 nm in
diameter, can isolate single receptors, can be selectively immobilized on a glass substrate
and can be utilized to study stoichiometric assembly of membrane proteins. However, to
validate that the membrane proteins isolated on the vesicles are functional, we have
conducted the characteristic calcium flux experiment of nicotinic receptors. Vesicles were
generated expressing α7-GFP β2-Flag nicotinic receptors in HEK293T cells and then
loaded with Fluo-8 AM dye. The acetoxymethyl (AM) group present in the Fluo-8 dye
helps it to penetrate through the cell membranes and enter inside the vesicles. As those
vesicles were generated from a native cell membrane, we assumed that esterase enzymes
would present in the vesicles, and this enzyme would remove the AM group of Fluo-8. The
resulted Fluo-8 become charged allowing to bind with calcium ion and to produce
fluorescence. The Fluo-8 AM loaded vesicles were immobilized on top of a coverslip with
the help of an anti-Flag antibody. An image was taken by exciting GFPs to determine the
positions of receptors in the field of view (Figure 2.8). Since GFP and activated Fluo-8
have similar excitation and emission spectra, a continuous excitation was applied to bleach
all GFP molecules before activating Fluo-8 dyes. Then, acetylcholine and calcium ions are
added on top of immobilized vesicles. Acetylcholine binds with the nicotinic receptor and
activates the channel, and calcium ions can move through the open channel. Once calcium
ions are inside the vesicles, they bind with Fluo-8 dye and activate the dye. Then, another
image was captured exciting Fluo-8 (488 nm) on the same field of view as GFPs. The
overlay image verified that all Fluo-8 spots were observed from the vesicles. Then the
number of particles present at both images was calculated to determine the number of
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Figure 2.6 Study the specific binding of the receptors inserted in a vesicle with the
corresponding antibody tethered on the surface. The presence of vesicles of CFTR-GFP
immobilized with the Anti-GFP antibody (A) but absent with the anti-HA antibody (B),
indicated that vesicles bound specifically to the glass substrate. The spots seen with CFTRHA EGFR-GFP immobilized with anti-HA (C) indicated that the anti-HA antibodies were
active but did not bind with GFPs in image (B). Thus, our observation was limited to the
specific binding of the receptors on the surface of the glass substrate.
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Figure 2.7 Determining if cell-derived vesicles can be utilized to study oligomerization
of membrane proteins. (A) A representative image from a movie acquired by
immobilizing CFTR-GFP containing vesicles on a coverslip. (B) A representative
photobleaching step of CFTR-GFP immobilized on a surface coated with the anti-GFP
antibody. The single step photobleaching indicates the presence of a single receptor in the
vesicle. (C) Another representative photobleaching event of the CFTR-GFP in a different
vesicle; this graph indicated the presence of two CFTR proteins in a vesicle. (D) The data
shows that about 80% of the vesicles have single CFTR proteins whereas the remaining
20% of the vesicles contain multiple CFTR proteins.
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Figure 2.8 Study the functional activity of α7-GFP β2-Flag receptors inserted in the
vesicles to probe the fully functional assembly of the receptors. (A) A representative
image acquired exciting GFP only, which indicates the positions of receptors. Then
acetylcholine and calcium ions are added to open the ion channel and allow calcium ions
to enter into the vesicles. Calcium ions bind with Fluo-8 dyes to activate it. (B) A
representative image captured exciting the activated Fluo-8 dyes. Image analysis indicates
about 60% of the receptors are functional.
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vesicles showing functional assembly. It was found that about 60% of the vesicles showed
functional activity. Since, to activate Fluo-8 AM dye inside a vesicle, it is necessary to
have an esterase inside the vesicle, this might have limited the percentage of receptors
showing the functional activity.

2.3.3 Determination of the Stoichiometry of α3β4
The α3β4 nicotinic receptor is expressed in the central and peripheral nervous
system. This receptor is a hetero-pentameric receptor and can be assembled into two
different stoichiometric isoforms. One isoform can have two α3 subunits and three β4
subunits while other isoform can have three α3 subunits and two β4 subunits. In order to
determine the predominant stoichiometry of this receptor, we expressed HEK293T cells
with α3-GFP β4wt, and α3-wt β4-GFP separately and then generated vesicles. An antiGFP antibody coated glass bottom dish was used to immobilize the vesicles (Figure 2.9).
The surface tethered receptors were visualized by exciting them with a 488 nm laser with
corresponding dichroic and filter under TIRF condition. Vesicles with α3-GFP β4wt
showed single, double and triple photobleaching steps of GFP molecules. But the number
of two bleaching steps is prevalent which indicates the primary existence of two α3subunits into the protein complex (Figure 2.9). As nicotinic receptors are pentamers, this
result also indicates the predominate existence of three β4-subunits in the complex.
Therefore, the predominate stoichiometry of α3β4 nicotinic receptor is (α3)2(β4)3. When
movies corresponding to the vesicles with α3-wt β4-GFP were analyzed, it also agreed with
the result of α3-GFP β4-wt displaying (α3)2(β4)3 as a predominate stoichiometry of α3β4
nicotinic receptor. The α3β4 nicotinic receptor cannot have one alpha or beta subunit, but
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Figure 2.9 Determination of the stoichiometry of α3β4 nicotinic receptors. A1-A3
show data for α3-GFP β4-wt and B1-B3 for α3-wt β4-GFP containing vesicles. (A1) A
representative image of the immobilized vesicles with TIRF excitation where every spot
represents a molecule. (A2 and A3) Two representative bleaching steps of GFP indicate
the presence of two and three α3 subunits respectively. (B1) A typical field of view of the
surface tethered α3-wt β4-GFP containing vesicles under TIRF microscopy. (B2 and B3)
Two representative bleaching steps indicate the presence of two and three β4 subunits.
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Figure 2.10 Determination of the stoichiometry of α3β4 nicotinic receptors using
binomial distribution. (A) It indicates that, with 90% probability of observing GFP, if
we provide 75% weight to the probability of observing of two α3-GFP subunits and 25%
to that of three α3-GFP subunits in the mixed stoichiometry of α3-GFP β4wt receptor, the
experimental and theoretical data are in a good agreement. (B) This represents the same
results with α3-wt β4-GFP receptor where 75% weight is provided to the probability of
observing three β4-GFP (complementary to two α3 subunits) and 25% to that of two β4GFP (complementary to three α3 subunits). Therefore the predominate stoichiometry have
two α3 subunits and three β4 subunits. The error bars for the subunit distribution are based
on counting events and are calculated as the square root of the counts.
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a number of single photobleaching step was observed. This might arise because of the
possibility of the nonzero probability of GFP being non-fluorescent. Thus, it is necessary
to carry out a statistical analysis to conclude the predominate stoichiometry of the receptor.

We determined two theoretical distributions of possible one, two and three
photobleaching events from two GFP and three GFP molecules using Binomial distribution
and a probability of 90% to a GFP being observable (see details in 2.2.14). These two
binomial distributions were weighted to obtain a theoretical or expected distribution which
was compared with observed distribution. When we weighted the probability distribution
of two α3-GFP by 75% and three α3-GFP by 25, the theoretical data showed a good
agreement with observed data of %, for α3-GFP β4wt receptors (Figure 2.10A). Later, with
α3-wt β4-GFP receptors, we assigned the same probability of observing a GFP, and
weighted the probability of observing three β4-GFP by 75% and two β4-GFP by 25%. This
result also shows a good agreement with the experimental data. Hence, whether GFP was
incorporated into the alpha or beta subunit of the α3β4 nicotinic receptor, 75% of the
receptors had two alpha subunits and three beta subunits, i.e. (α3)2(β4)3 stoichiometry;
while remaining showed (α3)3(β4)2.

While the results obtained from the alternate subunit labeling with GFP were
consistent, a simultaneous counting of all 5 subunits within the same receptor could provide
definitive evidence of the accurate stoichiometry. So, we have derived vesicles from
HEK293T cells with α3-mCherry β4-GFP receptor and immobilized on the surface of a
glass substrate though anti-GFP antibody. The 488nm and 561nm lasers and corresponding
filters and dichroics were employed to visualize GFP and mCherry respectively
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Figure 2.11 Determination of the stoichiometry of α3β4 nicotinic receptors by
counting both of the subunits simultaneously. The dual fluorophore labeled receptor
(α3-mCherry β4-GFP) containing vesicles were excited to visualize mCherry (A), and GFP
molecules (B). (C) An image obtained by overlaying the GFP and the mCherry channel on
the same field of view. (D and E) Two are representative bleaching steps of mCherry and
GFP labeled subunits, respectively, from the same receptor showing the presence of two
α3 subunits and three β4 subunits. (F) We counted only those events that showed a total of
5 bleaching steps (two mCherry & three GFP or three mCherry & two GFP). The result
indicates that α3β4 primarily assembles as (α3)2 (β4)3.
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(Figure 2.11). Moves were taken with 561 nm laser first and then 488 nm laser on the same
field of views. Time traces were obtained from the overlayed spots and subjected to
analysis. We counted only those spots that showed a total of 5 bleaching steps (2-mCherry
& 3-GFP) or (3-mCherry & 2-GFP). This dual color experiment also agreed with that of
single color experiment that the (α3)2(β4)3 is the predominate stoichiometry of the α3β4
nicotinic receptor.

2.3.4 Study of Ligand Receptor Interaction
In order to show the diversity of the application of vesicles generated from the live
cells, we have shown that these vesicles can be employed to study ligand receptor
interactions. We have generated EGFR-GFP containing vesicles from HEK293T cells.
FCS data shows that a freely moving EGFR-GFP containing vesicles (by exciting GFPs at
488 nm) have a mean diffusion time of around 33 ms while that of an EGF conjugated with
tetramethylrhodamine (EGF-TMR) (by exciting TMR with 561nm laser) is about 1.0 ms
(Figure 2.12). When EGFR-GFP containing vesicles were mixed with EGF-TMR, we
obtained two diffusion times by exciting TMR with 561nm laser. One diffusion time was
at 1 ms, corresponding to unbound ligands and another was at 33 ms indicating the
interaction of the ligand with the receptor inserted in the vesicle.

We have also examined ligand receptor interactions with immobilized receptors
inserted in vesicles. Vesicles were generated by co-transfecting HEK293T cells with
EGFR-GFP and CFTR-HA DNA plasmids. Vesicles (~100 µl) were mixed with EGFTMR (so that final concentration is 1 µM); the mixed solution was dialyzed with a Slide-
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Figure 2.12 Application of cell-derived vesicles for the study of ligand receptor
interaction. (A) FCS curve of an epidermal growth factor (EGF) conjugated with
tetramethylrhodamine (TMR) showed a diffusion time of 1 millisecond. (B) When
EGF-TMR was mixed with EGFR-GFP containing vesicles and FCS data was recorded
by exciting TMR, it shows a diffusion time of ~33 milliseconds along with a diffusion
time of unbound ligands (1 ms). The shift in the diffusion time clearly indicates the
biding of the ligands with receptors.

79

Figure 2.13 Study ligand receptor interaction on the surface of a glass substrate.
EGFR-GFP and CFTR-HA containing vesicles were immobilized with an anti-HA
antibody coated coverslip. (A) Receptors (EGFR) were visualized by exciting GFPs; (B)
Ligands (EGFs) were located by exciting tetramethylrhodamine (TMR) as EGF was
conjugated with TMR. (C) Overlay image indicates ligands and receptors were present on
the same spots for the same field of view.
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A-Layer MINI Dialysis Devices, 10K MWCO (Thermo Scientific) in 250 ml PBS buffer
for 30 min at room temperature on top of a magnetic stirrer. Then, the buffer was replaced
with a new 250 ml PBS buffer and dialysis was carried out. Buffer was changed in every
30 minutes for a total 8 times to make sure all unbound dyes was removed. An anti-HA
antibody coated coverslip was employed to immobilize 100 –fold diluted purified vesicles;
488 nm and 561 laser beams and corresponding filter and dichroic sets were used to
visualized receptors (through GFP of EGFR) and ligand (by locating TMR of EGF)
respectively (Figure 2.13). The overlay of receptor and ligand of the same field of view
show the specific binding of ligand and receptor.

2.4 Conclusion
Single molecule studies of membrane receptors are limited to live cells because of
the high expression level and movement along the membrane of the membrane proteins.
Isolation of the receptors in artificial membrane bilayers requires transferring proteins from
a cell membrane to the artificial membrane that includes an intermediate step of dissolution
of the protein in a detergent solution. This step endangers the loss of the functional integrity
of the large membrane receptor, thus hindering the application of the single molecular
studies of the receptors. Here we presented a new method where a receptor was isolated
into a cell derived vesicle which eliminated the intermediate step and kept the proteins
always in its physiological environment. Our preparation has shown to have a vesicle of
about 200 nm in diameter; and about 15% of the vesicles have receptors in them. Therefore,
about 98% of the vesicles will have single receptors. These isolated receptors are
assembled intact in the vesicles, which has been validated using the characteristic calcium

81

flux of α7β2 nicotinic receptors. We were able to isolate α3β4 nicotinic receptors in the
cell derived vesicles and found a mixed stoichiometry where predominate assembly is
(α3)2(β4)3. This result was verified with alternatively single subunit labeling and with
simultaneously both subunit labeling with fluorescent proteins. We have also shown that
ligand receptor binding can also be studied with the generated vesicles. We have employed
vesicles inserted with EGFR and corresponding ligands – EGF – to demonstrate the ligand
receptor interaction study in solution (with FCS) and on the surface of a glass substrate
(with TIRF). We strongly believe that these vesicles will enable isolation of all sorts of
transmembrane proteins to carry out single molecule studies.
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Organelle-Specific Single-Molecule Imaging of α4β2 Nicotinic Receptors to
Understand their Assembly and Trafficking
Copyright information: This chapter is an edited version of the preprint of doi:
10.1074/jbc.M117.801431. Reprinted with the permission from “Organelle-specific
single-molecule imaging of α4β2 nicotinic receptors reveals the effect of nicotine on
receptor assembly and cell-surface trafficking”, by Fox-Loe*, A.M., Moonschi*, F.H. and
Richards, C.I, 2017, Journal of Biological Chemistry, 292(51), pp.21159-21169. (*equal
contribution) Copyright © 2017, by the American Society for Biochemistry and Molecular
Biology

Contributions: The work presented in this chapter was accomplished in collaboration with
Dr. Ashley M. Loe. She completed the work related to the isolation and characterization of
ER and plasma membrane originated vesicles as well as single molecule studies of the ER
and Plasma membrane originated vesicles generated with and without the presence of
nicotine. She also completed the SEP based studies of α4β2 to understand ligand induced
upregulation. I did the experiments to understand the assembly of α4β2 nicotinic receptors
from whole cell samples with various nicotinic receptor ligands and the biased transfection
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originated vesicles. Additionally, I wrote the software packages to collect time traces, to
count number of photobleaching events, and to fit data to determine the ratio of
stoichiometric assemblies of nicotinic receptors. Source code of the software packages can
be found in the Appendix.
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3.1 Introduction
Nicotinic acetylcholine receptors (nAChRs) assemble in the endoplasmic reticulum
(ER) and traffic to the cell surface as pentamers composed of alpha (α2-α10) and beta (β2β4) subunits (82,221-224). Many subtypes of these receptors can assemble with varying
ratios of subunits, giving rise to multiple stoichiometries that exhibit different subcellular
localization and functional properties (225-228). In addition to the endogenous
neurotransmitter, acetylcholine, nicotine also binds to and activates these receptors. It has
been shown that nicotine influences the trafficking of nAChRs resulting in increased
expression on the cell surface (141,229-232). It has also been proposed that nicotine and
other ligands alter the assembly of the α4β2 nicotinic receptor resulting in a decrease in the
low sensitivity stoichiometry, (α4)3(β2)2, and an increase in the high sensitivity
stoichiometry, (α4)2(β2)3 (10,140,227,233,234). Until now, no techniques were capable of
specifically determining the stoichiometry of receptors in the ER versus those on the
plasma membrane. We developed a single molecule technique that allowed us to
differentiate between receptors localized in the ER and plasma membrane to quantify the
stoichiometry of individual receptors (Figure 3.1).

Single molecule fluorescence measurements are widely utilized to investigate
protein dynamics including the detection of conformational changes, stoichiometry and
protein mobility (10,28,215). Experiments with this level of detail are only feasible after
purification of the protein from its physiological cellular environment (235,236). This type
of purification is not achievable for many types of membrane proteins, which lose their
structural and functional integrity when removed from their native cellular environment.
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This restricts single molecule studies to a small number of membrane proteins. Other
techniques, such as single-molecule pull-down, have also been used to capture proteins
from cellular systems extending single molecule studies to a wider range of proteins
(28,237,238). Still, one of the primary limitations to applying these current approaches to
membrane receptors is that organelle-specific information is lost during protein
purification. Membrane proteins are synthesized in the ER and then trafficked to the cell
surface through the secretory pathway. Assembly of individual subunits that comprise
oligomeric membrane proteins also takes place in the ER prior to transport to the cell
surface. Understanding drug induced changes in the distribution of protein isoforms
between the ER and plasma membrane is vital to determining how moderately different
structural properties can vastly impact functional properties. Isolation of individual
membrane receptors in cell-derived nanoscale vesicles composed of original membranes
enables the separation of receptors based on organelle (239). Investigation of oligomeric
proteins from specific organelles at a single molecule level provides a way to distinguish
between different structural and functional populations of these proteins, allowing the
effect of changes in assembly on protein trafficking to be directly studied.

Here we report a novel approach that enables us to perform organelle-specific
single molecule studies of membrane proteins. We can effectively select populations from
the ER and the plasma membrane to quantify properties such as the distribution of
stoichiometric assemblies of oligomeric proteins. We applied this technique to study
nicotine-induced changes in the assembly of α4β2 nAChRs in the ER and changes in
trafficking to the cell surface.
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Figure 3.1 Schematic showing the generation of organelle-specific nanovesicles
containing a single nAChR. Cells expressing fluorescently labeled membrane
receptors are expressed throughout the ER and on the plasma membrane. Nitrogen
cavitation is used to fragment the cells forming small membrane domains from cellular
organelles. These membrane domains spontaneously form nanoscale vesicles. The
domains and subsequent vesicles are small enough that there is a low probability of
more than one receptor being encapsulated. The resulting vesicles have the same
membrane properties as the organelle of origin, thus maintaining a physiological
environment. Differences in the densities between the organelle membranes are used to
separate them via gradient centrifugation. Vesicles are isolated on glass substrates for
TIRF imaging
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3.2 Experimental Procedures
3.2.1 Plasmid Construct
Plasmid constructs for fluorescently labeled nicotinic receptors (SEP and GFP)
were generated as previously reported (239). The α4 –SEP construct was made by fusing
the DNA sequence of super ecliptic pHluorin (SEP) to the 3’ end of the DNA sequence of
the α4 subunit. GFP constructs were made by inserting the label between the M3 and M4
transmembrane segments of the α4 subunit. Both constructs have been shown to produce
functional receptors in previous studies (239-241).

3.2.2 Cell Culture
Undifferentiated mouse neuroblastoma 2a (N2a) cells were employed to study the
trafficking of α4β2 nAChRs. N2a cells were cultured and maintained with an N2a growth
media (equal volume mixture of DMEM and OptiMEM supplemented with 10% fetal
bovine serum and 1% penicillin and streptomycin) at 37 C with 5% CO2 in a humidified
incubator. Approximately 90,000 N2a cells were plated on a poly-D-lysine coated glass
bottom dish (35 mm in diameter, Cell E&G, San Diego, CA). The coated dish was prepared
by incubating it with 0.1% poly-D-lysine in sterile deionized water at 37 C for 1 hour. The
unbound poly-D-lysine was removed by rinsing with sterile deionized water, and the dish
was dried for 2 hours in a biosafety hood. After 16-24 hours, the N2a cells were transfected
with 500 ng of each α4-SEP and β2-wt plasmids with 2 μl Lipofectamine 2000 as described
previously (239). Briefly, cells were transfected for 24 hours, followed by a 24-hour
incubation in growth media prior to imaging. Transfection mix was prepared by incubating
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a mixture of 250 μl OptiMEM and 2 μl Lipofectamine 2000 transfection agent for 5 minutes
at room temperature, followed by a 25-minute RT incubation upon combination with a
mixture of 250 μl OptiMEM and 500 ng of each plasmid DNA. The 500 μl of transfection
mix was added to pre-plated cells in 1.5 mL OptiMEM. After 24 hours, transfection media
was replaced with N2a growth media for an additional 24-hour incubation. Transfected
cells were imaged 48 hours after initial transfection. When applicable, 500 nM of each
nicotinic ligand, (−)-nicotine hydrogen tartrate salt (>98%), bupropion hydrochloride
(>98%), varenicline tartrate, or (−)-Cytisine (>99%), was added to the transfection media
and replenished later in the growth media. Transfection efficiency was generally 80% and
was not significantly altered by the presence of any of the ligands.

3.2.3 Total Internal Reflection Fluorescence
The total internal reflection fluorescence (TIRF) microscope system employed to
visualize SEP or GFP molecules was previously described (239,242). Briefly, a 488 nm
DPSS laser excitation source was directed toward the back aperture of an objective (60x,
1.49 NA) mounted on an inverted microscope (Olympus IX81). The angle of excitation
light was adjusted to obtain total internal reflection through the objective using a stepper
motor that translated the beam across the back aperture of the objective. The emission was
collected though the objective and a dichroic mirror was used to direct the light to an
EMCCD camera (Andor).
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3.2.4 Receptor Expression and Distribution
For in vivo fluorescence imaging studies, the growth media of the transfected N2a
cells was replaced with an extracellular solution (10mM HEPES, 10 mM D-glucose, 150
mM NaCl, 4 mM KCl, 2 mM MgCl2 and 2 mM CaCl2) of pH 7.4. The dish was then
mounted on a translational stage and cells were located by exciting the SEP molecules with
a 488 nm laser (~1mW) source. Images of cells were captured using an EMCCD camera
with a 200 ms exposure time. The extracellular solution was then replaced with an identical
solution of pH 5.4, followed by a 10-minute stage-top incubation before capturing images
of the same cells. An open source software, ImageJ (NIH, USA) was employed to analyze
the images. Background was subtracted using the rolling ball background subtraction with
a diameter of 25 pixels. A freehand region of interest (ROI) was drawn around a cell and
an intensity based threshold was used to obtain an integrated density for each cell. The
integrated density of the cell at pH 5.4 (ER ID) is subtracted from the integrated density of
the same cell at pH 7.4 (total ID) to calculate the relative number of receptors on the plasma
membrane, or plasma membrane integrated density (PM ID). The percentage of receptors
located on the plasma membrane within the TIRF region of excitation (% PM) is calculated
by dividing the PM ID by the total ID at pH 7.4, multiplied by 100. Data are reported as
mean ± STD.

3.2.5 Nanovesicle Preparation
Human embryonic kidney 293T (HEK-293T) cells were cultured and maintained
with a growth media (DMEM supplemented with 10% fetal bovine serum and 1%
penicillin and streptomycin) at 37 C temperature with 5% CO2 in a humidified incubator.
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Three million HEK-293T cells were plated in a matrigel coated T75 flask 16-24 hours prior
to transfection. Cells were transfected with 14 l Lipofectamine 2000 and 3.5g of each
plasmid as previously described (239). For biased expression experiments, a 1:10
transfection ratio of 4-GFP:2-wt using 1 g 4-GFP and 10 g 2-wt was employed.
Briefly, a mixture of 250 l OptiMEM and the above mentioned amount of 4-GFP and
2-wt plasmids was prepared. Separately, 14 l Lipofectamine 2000 was added to 250 l
OptiMEM and incubated for 5 min at RT before being added to the DNA mixture. This
new mixture was incubated at room temperature for 25 minutes.

Afterwards, the

transfection mixture was added to the flask of HEK-293T cells. The following day, vesicles
were prepared from transfected cells as previously described (239).

Briefly, cells

underwent nitrogen cavitation at 250 psi for 5 minutes while suspended in 5 mL sucroseHEPES buffer supplemented with a protease inhibitor (250 mM sucrose, 10 mM HEPES,
1 Pierce protease inhibitor mini tablet per 10 mL buffer (ThermoScientific), pH 7.5). Cell
lysate was then centrifuged at 4000 x g for 10 minutes. Supernatant was collected and
centrifuged at 10,000 x g for 20 minutes. Supernatant was again collected and centrifuged
at 100,000 x g for 1 hour. The pellet was resuspended in 800 μl sucrose-HEPES buffer
(250 mM sucrose, 10 mM HEPES, pH 7.5). Nanovesicles were stored at -80 oC until use.

3.2.6 Generation of ER and Plasma Membrane Vesicles
HEK-293T cells were transfected as described above. After transfection for 24
hours, transfection mix was removed and cells were rinsed once with PBS. To generate
nanoscale plasma membrane vesicles containing a single nAChR, transfected cells were
first swollen for 20 minutes in a hypotonic solution (10 mM NaCl, 10 mM Tris-HCl, 1.5
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mM MgCl2, 0.2 mM CaCl2, pH 7.4) at 0 °C. To prepare both plasma membrane and ER
derived vesicles, cells were treated with 5 mL 1x versene (Invitrogen), incubated at 37 °C
for 5 minutes, and pelleted by centrifugation at 200 x g for 5 minutes, as previously
described. The cell pellet was resuspended in 3 mL sucrose buffer plus protease inhibitors
(250 mM sucrose, 10 mM HEPES, 1 Pierce protease inhibitor mini tablet per 10 mL buffer
(ThermoScientific), pH 7.5) before undergoing nitrogen cavitation in a nitrogen
decompressor (Parr Instrument Company, IL, USA). To generate ER nanovesicles, cells
were pressurized to ~250 psi for 20 minutes. At this pressure, plasma membrane rupturing
is minimal and therefore nanoscale vesicle formation from this organelle is negligible. To
generate plasma membrane nanovesicles, cells were pressurized to ~600 psi for 20 minutes.
Cell lysate was collected and dispensed onto an OptiPrep gradient.

3.2.7 Separation of Organelle-Specific Vesicles
A 9-fraction OptiPrep (60% (w/v) iodixanol in H 2O, Accurate Chemical &
Scientific Corp., NY, USA) gradient was used to purify organelle-specific nanovesicles.
Gradient solutions of OptiPrep were prepared by diluting the 60% stock solution to 30%,
20%, and 10% in sucrose-HEPES buffer (250 mM sucrose, 10 mM HEPES, pH 7.5), and
stored at 4 oC. The gradient was prepared in an Ultra-Clear centrifuge tube (Beckman
Coulter), with 3 mL of the densest fraction added first.

ER or plasma membrane

nanovesicles containing cell lysate, based on nitrogen pressure during cavitation, was
dispensed on top of the 10% fraction, before centrifugation at 112,000 x g for 1.5 hours.
After centrifugation, nine 1-1.5 mL fractions, with density interfaces in the same fraction,
were collected using a peristaltic pump. Tubing connected to the pump was vertically
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inserted into the centrifuge tube so that the highest density fraction is collected first. After
fractionation, OptiPrep was removed from nanovesicles by centrifugation at 10,000 x g for
1 hour.

3.2.8 Western Blot Analysis
Resuspended OptiPrep fractions containing membrane proteins were ran on a
prepackaged NuPAGE 4-12% Bis-Tris gel (Life Technologies), followed by transfer to a
nitrocellulose membrane. The membrane was first blocked for one hour with a PBST
solution (5% non-fat milk, 0.1% Tween in PBS). Primary antibodies specific for calnexin
(Santa Cruz, calnexin antibody (H-70): sc-11397) or plasma membrane calcium ATPase
(PMCA) (Santa Cruz, PMCA antibody (D-1): sc-271193) were added to the membrane in
a 1:1000 dilution and incubated overnight at 4oC. Endogenous calnexin is solely found in
the membrane of the ER, while PMCA is expressed on the plasma membrane, thus
providing a means to identify fractions that consist of exclusively ER or plasma
membranes.

After overnight incubation, primary antibodies were removed by four

repeated five minute washes with PBST. Secondary rabbit antibody (calnexin) or mouse
antibody (PMCA) (Jackson ImmunoResearch) was added in a 1:5000 dilution and
incubated for one hour at room temperature, followed by another series of four repeated
five minute washes with PBST. Bands were visualized by addition of western blotting
substrate for chemiluminescence (Clarity, Bio-Rad) on a Chemi-Doc system (Bio-Rad). In
order to validate these results, blots were repeated with a completely different set of
antibodies. For primary antibodies, we used 1:2000 diluted rabbit monoclonal anti calnexin
(ab92573, Abcam) for ER identification and 1:2000 diluted rabbit monoclonal anti Na K
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ATPase (ab76020, Abcam) for plasma membrane identification. In both sets of orthogonal
studies the ER and plasma membrane bands matched the expected molecular weights.

3.2.9 Imaging Nanovesicles
A 35 mm glass bottom dish was cleaned by sonicating the dish in 5 M NaOH
solution for 30 minutes at 45 C and then in 0.1 M HCl solution for 30 minutes at 45 C.
The dish was rinsed with water and sprayed with 100% ethanol three times after each step,
and then dried using compressed air. Finally, the dishes were treated in an oxygen plasma
(21 % oxygen for ~5 minutes). A biotinylated anti-GFP antibody functionalized glass
bottom dish was prepared by incubating a cleaned dish at room temperature with 1 mg/ml
Silane-PEG-Biotin in 95% Ethanol for 30 minutes, 0.1 mg/ml NeutrAvidin in PBS (1x
phosphate buffered saline, pH 7.4) solution for 5 min, and finally 1 g/ml biotinylated anti
GFP antibody in PBS for 15 minutes. Between each of the steps, the dish was rinsed three
times with 1X PBS solution. Vesicles were immobilized on the biotinylated anti-GFP
antibody functionalized dish by adding 50 to 200 fold diluted vesicles in PBS for 30
minutes at room temperature. The unbound vesicles were removed by rinsing with PBS,
and ~1 mL PBS solution was added to the dish. The microscope set-up employed to capture
images for SEP based studies was also utilized to obtain movies of about 1000 frames (100
ms exposure time) during 488 nm laser excitation (~3 mW).

3.2.10 Data Analysis
A customized software package was written in Matlab to populate time traces from
the movies collected with immobilized vesicles. Briefly, the first 10 frames of a movie
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were combined together to make a composite frame which was utilized to find peaks with
a user defined threshold level. A 3-pixel by 3-pixel region of interest (ROI) was selected
for each peak position to obtain the mean intensity of the ROI. A 5-pixel by 5-pixel ring
around the peak was selected, and the mean value of the pixels located on the ring was
considered as background which was subtracted from the mean value of the ROI of the
corresponding frame to obtain a background subtracted mean intensity of the ROI. Time
traces for all peaks were stored in a temporary file. During the initial evaluation, a time
trace of the temporary file was accepted if the difference of the mean of the intensities of
first 20 frames and last 20 frames was more than twice the standard deviation of last 20
frames. All time traces for the qualified molecules were collected and stored for further
analysis.

A photobleaching step was counted only if it lasted at least one second and the
intensity levels of a step and the next lower level had a difference of at least twice the
standard deviation of the lower level. A time trace was considered to arise from a single
molecule if it showed at least one clear bleaching step. Each set of data was independently
analyzed at least twice and the results were compared.

3.2.11 Data Fitting
The probability of observing a photobleaching event from a GFP molecule is less
than 1. Therefore, a binomial distribution was employed to determine the distribution of
the number of photobleaching events observed from a population of GFP labeled receptors.
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A general equation for observing k number of photobleaching events from n number of
GFP labeled receptors can be written as:

𝐅(𝐤; 𝐧, 𝐩) =

𝒏!
𝒌!(𝒏−𝒌)!

𝒑𝒌 (𝟏 − 𝒑)𝒏−𝒌

Eq. 3.1

Where p is the probability of observing a photobleaching event from a GFP labeled
subunit which has been previously determined as 0.90 (239).

A matrix (M2) with the probabilities of obtaining 1, 2, and 3 photobleaching events
from two GFP containing 42 nAChRs (i.e. (4-GFP)2(2-wt)3) can be written as:

𝑴𝟐 = [𝐅(𝟏; 𝟐, 𝟎. 𝟗), 𝐅(𝟐; 𝟐, 𝟎. 𝟗), 𝟎]

Eq. 3.2

Similarly, a matrix M3 containing the probabilities of observing 1, 2, and 3
photobleaching events from three GFP containing 42 nAChRs (i.e. (4-GFP)3(2-wt)2)
can be expressed as:

𝑴𝟑 = [𝐅(𝟏; 𝟑, 𝟎. 𝟗), 𝐅(𝟐; 𝟑, 𝟎. 𝟗), 𝐅(𝟑; 𝟑, 𝟎. 𝟗)]

Eq. 3.3

Since the probability of obtaining zero photobleaching events from 2 or 3 GFP
labeled 42 nAChRs can be greater than zero, the probability distributions, M 2 and M3,
were normalized as follow:

𝑴′𝟐 = [

𝐅(𝟏; 𝟐,𝟎.𝟗) 𝐅(𝟐; 𝟐,𝟎.𝟗)

𝑴′𝟑 = [

𝐅(𝟏; 𝟑,𝟎.𝟗) 𝐅(𝟐; 𝟑,𝟎.𝟗)

𝑺𝟐

𝑺𝟑

,
,

𝑺𝟐

𝑺𝟑

, 𝟎]
,

Eq. 3.4

𝐅(𝟑; 𝟑,𝟎.𝟗)
𝑺𝟑

]

Eq. 3.5
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Where M’2 and M’3 are normalized probability distribution matrices corresponding
to M2 and M3 respectively, S2=F(1;2,0.90) + F(2;2,0.90) + 0 and , S3=F(1;3,0.90) +
F(2;3,0.90) + F(3;3,0.90).

Since the experimentally observed distribution emerged from a mixture of (4GFP)2(2-wt)3 and (4-GFP)3(2-wt)2 stoichiometries, a theoretical probability
distribution (Tpd) was computed by providing a weight to each normalized probability
matrix:

𝐓𝐩𝐝 = 𝐚𝟐 × 𝐌′𝟐 + 𝐚𝟑 × 𝐌′𝟑

Eq. 3.6

Where, a2 and a3 are the weights assigned to M’2 and M’3 distributions respectively
and a2 + a3 = 1. Therefore, a2 and a3 are the proportions of (4-GFP)2(2-wt)3 and (4GFP)3(2-wt)2 stoichiometries, respectively. This probability distribution (Tpd) was
multiplied by total number of observed 1, 2, and 3 photobleaching events to generate a
theoretical distribution. A Chi-square goodness-of-fit test was employed to compare
theoretical and observed distributions. The error bars for subunit distribution are based on
counting events and are calculated as the square root of the counts. The values of a2 and a3
were iteratively assigned and a Chi-square goodness-of-fit test statistics was calculated for
each set of a2 and a3. A customized Matlab script was written to calculate a 2 and a3 from
the best Chi-square goodness-of-fit test statistics.
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3.3 Results
3.3.1 Ligand Induced Upregulation of α4β2 Receptors
Nicotine and several other nicotinic receptor ligands have been shown to upregulate
the number of receptors on the cell surface. It has been hypothesized that this upregulation
is connected to changes in receptor stoichiometry (234,243). We first evaluated a series of
ligands to determine if they altered the expression and trafficking of α4β2 by using a pH
sensitive fluorophore, super ecliptic pHluorin (SEP) (141,244,245). The SEP label was
genetically incorporated into the protein sequence of the receptor so that it was on the
luminal side of the ER and the extracellular side of the plasma membrane (Figure 3.2A &
B). SEP is fluorescent at neutral pH and quenched at acidic pH. Thus, receptors in the ER
and plasma membrane will exhibit fluorescence, while receptors in the Golgi and
trafficking vesicles are not fluorescent. Using total internal refection fluorescence
microscopy, we measured ligand-induced upregulation of α4β2 expression on the plasma
membrane as an increase in plasma membrane integrated density (PM ID) and a change in
the distribution between the ER and plasma membrane (% PM) as compared to control
cells (239,246). Exposure to nicotine or cytisine resulted in a 2.5-fold increase, varenicline
yielded a 2-fold increase, and bupropion resulted in a 1.5-fold increase in α4β2 expression
on the cell surface (Figure 3.2C). Additionally, the intracellular distribution of α4β2
between the plasma membrane and peripheral ER (% PM) shifted towards the plasma
membrane upon exposure to each of these ligands (Fig. 2D). Comparisons between the
ligands showed that nicotine provides the highest level of upregulation in terms of
expression and distribution towards the plasma membrane.
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Figure 3.2 Ligand induced upregulation of nAChRs. Schematic showing that TIRF
imaging of super ecliptic phluorin (SEP), a pH sensitive analog of GFP, is used to
determine the expression and distribution of receptors between the ER and plasma
membrane. SEP was genetically encoded into the alpha 4 subunit to generate an α4-SEP
construct. The α4-SEP β2-wt nicotinic receptors were expressed in N2a cells and imaged
under TIRF. (A) When the pH of the extracellular solution (ECS) was maintained at 7.4,
receptors both in the ER and plasma membrane were observable. The observed
fluorescence intensity is due to both the ER and plasma membrane receptor populations.
(B) When the extracellular solution was replaced with a pH 5.4 solution, all SEP on the
plasma membrane transition to a non-fluorescent state and only the receptors within the
ER are visible. (C) The integrated density of α4β2 on the plasma membrane increased
from approximately 2.5 x 106 in the absence of any compound to 7 x 106 in the presence
of nicotine or cytisine. Varenicline and bupropion both resulted in a 2-fold increase in
the integrated density on the plasma membrane demonstrating ligand-induced
upregulation. (D) The percentage of the receptors present on the plasma membrane
increased from 21.5% for control cells to 30 to 40% for all nicotinic receptor ligands,
showing a shift in distribution of receptors toward the plasma membrane. (n = 61, 47, 42,
38, 51) Data are mean values ± S.D.) (***, p < 0.001). Integrated density (avg
fluorescence intensity x area) is the total gray values background within a region of
interest that encompasses a cell. Plasma membrane integrated density (PMID) is obtained
by subtracting the integrated density of pH 5 image of a cell from pH 7 image of the same
cell.
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Figure 3.3 Single molecule photobleaching to determine nAChR stoichiometry. (A)
Representative mouse N2a cell expressing GFP labeled nicotinic receptors in TIRF. (B)
Representative TIRF image of isolated nanovesicles containing individual GFP-labeled
receptors on a glass substrate. (C & D) Two representative time traces of two and three
photobleaching steps respectively corresponding to two or three GFP-labeled α4 subunits
respectively.
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3.3.2 Ligand Induced Changes in α4β2 Assembly
In order to determine if ligands that upregulated nicotinic receptors also changed
their assembly, we then generated whole-cell nanovesicles from cells expressing α4GFP
β2wt nAChRs (Figure 3.3A) and examined the distribution of the two possible α4β2
isoforms, (α4GFP)2(β2)3 and (α4GFP)3(β2)2. Nanovesicles were derived from cells both
in the presence and absence of the nicotinic ligands. Single receptors were then isolated
into membrane derived vesicles via nitrogen cavitation, immobilized on a glass surface and
imaged using total internal reflection fluorescence microscopy (TIRFM). A representative
image of isolated vesicles is shown in Figure 3.3B. We then determined the number of
photobleaching events (214,217,218) from the intensity time traces recorded for the
fluorescence of each nanovesicles (Figure 3.3C & D). The assignment of the stoichiometric
distribution is complicated by the fact that a small fraction of GFP exists in a nonfluorescent state (239,247). Additionally, the observed distribution of photobleaching
events arises from a combination of (α4GFP)2(β2)3 and (α4GFP)3(β2)2 stoichiometries. To
account for these factors, the observed distribution was fit to two binomial distributions,
corresponding to the distributions of the photobleaching events of (α4GFP)2(β2)3 and
(α4GFP)3(β2)2. They were weighted iteratively to determine the contribution of each
stoichiometry. Results from these unsorted vesicles provided a measure of the whole cell
distribution of α4β2 stoichiometries. In the absence of any ligand, we observed a
distribution of 41% (α4)2(β2)3 and 59% (α4)3(β2)2 (Figure 3.4A). The presence of nicotine
shifted the distribution of stoichiometry to 59% (α4)2(β2)3 and 41% (α4)3(β2)2 (Figure
3.4B). A comparison of all ligands showed that each altered the assembly toward
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Figure 3.4 Whole cell evaluation of (α4)2(β2)3 versus (α4)3(β2)2assembly upon
exposure to nicotinic receptor ligands. Expected distributions of 1, 2, and 3
photobleaching steps were obtained by weighting two binomial distributions. A chisquare goodness of fit test was used to verify expected and observed distributions of
two and three GFP labeled α4 subunits. (A) In the absence of a pharmacological agent,
the α4β2 population exists as 41% (α4)2(β2)3 and 59% (α4)3(β2)2. (B) 500 nM nicotine
alters the ratio of isoforms to 59% (α4)2(β2)3 and 41% (α4)3(β2)2. (C) 500 nM cytisine
shifts the stoichiometry to 50% high sensitivity receptors (D) 500 nM varenicline
shifts the distribution to 54% high sensitivity receptors. (E) 500 nM bupropion shifts
the stoichiometry to 55% high sensitivity receptors, (α4)2(β2)3. The error bars for the
subunit distribution are based on counting events and are calculated as the square root
of the counts.
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Table 3.1 The observed distribution of bleaching steps for whole cell nanovesicles
expressing α4β2

# Vesicles
Counted

1 Step

2 Steps

3 Steps

4 Steps

Control

767

53

386

328

54

Nicotine

192

22

112

58

9

Cytisine

357

41

187

130

17

Varenicline

833

94

459

280

30

Bupropion

1089

102

598

389

43
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(α4)2(β2)3 with cytisine increasing to 50%, varenicline 54%, and bupropion 55% of the
high sensitivity stoichiometry (Figure 3.4C, D, and E). The observed distribution of
bleaching steps is shown in Table 3.1.

3.3.3 Organelle-Specific Stoichiometry of α4β2.
We isolated nanovesicles and then sorted them via gradient centrifugation into
those derived from the ER and plasma membrane (Figure 3.1). Differences in the density
of endogenous ER and plasma membrane allow nanovesicles originating from these
organelles to be separated using a density gradient (223). We verified the separation of
vesicles using organelle-specific antibodies via western blot analysis. The ER marker, anticalnexin, was only found in the 3 fractions with the highest density while the PM marker,
anti-PMCA (plasma membrane calcium ATPase) or anti-Na+/K+ ATPase was found in
fractions with the lowest density (Figure 3.5). We utilized this organelle-specific approach
to distinguish between changes in receptor stoichiometry during assembly versus altered
trafficking. Since nicotinic receptors are synthesized in the ER, differences in assembly
are reflected in the stoichiometry of this population. Receptors are trafficked to the cell
surface after assembly, thus a change in the stoichiometry on the plasma membrane reflects
preferential trafficking or increased stability on the cell surface. We performed separate
single molecule studies on both the ER and plasma membrane specific nanovesicles. Single
molecule photobleaching analysis relies on the observation of single step bleaching events
of GFP where each bleaching event corresponds to a single subunit. Our results using GFP
labeled alpha subunits showed the predominately-expressed stoichiometry of α4β2
nAChRs depends on the subcellular region. Receptors encapsulated in nanovesicles
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Figure 3.5 Western blots verifying separation of ER and plasma membrane
derived nanovesicles. Anti-calnexin was used as an ER marker to identify
nanovesicles originating from the ER. Anti-PMCA (plasma membrane calcium
ATPase) was used to detect nanovesicles formed from the plasma membrane. Calnexin
is detected in higher density fractions when vesicles are formed at 250 psi (A) and at
600 psi (B). Minimal PMCA is detected at fragmentation of 250 psi (C), but are
localized to lower density fractions upon swelling with a hypotonic solution and a
higher cavitation pressure of 600 psi (D). ER specific nanovesicles are collected from
fraction 2 after 250 psi. Plasma membrane specific nanovesicles are collected from
fraction 7 after formation at 600 psi.
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Table 3.2 The observed distribution of bleaching steps for organelle-specific
nanovesicles expressing α4β2

#Vesicles
Counted

1 Step

2 Steps

3 Steps

4 Steps

ER No Drug

458

26

199

233

14

PM No Drug

545

26

199

233

1

ER + 500
nm Nic

465

40

273

152

27

PM + 500
nM Nic

883

100

592

191

18
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derived from the ER show that in the absence of nicotine, α4β2 nAChRs predominately
assemble with the low sensitivity stoichiometry of (α4) 3(β2)2. The distribution of
photobleaching events from the ER resident α4β2 nAChRs fit to a theoretical distribution
weighted for 30% (α4)2(β2)3 and 70% (α4)3(β2)2 (Figure 3.6A). Single molecule analysis
of isolated α4β2 nAChRs encapsulated in nanovesicles derived from the plasma membrane
had a higher fraction of the high sensitivity isoform. This fit to 54% (α4) 2(β2)3 and 46%
(α4)3(β2)2 is shifted from the distribution observed in the ER suggesting that the two
isoforms traffic to the cell surface with different efficiencies (Figure 3.6B). The observed
distribution of bleaching steps is shown in Table 3.2.

3.3.4 Nicotine changes the stoichiometry of α4β2 in the ER
We next prepared ER and plasma membrane specific vesicles from cells expressing
α4β2 in the presence of 500 nM nicotine. We observed a clear nicotine-induced shift in the
stoichiometry of ER resident α4β2 receptors (Figure 3.6C). When nicotine was present,
single molecule bleaching step analysis showed the majority of endoplasmic α4β2
assembled as the high sensitivity isoform, fitting a 55% (α4)2(β2)3 and 45% (α4)3(β2)2
distribution. This shift from the stoichiometry seen in the absence of nicotine indicates that
nicotine drives the assembly of the high sensitivity isoform, (α4)2(β2)3. While some groups
have previously hypothesized that nicotine alters the assembly of α4β2 receptors
(134,227,228,248), these organelle-specific single molecule studies allowed us to directly
observe the process of nicotine altering the assembly of receptors in the ER for the first
time. In addition to nicotine altering the assembly of α4β2 within the ER, the percentage
of the high sensitivity (α4)2(β2)3 stoichiometry on the plasma membrane was also increased
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Figure 3.6 Single molecule bleaching step analysis shows organelle-specific
differences in α4β2 nAChR isoforms. (A) The observed ratio of vesicles showing one,
two, or three steps was 0.057, 0.43, and 0.51, respectively (blue columns). These
observed values were then fit to a 30:70 (HS:LS) stoichiometry. The fit was verified
using a Chi-square goodness of fit analysis. (B) The expression of α4β2 nAChRs on the
plasma membrane fit binomial distributions weighted for 56% (α4)2(β2)3 and 44%
(α4)3(β2)2. The observed fraction of vesicles showing one, two, or three bleaching steps
was 0.12, 0.56, and 0.32, respectively. (C) For ER resident receptors in the presence of
nicotine, the observed fraction of one, two, and three bleaching steps were 0.086, 0.59,
and 0.33, respectively. These observed values were then fit to a 55:45 distribution. (D)
The observed fraction of vesicles with one, two, or three bleaching steps were 0.11,
0.67, and 0.22, respectively. This was fit to a 70:30 distribution. The error bars for the
subunit distribution are based on counting events and are calculated as the square root
of the counts.
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(Figure 3.6D). After exposure to nicotine, the distribution of photobleaching events
obtained from plasma membrane resident α4β2 nicotinic receptors was fit to a distribution
of 70% (α4)2(β2)3 and 30% (α4)3(β2)2.

3.3.5 Biased Transfection to Validate Nicotine Induced Shifts in Receptor
Stoichiometry
Our studies indicate that nicotine induces a shift toward the assembly of the high
sensitivity stoichiometry in both the ER and the plasma membrane. Biased transfection has
previously been used to induce a shift in stoichiometry that mimics the effect seen with
nicotine (75,249). We performed a set of control studies to verify that in our experiments
we could observe a shift in stoichiometry in the ER and the plasma membrane. We
transfected HEK293T cells with 1:10 ratio of α4-GFP:β2-wt plasmids and generated
vesicles from whole cells, the ER, and plasma membrane. Single molecule photobleaching
analysis studies of the unsorted receptors showed 73% (α4) 2(β2)3 and 27% (α4)3(β2)2
(Figure 3.7A). The ER originated receptors exhibited 67% (α4)2(β2)3 and 33% (α4)3(β2)2
(Figure 3.7B). The plasma membrane population exhibited 82% (α4)2(β2)3 and 18%
(α4)3(β2)2 (Figure 3.7C). These control studies verify that our technique is capable of
independently measuring organelle specific shifts in stoichiometry.

3.4 Discussion
We have developed a new technique that allows us to perform organelle-specific
single molecule studies on membrane proteins. We utilized this novel method to determine
that changes in nicotinic receptor stoichiometry related to nicotine induced upregulation
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Figure 3.7 Biased transfection of α4β2 to shift assembly towards the high sensitive
((α4)2(β2)3) subtype in both the ER and the plasma membrane. The expected
distribution of 1, 2 and 3 photobleaching steps was determined by weighting two
binomial distributions and the fit of expected and observed distribution was validated
using chi-square goodness of fit test. The assigned weight represent the proportion of
the high and low sensitive stoichiometries. (A) The observed photobleaching
distribution of the receptors obtained from the whole cell homogenate fit with the
expected distribution obtained with 73% (α4)2(β2)3 and 27% (α4)3(β2)2. (B) The ER
originated receptors exhibited a photobleaching step distribution which agreed with
67% (α4)2(β2)3 and 33% (α4)3(β2)2 stoichiometries. (C) The stoichiometry for
receptors from the plasma membrane was 82% (α4) 2(β2)3 and 18% (α4)3(β2)2. The
error bars for the subunit distribution are based on counting events and are calculated
as the square root of the counts.
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(250) are likely driven by both changes in the assembly in the ER and the preferential
trafficking of the high sensitivity stoichiometry. The consequences of these changes are an
increase in the number of receptors both in the ER and on the plasma membrane as well as
a shift in stoichiometric distribution toward the high sensitivity assembly. Previous studies
to measure ER specific changes in stoichiometry have primarily been limited by a lack of
existing techniques that are capable of directly quantifying subcellular specific structural
assemblies of complex proteins in a physiological cellular environment. The isolation of
membrane proteins in organelle-specific nanovesicles provides a snapshot of membrane
protein assembly in each subcellular location at the time the vesicles are generated. We
observed that nicotine, cytisine, varenicline, and bupropion all upregulated the number of
receptors on the cell surface. We also observed that these same compounds all altered the
stoichiometry of α4β2 nAChRs toward the high sensitivity stoichiometry. Nicotine induced
the largest increase in membrane expression and the largest shift toward the high sensitivity
stoichiometry, (α4)2(β2)3. The only previous single molecule study of α4β2 stoichiometry
on the plasma membrane showed that cytisine elicited a shift toward the low sensitivity
stoichiometry in contrast to our findings (10). This previous study only examined the
stoichiometry in the very tip of filopodia projected into 150-200 nm apertures. This
restricted studies to a specialized surface domain likely accounting for the differences seen
here. Our studies sample the entire plasma membrane providing a snap shot of the whole
population trafficked to the cell surface. Our results indicate that a wide variety of
molecules with different pharmacological properties including agonists, partial agonists,
and antagonists all alter receptor assembly. This suggests a possible connection between
ligand-induced upregulation and changes in receptor assembly.
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We then performed organelle-specific single molecule studies of α4β2 nAChRs in
the presence and absence of nicotine to resolve the connection between increased
expression and changes in stoichiometry. Comparing the distribution between the low
sensitivity stoichiometry and high sensitivity stoichiometry in the ER and plasma
membrane showed a much larger fraction of receptors exhibiting the high sensitivity
stoichiometry on the plasma membrane. This strongly suggests that the high sensitivity
stoichiometry traffics to the cell surface more efficiently than the low sensitivity
stoichiometry. We also observed a shift in the ER stoichiometry toward the high sensitivity
isoform in the presence of nicotine. This suggests that nicotine induces an intracellular
change in the assembly of the α4β2 nAChR. Biased transfection can shift the production
of the α4β2 toward the high sensitivity isoform. Single molecule photobleaching event
analysis of vesicles from biased transfections experiments confirmed a shift toward the
high sensitivity stoichiometry in vesicles originating from the ER. We observed an even
larger shift toward the high sensitivity stoichiometry on the plasma membrane. The
presence of a higher proportion of the high sensitivity subtype in the plasma membrane
compared to the ER verifies the preferential trafficking of the (α4) 2(β2)3 stoichiometry
from the ER to plasma membrane. Figure 3.8 summarizes the fitted values from Figure
3.6 to illustrate the shift in stoichiometry. The observed differences in organelle
stoichiometry show that endogenous assembly in the ER favors the low sensitivity
stoichiometry, but that the high sensitivity isoform is preferentially trafficked from the ER
to the plasma membrane. Despite having a lower fraction in the ER, this preferential
trafficking results in a larger fraction of high sensitivity receptors on the plasma membrane.
Recent work by several groups has proposed that nicotine acts as a pharmacological
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Figure 3.8 Organelle-specific single molecule studies reveal a combination of
endogenous preferential trafficking and an intracellular increase in assembly may
be responsible for nicotine induced upregulation. (A) Organelle-specific single
molecule photobleaching step studies of stoichiometry show that in the absence of
nicotine, α4β2 predominately assembles into the 3 alpha stoichiometry (blue) (70%).
(B) In the absence of nicotine, the 2 alpha stoichiometry (green) is preferentially
trafficked to the cell surface resulting in a higher proportion of receptors on the cell
surface having the 2 alpha stoichiometry. (C) In the presence of nicotine, the
intracellular assembly of α4β2 is altered to favor the high sensitivity, 2 alpha isoform
(green). (D) The increase in availability of the preferentially trafficked stoichiometry,
(α4)2(β2)3, leads to an even higher proportion of the 2 alpha stoichiometry (green) on
the plasma membrane (70%). The error bars were calculated as the square root of the
counts.
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chaperone either altering the assembly of nAChRs or influencing the trafficking. Previous
studies have also shown that this increases the numbers of α4β2 nAChRs in the ER and the
plasma membrane. In these studies, we confirm that increased numbers of receptors in the
ER and altered assembly likely play roles in plasma membrane upregulation but are only
part of the mechanism. Upon addition of nicotine, the assembly of subunits into a pentamer
within the ER is altered to a higher ratio of high sensitivity receptors that can then be
efficiently trafficked to the cell surface. This suggests a mechanism of nicotine induced
plasma membrane upregulation that is tied to increased numbers of receptors in the ER,
preferential trafficking, and a change in assembly. The shift in assembly of α4β2 nAChRs
within the ER upon exposure to nicotine towards the preferentially trafficked high
sensitivity isoform is likely responsible in part for the nicotine-induced upregulation that
has been previously observed. It is possible that residues in the M1-M2 and M3-M4 loops
on the intracellular side of each of the subunits of α4β2 regulate preferential trafficking to
the cell surface. These intracellular loops contain a number of ER retention and ER exit
motifs as well as sites that undergo post translational modification in the secretory pathway
(228,251). These same processes are also responsible for targeted trafficking to neuronal
subcellular regions. Additionally, recycling from Golgi back to the ER has been shown to
be necessary for nicotine induced upregulation of some nicotinic receptor subtypes (140).
It is likely that differences in post translational modification sites of the intracellular
regions of α4 and β2 lead to the observed differences in trafficking between the two
stoichiometries. Employment of our organelle-specific single molecule method enabled the
distinction between changes in trafficking compared to changes in assembly of α4β2
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nicotinic receptors to partially delineate the underlying mechanism of nicotine-induced
upregulation.
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Nanovesicles for Drug Delivery

Contributions: Dr. Rob McCorkle implanted xenografts, injected vesicles and imaged the
mice. Hannah Wang and Karli Lipinski assisted to prepare samples for preliminary studies.
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4.1 Introduction
Strategies to deliver therapeutics into the human body generally take advantage of
the ability of drug molecules to circulate throughout the entire circulatory system. This
leads to the interaction of drugs with both healthy and diseased tissue potentially generating
undesirable side effects. Researchers have been working to develop a number of artificial
drug delivery vehicles that can be utilized to selectively deliver drug molecules to the tissue
of interest without affecting off target tissue (143-150). Incorporation of therapeutics into
liposomes is the most widely studied approach which has created excitement among
researchers after obtaining FDA approval for delivering a chemotherapeutic, doxorubicin,
formulated in pegylated liposomes (252). Liposomes are spherical vesicles composed of at
least one lipid bilayer and an aqueous center. In this vesicle system, hydrophobic drug
molecules can be absorbed into lipid bilayer and hydrophilic molecules can be absorbed
into the aqueous center. The lipid bilayer can also be modified with polyethylene glycol
molecules to increase therapeutic efficacy of encapsulated drug molecules (252,253).
However, these vesicles are rapidly cleared by body’s immune system leading to premature
degradation of the payload (254). Another lipid based drug delivery system, exosomes, is
being extensively studied to utilize advantages of lipid based delivery system while
decreasing the limitation of artificial lipid systems such as liposomes (2,255,256).
Exosomes are spherical vesicles generated by cells to communicate with other cells and to
transfer lipids, proteins, DNA and RNA from donor cells to acceptor cells (1). Exosomes
are considered as potential drug delivery vehicles because they are secreted by a wide
variety of cells in the human body, retain biomarkers of the cell producing the vesicles, and
may selectively carry therapeutics to the cells from which the vesicles were generated (257-
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259). Exosomes have potential to be utilized as a personalized treatment system in which
patient derived exosomes can be loaded with therapeutics to deliver them to the cells which
generated the vesicles (260,261). However, a number of challenges has limited the
applicability of exosomes as a drug carrier. One such challenge is to isolate a specific type
of exosomes from body fluid which contains hundreds of different types of exosomes
generated from the different types of cells in the body. One way to overcome this limitation
is to isolate exosomes from cultured cells, but this approach is inefficient because it has
been reported that only 0.1 μg of vesicles can be produced from one million cells per day
(262). Additionally, this method is costly (39) because cells are usually cultured in a media
containing exosome depleted fetal bovine serum (FBS) which is 3-4 times more expensive
than normal FBS and a large quantity of cells in a large volume of media usually needs to
be cultured to obtain significant quantities of exosomes suitable for drug delivery. Here we
present cancer cell-derived vesicles as drug carriers which possess the positive aspects of
exosomes including biocompatibility, specificity to targeted tissue and the potential to be
utilized in personalized medicine. This new approach can load therapeutics more
efficiently, has high yields of vesicle production and can easy be scaled up for commercial
production.

To test the feasibility of this strategy, we generated cell-derived vesicles and tested
the applicability of these vesicles as general delivery vehicles by separately delivering
protein, DNA, and a chemotherapeutic into cultured cells. We then extended these
experiments and tested their ability to target implanted A549 cancer cell xenografts in nude
mice with compromised immune systems. We performed in vivo imaging to locate the
position of vesicle delivery. Our data suggested that vesicles could selectively reach the
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Figure 4.1 An overview of the overall approach of treating cancer patient with
cancer-cell derived vesicles of the host. At first, a part of the diseased tissue will be
collected through autopsy and cancer cells will be isolated using affinity
chromatography. Nanovesicles loaded with chemotherapeutics will be prepared from
the cells and will be injected back into the patient. Cancer cells derived vesicles being
endogenous to the patient should be able to avoid clearance by the patient’s immune
system and should selectively deliver the payload to the cancer cells.
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xenograft and this finding validates our concept that cell-derived vesicles can be utilized
as a drug delivery vehicle. Ultimately, it may be feasible to use this approach for
personalized medicine where cancer cells are extracted from a patient and used to prepare
vesicles. These vesicles can be loaded with therapeutics and injected back to the patient for
targeted delivery (Figure 4.1).

4.2 Experimental Procedures
4.2.1 Preparation of Empty Vesicles
In order to determine the effect of nitrogen cavitation pressure on the size of the
vesicles, vesicles were generated with varying nitrogen cavitation pressures of 200, 300,
400, 500, 600, 700, 800, and 900 psi for 5 minutes. Briefly, one flask of HEK293T cells
were employed to prepare vesicles for each condition. The cells were detached from the
flask by incubating them with 5 ml 0.45 mM EDTA solution in PBS buffer at 37 °C for 5
minutes. The cell slurry was centrifuged at 400×g for 5 minutes and the obtained cell pellet
was resuspended in 5 ml of sucrose protease inhibitor buffer (10 mM HEPES, 250 mM
Sucrose, pH adjusted to 7.5 and one Pierce protease inhibitor mini tablet per 10 ml buffer).
The total number of cells was counted to determine the volume of solution needed to
resuspend the vesicle pellet to be generated at the end of the preparation. Vesicles were
generated by placing the cells into a nitrogen cavitation chamber (Parr Instruments
Company, IL, USA) and applying varying pressure of 200 to 900 psi with 100 psi
increment for 5 minutes on ice. The cell lysate was centrifuged at 4000×g for 20 min at 4
°C and the obtained supernatant was centrifuged at 10,000×g for 20 minutes at 4 °C. The
resulted supernatant was centrifuged at 100,000×g for 60 min at 4°C to obtain a pellet
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containing vesicles. The pellet was then resuspended in PBS buffer so that the vesicles
generated from 15 million cells would present into 1 ml PBS buffer.

4.2.2 Extrusion of Vesicles to Reduce Their Size
In order to reduce the size, vesicles were initially generated with 300 psi nitrogen
cavitation pressure, unless otherwise mentioned, and the vesicles were extruded with an
extruder (Avanti Polar Lipids, Inc., Alabama). Extrusion was conducted for 11 passages
each through 200, 100 and 50 nm polycarbonate membrane (Avanti Polar Lipids, Inc.,
Alabama) in a series. The extruded vesicles were then subjected to dynamic light scattering
to determine the size of the vesicles.

4.2.3 Determining the Size of Vesicles with Dynamic Light Scattering
To determine the hydrodynamic diameter of vesicles, the vesicle solution (vesicles
generated from 15 million cells were resuspended in one ml PBS buffer) was diluted 1:10
in PBS buffer. About 200 μl of vesicle solution was transferred into a disposable cuvette
and the cuvette was placed in a Malvern Zetasizer Nano ZS. Three measurements were
taken for 3 minute for each sample. The mean diameter of the vesicles was calculated from
the peak value of the fitted curve.

4.2.4 Generation of Protein, DNA and Drug loaded Vesicles
Carboplatin, Dendra2 DNA or proteins (Streptavidin -Alexa Fluor 647) loaded
vesicles were generated from HEK293T cells with the same procedure used to prepare
empty vesicles, except the sucrose buffer (10 mM HEPES, 250 mM Sucrose, pH adjusted
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to 7.5 and one Pierce protease inhibitor mini tablet per 10 ml buffer) used in nitrogen
cavitation contained Streptavidin -Alexa Fluor 647 (100 μg/ml), carboplatin (30 mg/ml),
or Dendra2 DNA (36.2 μg/ml). Since nitrogen cavitation is believed to generate cell
fragments which reorganize to form spherical vesicles, the carboplatin, DNA, proteins or
any other materials present in the solution is entrapped inside the vesicles. This is a more
efficient approach to loading than either liposomes or exosomes where those vesicles are
fully formed and intact prior to drug loading. As a result, those approaches require
additional loading steps which are often inefficient and lead to heterogeneity in the
concentration of therapeutic in either liposomes or exosomes. The loading process for cell
derived vesicles which takes place during formation naturally leads to homogeneous
concentrations of encapsulated therapeutics. The free proteins or carboplatin molecules
which remained in solution after vesicle formation were removed by passage through a
Sephadex G-25 column (PD MidiTrap columns, GE Healthcare). To remove free, proteins
molecules, vesicles were resuspended in 5 ml of sucrose buffer and centrifuged at
100,000×g for 1 hour. The supernatant was discarded and the pellet was resuspended in
PBS buffer. The volume of the buffer was chosen in way that vesicles generated from 15
million cells were resuspended into 1 ml buffer.

4.2.5 Determination of Carboplatin Concentration in Vesicles
The concentration of carboplatin in the vesicle solution was determined by
calculating the amount of platinum present in the solution. At first, 50, 5, 1, 0.5, 0.1, 0.05
ppm platinum standard solutions were prepared in a 5% HCl solution and these solutions
were used to obtain atomic emission using inductively couple plasma optical emission
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spectrometry (ICP-OES, VISTA-PRO). Carboplatin loaded vesicles were mixed with
hydrochloric acid to obtain 5% HCl in the vesicles solution, and this solution was injected
with 1 ppm yttrium in a 5% HCl solution. Emissions were recorded at 191.107, 265.945,
204.939, 214.424, 177.648 and 203.646 nm wavelengths to detect platinum and 371.029
nm wavelength to detect yttrium. A standard curve was obtained by plotting the detected
emission counts vs the concentration of standard solutions of platinum. The standard curve
and emission obtained for a carboplatin solution were utilized to determine the
concentration of the carboplatin solution. To validate the accuracy of the concentration of
platinum in a sample, an internal standard of 1 ppm Pt solution was added to the sample.
When the concentration of platinum in the sample plus the standard was 1 ppm higher than
the concentration of Pt in the sample only, the obtained concentration value was considered
accurate. The concentration of platinum was converted to the concentration of carboplatin
using the molar ratio.

4.2.6 Effect of Carboplatin Loaded Vesicles on the Cell Viability
16 dishes of HEK293T cells (50,000 cells per dish) were plated and cultured in a
humidified hood at 37 °C with 5% carbon dioxide. 24 hours later, 2 ml 75 μM carboplatin
loaded vesicles were added to 8 dishes and only media was added to the remaining 8 dishes
of cells. At 0, 0.5, 1.0, 1.5, 2, 2.5, 3.0 and 3.5-day time points, the total number of live cells
present in one dish was counted using a hemocytometer. The live cells were separated from
dead cells using a Trypan blue (ThermoFisher, catalog number: 15250061) assay where an
equal volume of Trypan blue and cell suspension were mixed. In this assay, the color of
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the live cells remained colorless while that of dead cells turned to blue when located using
a phase contrast microscope.

4.2.7 Labeling Vesicles with Lipophilic Dyes
The generated empty vesicles were usually mixed with 0.5 to 2 μM lipophilic DiI
(ThermoFisher, catalog number: D282) or DiO (ThermoFisher, catalog number: D275)
dyes and the mixture was incubated at 37 °C for 30 minutes. The free dye molecules were
removed using a size exclusion spin column (PD MidiTrap column, GE Healthcare Life
Science, catalog number: 28918008). Briefly, the column was equilibrated with 25 ml PBS
buffer and then centrifuged at 1000×g for 2 minutes to remove remaining buffer. Then, 1
ml vesicle solution was added on top of the column and centrifuged at 1000×g for 2 min
and the eluate was collected. Unless otherwise mentioned, the separation process was
repeated with a second column to ensure removal of trace amount of free dye.

4.2.8 Determining Concentration of Vesicles
Empty vesicles generated from HEK293T cells were first dissolved into PBS buffer
in a way that 15 million cell generated vesicles were present in 1 ml of buffer. For this
experiment, vesicles were diluted 1:4 in PBS buffer and about 2 ml of empty vesicles were
mixed with 0.5 to 1 μM of DiI dye and the mixture was incubated at 37 °C for 30 minutes.
One ml of this mixture was passed through a PD MidiTrap column (see section 4.2.7 for
details) and the flow through was collected as gel purified vesicle solution. A negative
control sample was prepared where DiI was added into 1 ml PBS buffer to make 1 μM DiI
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solution and this solution was also incubated at 37 °C for 30 minutes but was not purified
with any PD MidiTrap columns.

About 50 μl of this sample was added on top of a coverslip and placed on top of a
microscope containing a water immersion objective (LUMPlanFL N, 60X, Olympus). A
532 nm pulse laser source of 20 μW power was directed to the sample through the
objective. As fluorescent molecules pass through the confocal beam generated by the
objective, the fluorescence intensity fluctuates which was recorded by an avalanche
photodiode, τ-SPAD single photon counting module (PiCoQuant GmBh, Germany) and
PicoQuant Symphotime 64 (PiCoQuant GmBh, Germany) software. Autocorrelation of the
signal was determined to calculate the number of particles present in the focal volume. To
determine the concentration of particles, the focal volume needs to be determined as well.
Tetraspeck (100 nm, ThermoFisher Scientific, catalog number: T7279) beads of known
concentration (1 nM) and diffusion coefficient (0.044 ×10-6 cm2s-1) were used to determine
the focal volume of the confocal bream.

4.2.9 Preparation of Vesicles from RAW Cells
About 65 million RAW 264.7 cells were used to prepare vesicles with 300 psi
nitrogen cavitation pressure for 5 min as described in section 4.2.1. The vesicles pellet
obtained after 100,000×g centrifugation was resuspended in 2 ml sucrose buffer (details in
section 4.2.1). 5 μl 2 mM DiR dye (Thermofisher Scientific, Catalog number: D12731)
was added into the 2 ml vesicle solution and the mixture was incubated at 37 °C for 30
minute. The unbound dye molecules were removed using an OptiPrep gradient solution
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which was prepared by adding 2 ml 50 % OptiPrep and followed by 2 ml 10 % OptiPrep
solution into an Ultra-Clear centrifuge tube (Beckman Coulter, catalog number: 340061).
Then, the 2 ml vesicle solution with DiR was added on top of the OptiPrep gradient
solution. This tube with the gradient solution was centrifuged at 112,000×g for 60 min at
4 °C. A Variable-Flow Peristaltic Pumps (Fisherbrand, ThemoFisher) was used to collect
the vesicles solution from the gradient as follows (263). Inlet tubing of the pump was
inserted into the Ultra-Clear tube so that the tubing can reach to the bottom-center of the
solution without mixing the layers. Then, 1.5 ml solution was pumped out and discarded,
and next 1 ml solution was collected. To remove the OptiPrep from the vesicle solution
before injecting it into a mice, a PD MidiTrap column was used as described in section
4.2.7.

4.2.10 Mouse Xenograft implantation and Vesicles Injection
In order to develop a xenograft on a mouse, about 200 μl of 12.5 million per ml
A459 cells (i.e. 2.5 million total cells) in 50% Matrigel was injected under the skin of an
immune deficient nude mouse (Jackson Laboratory, Jax 007850). The xenograft was
allowed to grow to become sufficiently large of subsequent experiments. Vesicles were
generated from RAW 234.7 cells and labeled with DiR dye as described in section 4.2.9.
About 200 μl of the vesicle solution was injected into the tail vein of a mouse containing
the xenograft. For positive control experiments, the same volume of vesicle solution
labeled with DiR was directly injected into the xenograft of a mouse. For negative control
experiments, DiR solution of the similar concentration was passed through a PD MidiTrap
column and 200 μl solution was injected though tail vein of a mouse with a xenograft. The
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mouse was imaged before injection, immediately following injection, and after 24, 48 or
66 hours of injection using 710 nm excitation and 750 nm emission with an in vivo imaging
system (IVIS) (Xenogen 50, PerkinElmer, Inc.).

4.3 Results
4.3.1 Vesicle Characterization
We have previously utilized nanovesicles to isolate single receptors in their
endogenous membrane (239,263-265). This same technique can be utilized to prepare
vesicles loaded with therapeutics to deliver into a targeted location. During vesicle
preparation, when cells are ruptured using nitrogen cavitation, cell fragments are generated
momentarily and these fragments are spontaneously reorganized to produce vesicles
(35,36). Since these vesicles encapsulate the solution where the cells were maintained, we
can maintain the cells with a solution containing chemotherapeutics. The vesicles
generated through this process would be loaded with the same concentration of therapeutics
in the initial solution (Figure 4.2). Since nanoscale particles are absorbed by biological
systems faster and more efficiently than microscale particles (266,267), we explored the
conditions capable of forming the smallest vesicles. Therefore, I prepared 8 vesicle samples
from 8 flasks of HEK293T cells with 200-900 psi in 100 psi increment. The size
distribution of the vesicles was determined using dynamic light scattering (DLS) (Figure
4.3) in which sizes of particles moving into a solution are determined based on the motion
of the particles. Larger particles move slower while smaller particles move faster and the
ability of light scattering by moving particles is dependent on the size of the particle.
Hence, in DLS, particle size is determined by monitoring scattered light of a laser source.
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Figure 4.2 A cartoon presenting the evolution of our concept for encapsulating
therapeutics into cell-derived vesicles. (A) Previously, we kept cells in a solution
(yellow color in A) and upon nitrogen cavitation, we obtained vesicles (B) which
encapsulated the solution (yellow center of vesicles, in B). (C) A zoomed-in vesicle
would display lipid bilayer holding proteins and encapsulating the cell suspension
solution. In the same vesicle preparation technique, if we maintain therapeutics in the
cell suspension (blue color in D), upon vesicles preparation, vesicles would
encapsulate the therapeutics (E). A zoomed-in image of a vesicle would look similar
to the image of C, except this vesicle would entrap therapeutics inside (blue color in
F).
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Figure 4.3 Variation of the size of vesicles with the change in nitrogen cavitation
pressure and the pore size of membrane used in extrusion. (A) The effect of nitrogen
cavitation pressure on the size of the vesicles. 300 psi nitrogen cavitation generated the
smallest vesicles and an increase in nitrogen cavitation pressure resulted in an increase
in vesicle size. *, p<0.05 compared to 300 psi. (B) Determining the effect of extrusion
in the size of the vesicles. The vesicles obtained from 300 psi nitrogen cavitation
(control in B) were extruded through 200, 100 and 50 nm pore containing polycarbonate
membranes. Extrusion with 100 and 50 nm pore containing membrane significantly
reduce the size of the vesicle while later one produced smallest vesicles. *, p<0.05
compared to control sample. The error bar presented as standard deviation. P-value was
calculated using t-test.
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The average sizes of the vesicle solution of triplicate measurements were determined
(Figure 4.3A). The data showed that 200 psi nitrogen cavitation generated vesicles of 161
nm in diameter while 300 psi produced vesicles of 145 nm. Nitrogen cavitation pressure of
400-800 psi produced vesicles of about 200 nm in size and 900 psi generated the largest
vesicles (270 nm in diameter). Ultimately, the data indicated that 300 psi generated the
smallest vesicles while any increase in pressure thereafter increases the size of the vesicles.

4.3.2 Effect of Extrusion in the Content of Vesicles
Since nitrogen cavitation generates vesicles larger than 100 nm in size and smaller
vesicles are more appropriate as drug delivery vehicles, extrusion can be employed to
reduce the size of the vesicles. We have utilized the vesicles obtained from 300 psi nitrogen
cavitation pressure and passed those vesicles though a series of polycarbonate membrane
filters. Dynamic light scattering was utilized to determine the size of the vesicles. The 200
nm membrane does not change the size of the vesicles since the mean size of the vesicles
(150 nm) was smaller than the membrane pore size. 100 nm and 50 nm membranes reduce
the size significantly, but the 50 nm membrane generated the smallest size with about 110
nm in diameter (Figure 4.3B). Therefore, an extrusion of vesicles though a 50 nm
membrane can be applied to reduce the size of the vesicles.

However, it is necessary to probe if the extruded vesicles can keep the cargo intact.
Hence, I prepared vesicles loaded with fluorescein dye by nitrogen cavitation of HEK293T
cells at 600 psi in the presence of 1 mM fluorescein dye. A pressure of 600 psi was found
to provide large vesicles which can be easily visualized with a total internal reflection
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Figure 4.4 Probing whether extrusion of vesicles can maintain the content of the
vesicles. (A) An image of vesicles loaded with fluorescein dye molecules. The well
distributed large size of the fluorescent spots indicated that fluorescein molecules were
present inside the vesicles. (B) An image of fluorescein dye loaded vesicles after
extruding through a 100 nm polycarbonate membrane. The relative smaller size of spots
indicated the size of the vesicles became smaller and the extrusion did not remove their
content.
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fluorescence (TIRF) microscope. The fluorescein loaded vesicles were absorbed on a glass
substrate and imaged with a TIRF microscope. The presence of bright fluorescent spots on
the image clearly indicated the encapsulation of dye molecules inside the vesicles (Figure
4.4). These vesicles were then extruded through a 100 nm polycarbonate membrane, and
the extruded vesicles were absorbed on a coverslip and imaged to locate the vesicles. The
resultant image indicated that the size of the vesicles was smaller than those of unextruded
vesicles, and the extruded vesicles can hold the content inside. Therefore, extrusion can be
employed to reduce the size of vesicles without losing cargo.

4.3.3 Effect of Size Exclusion Chromatography in the Concentration of Vesicles
In order to remove free dye or other free cargo molecules from the vesicle
preparation, we filtered the vesicle solution through size exclusion columns (PD MidiTrap
columns containing Sephadex G-25). Since the vesicles can interact with the beads of the
columns, it was necessary to determine if the interaction caused any retention of the
vesicles inside the column. Hence, at first, I generated vesicles from HEK293T cells and
labeled the lipid bilayer of the vesicles with 0.5 to 1.0 μM DiI dye. The dye labeled vesicles
were subjected to fluorescence correlation spectroscopy (FCS) to determine their
concentration (Figure 4.5A). In FCS, a confocal beam is directed into a dilute solution
containing fluorescent molecules. When a molecule diffuses through the confocal beam it
is excited and the resulting fluorescence intensity fluctuation are recorded. The signal is
autocorrelated with itself to determine the number of particles present on average in the
focal volume. I determined the focal volume using Tetraspeck beads of know
concentration, size and diffusion coefficient. Using the focal volume and the number of
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molecules in the focal volume, the concentration of the fluorescent particles was calculated.
The concentration of vesicles (obtained from 15 million cells and resuspended in 1 ml
buffer) was determined to be 150 ± 31 nM. Then, the same sample was passed through a
size exclusion column to remove free dye molecules. In this sample, the concentration of
vesicles was found to be 157 ± 39 nM. These concentrations were determined not to be
statistically significantly different (n=7 for each sample). Since, the first measurement was
acquired without removing free dyes from the sample, I recorded the change in
fluorescence intensity for a dye solution only and found no autocorrelation in the signal.
This result indicated that the signal of the dilute fluorescent dye is not detectable. We
observed the same concentration of vesicles before and after size exclusion
chromatography indicating this approach can be employed to remove free dyes form the
mixture.

4.3.4 Delivering DNA, Protein, and Drug Molecules to Cells
DNA polymers are commonly delivered to cells by entrapping them inside cationic
lipid solutions, such as lipofectamine, which can cross the cell membrane. Protein
expression generated from the delivered DNA is assessed to validate transfection of the
DNA. I wanted to test the applicability of cell-derived vesicles as general delivery vehicles
by delivering cargo into cultured cells. I performed a series of experiments to deliver
different cargo including DNA, protein, and therapeutics via cell-derived vesicles. First, I
prepared vesicles loaded with DNA plasmid for the fluorescent protein Dendra2. This was
done using nitrogen cavitation of HEK293T cells in the presence of the DNA containing
solution. The cavitation process momentarily generates cell fragments which
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Figure 4.5 Determining the effect of size exclusion chromatography (gel filtration)
in the concentration of the vesicles. Vesicles were generated from HEK293T cells with
300 psi nitrogen cavitation pressure and treated with a lipophilic dye (DiI) to label the
surface of the vesicles. Fluorescence correlation spectroscopy (FCS) was employed to
determine the concentration of vesicles before and after running through gel filtration
columns. (A) A representative curve of FCS whose y-intercept value is employed to
determine the total number of molecule in the focal volume and the focal volume was
determined using standard fluorescence molecules. (B) Concentrations of vesicles
before and after passing through a Sephadex G-25 column were determined to be 150
and 160 nM which are not statistically significantly different. Error bars are presented
as standard error of the mean.
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Figure 4.6 Delivery of the DNA of a fluorescent protein (Dendra2), dye conjugated
protein, and therapeutic loaded vesicles into HEK293T cells. (A) HEK293T cells were
treated with Dendra2 plasmid loaded vesicles for 24 hours, and an image was taken exciting
the fluorescent proteins. (B) Alexa Fluor-647 conjugated Streptavidin protein loaded vesicles
were added on top of HEK293T cells. The presence of fluorescence signal on the cells
indicates the delivery of the protein into the cells. (C) Carboplatin loaded vesicles were added
on top of HEK293T cells and the total number of live cells were counted over 3.5-day time
periods. Although the total number of live cells for control sample increases exponentially,
that of the carboplatin loaded vesicles treated cells remained almost constant. We conclude
that the cargoes of the vesicles were delivered into the cells. The error bars are presented as
the standard deviation.
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spontaneously form vesicles entrapping the cavitation solution. I treated HEK293T cells
with the DNA loaded vesicles and simultaneously allowed the cells to grow and express
proteins from the delivered DNA for 24 hours. The cells were imaged with a total internal
reflection fluorescence microscope. The presence of bright fluorescence in the cells
indicated the presence of the Dendra2 fluorescence signal validating the delivery of the
DNA into the cells (Figure 4.6A). I then set up a set of experiments to determine if protein
could also be delivered into cells. Streptavidin proteins conjugated with Alexa Fluor 647
were similarly loaded into vesicles, and the vesicles were added to HEK293T cells plated
on a glass bottom Petri dish. The cells were imaged with a fluorescence microscope
exciting the Alexa Fluor 647 dyes to locate the position of delivered proteins. The bright
fluorescence in the cells indicated the successful delivery of protein into the cells via cell
derived vesicles. Finally, carboplatin loaded vesicles were prepared by nitrogen cavitation
in the presence of 30 mg/ml carboplatin in sucrose protease buffer (10 mM HEPES, 250
mM Sucrose, pH 7.5, one Pierce protease inhibitor mini tablet per 10 ml buffer). The
concentration of carboplatin in the vesicle solution was determined using an inductively
coupled plasma optical emission spectrometry (ICP-OES). 75 μM of carboplatin
containing vesicles were added to HEK293T cells and the total number of live cells present
on a dish was counted using trypan blue assay. The number of live cells increased
dramatically for the control sample (no treatment) whereas that of the carboplatin loaded
vesicles treated cells remained almost constant. The difference between the total number
of live cells for these two conditions indicates the effect of carboplatin delivered via
vesicles. These studies indicate that cell-derived vesicles can be employed to deliver cargo
into cells.
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Figure 4.7 Probing that in vivo imaging can be employed to locate fluorescence
signal when dye labeled vesicles reach to the tumor. Vesicles were generated from
A549 cells and labeled with DiR dye. The vesicle solution was directly injected into the
tumor and the mouse was imaged in vivo at pre-injection (left) and 48-hour post
injection (right). The presence of fluorescence signal on the tumor up to 48 hours
indicates that if intravenous injection of dye labeled vesicles reach the tumor we will be
able to locate them using an in vivo imaging system (IVIS).
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4.3.5 Delivery of Vesicles to Tumors
In order to validate that cancer cell derived vesicles loaded with drug molecules can
be delivered to tumors in vivo, we first implanted tumors into immune compromised nude
mice by subcutaneous injection of A549 cancer cells. About a month later, vesicles were
generated from A549 cells using nitrogen cavitation and were labeled with lipophilic dye
molecules- DiR. The dye labeled cell-derived vesicles were injected directly into the tumor
of a mouse (Figure 4.7). The mouse was imaged in vivo to locate the dye in the tumor, and
the presence of fluorescence on the tumor was used as a positive control for the
experiments. Next, we injected a mouse with the RAW 264.7 cell derived vesicles through
its tail vein. In the same manner, another mouse was injected with DiR solution only to
serve as a negative control. The control sample did not display any detectable signal on
any part of the body of the mouse but the vesicle sample injected into a mouse showed a
very bright signal on the location of tumor even after 66 hours of injection (Figure 4.8).
These findings validated the concept that cell-derived vesicles generated from nitrogen
cavitation can reach tumors and these vesicles can be utilized to deliver chemotherapeutics
into a targeted tumor.

4.4 Discussion
At first, we prepared vesicles from HEK293T cells using nitrogen cavitation and
characterized the size of vesicles using dynamic light scattering. We have also
characterized the effect of nitrogen cavitation pressure on the size of the vesicles. We found
that 300 psi nitrogen cavitation pressure generated the smallest vesicles with a diameter of
about 150 nm. When the pressure was increased above 300 psi, the size of the vesicles also
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Figure 4.8 Determining whether vesicles can reach into the tumor when the vesicle
solution is injected though tail vein of a mouse. Vesicles were generated from RAW
264.7 cells and labeled with DiR molecules. This vesicle solution was injected into a
mouse with a xenograft. No signal was obtained in the image captured before injection
(circle on the left image indicates the position of the xenograft). After the injection, a
bright fluorescent spot was observed in the location of the xenograft (right). This finding
validated the concept that cell-derived vesicles using nitrogen cavitation could be used
to delivery therapeutics into a targeted location in the body.
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increased. We hypothesized that the high pressure causes the cells to rupture unevenly
compared to what occurs at 300 psi pressure. Nanoscale vesicles have advantages over
larger vesicles in terms of blood circulation time, clearance by the reticulo-endothelial
system and delivering of drug molecules through capillaries of the tumors (254,268,269).
Hence, obtaining smaller vesicles is more desirable as a drug carrier system (269,270).
One of the prominent methods to reduce the size of the vesicles is extruding them through
a polycarbonate membrane (38). We employed extrusion with varying pore sizes of
polycarbonate membranes to monitor the size change of the vesicles. We demonstrated that
50 nm membranes can produce vesicles of about 100 nm in size which is significantly
lower in size than those generated at 300 psi nitrogen cavitation. Other types of vesicles
with diameters of 100 nm were reported not to be recognized by the reticulo-endothelial
system during in vivo delivery of cargo (268,271).

Next, we prepared vesicles from HEK293T cells using nitrogen cavitation and
labeled the vesicles with DiI dye molecules which are lipophilic and weakly fluorescent
when not bound with lipids. Then, we passed the vesicle solution through PD MidiTrap
columns to remove the free dye molecules. We determined the concentration of vesicles
using fluorescence correlation spectroscopy and found that the concentration of the vesicles
before and after passing through gel columns was around 150 nM. This result suggested
that no detectable quantity of vesicles was retained inside a size exclusion column which
made them suitable for removing unbound dye molecules from the vesicles solution.

Nitrogen cavitation produces cell fragments which spontaneously reorganize to
generate vesicles encapsulating the solution containing cargo molecules. Thus, we made
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vesicles loaded with DNA, proteins or therapeutics by maintaining these cargo molecules
in the nitrogen cavitation solution. Before testing the delivery of the cargo molecules into
the tumor of a mouse model, we tested the delivery to HEK293T cells. The vesicles were
added on top of the cells for a given time period and images of the cells were analyzed to
determine the delivery of the cargo. For example, Dendra2 plasmid was loaded into
vesicles and the vesicle solution was added on top of HEK293T cells. The cells were
allowed to grow for 24 hours and then imaged with fluorescence microscopy to locate the
presence of Dendra2 fluorescent proteins. Similarly, we demonstrated that vesicles can be
employed to deliver proteins and therapeutics to cells. Since cell-derived vesicles are
structurally similar to exosomes (40), the mechanism of delivery of cargo by cell-derived
vesicles might be similar to that of exosomes. Although, the mechanism of exosome
internalization is not clearly understood, it has been reported that exosomes might deliver
its cargo into the recipient cell by endocytosis or direct fusion of vesicles into the recipient
cells (272).

Next, we validated the concept that therapeutic loaded cell-derived vesicles
prepared with nitrogen cavitation can reach a tumor engrafted in an animal. First, we
implanted a xenograft into an immune compromised nude mouse with A549 cancer cells.
When the tumor grown enough, we generated vesicles from cells and ran a positive control
experiment. In this experiment, the cell-derived vesicles labeled with DiR dye molecules
were directly injected into the tumor. The mouse was imaged with an in vivo imaging
system, and we compared the images obtained from subsequent imaging session to probe
the delivery of vesicles into the tumor. Then, we injected DiR dye molecules containing
solution into the tail vein of another mouse with a xenograft and found no detectable
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location of dyes in the tumor. Finally, we prepared vesicles labeled with DiR molecules
and injected this sample into the tail vein of a xenograft containing mouse. Images of the
mouse showed that vesicles can successfully reach to the tumor. The result validated our
hypothesis that cell derived vesicles obtained from nitrogen cavitation could be utilized to
delivery therapeutics selectively to tumors.

4.5 Conclusion
We have demonstrated that nanoscale cell derived vesicles can be generated from
mammalian cells with a combination of nitrogen cavitation and extrusion. We have
employed these vesicles to deliver plasmids, chemotherapeutics, and proteins into cells.
Then we made cell derived vesicles labeled with an organic dye and injected these dye
labeled vesicles into mice engrafted with a tumor. Our preliminary data suggests that the
vesicles can successfully recognize and reach cancer cells. In the future, we can extend this
study to patient derived xenografts. In this new study, we plan to isolate cancer cells from
a cancer patient through biopsy, and a fraction of the cells will be implanted into a mouse
to develop a xenograft. The remaining cells will be cultured and used to prepare vesicles
which will be labeled with dye molecules and injected into the mouse to check if the
vesicles can reach the xenograft. Chemotherapeutic loaded vesicles will also be injected
into the mouse to determine the effectiveness of the drug vs those injected without any
delivery systems.
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Conclusions and Future Directions
5.1 Conclusions
One of the main goals of my graduate research was to develop a method to isolate
single transmembrane proteins into a diffraction-limited spot without compromising its
functional and structural integrity. Single molecule fluorescence methods can provide
detailed knowledge about the conformational changes of biomolecules (4,5), dynamics of
the gating of ion channels (6), folding and unfolding of proteins (7,11) and assembly of
oligomeric receptors (10,13). In order to obtain these details of molecular events, single
transmembrane proteins need to be isolated into diffraction limited spots. One common
approach to isolating single transmembrane proteins involves expressing a very low level
of proteins in mammalian cells or oocytes. The low expression rate can reduce the
probability of isolating multiple proteins on a diffraction limited spot (13). However, the
cells tend to produce auto-fluorescence which increases the background fluorescence level
and thus reduces signal to noise ratio (15,16). Additionally, membrane proteins tend to
move laterally along the membrane increasing the local concentration of the protein (273).
This phenomenon along with low signal to noise ratio difficult the single-molecule studies
of transmembrane proteins located in live cells. Another common approach involves
isolation of the membrane protein into an artificial lipid bilayer (273). One of the
intermediate steps of this approach involves isolation of the protein into a detergent
solution which endangers the structural integrity of oligomeric transmembrane proteins.
To circumvent the issue associated with the concentration barrier, the low signal to noise
ratio, and the structural integrity, I have expressed transmembrane proteins in mammalian
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cells with a very low expression level and then isolated the proteins into cell-derived
vesicles without removing them from their physiological membrane. In Chapter 2, I
utilized cell-derived vesicles prepared with nitrogen cavitation to isolate single membrane
proteins. I showed that cell-derived vesicles can be employed to study stoichiometric
assembly of CFTR, EGFR, and nicotinic receptors. We determined the stoichiometry of
α3β4 nicotinic receptor with single color and two colors experiments. We also
demonstrated that receptors isolated in cell derived vesicles are functional. Therefore,
proteins isolated in cell-derived vesicles can maintain their functional and structural
integrity.

Although single molecule studies of transmembrane proteins can provide an
overview of the structural properties of a protein, organelle specific information is sparse
due to the lack of a proper methods of isolating membrane proteins from different
organelles. The ER is the organelle where transmembrane proteins become synthesized and
assembled and the assembled proteins are transported from the ER to the plasma
membrane. Isolation of oligomeric receptors into cell-derived vesicles of different
organelles can provide information of the freshly assembled receptors and the already
trafficked receptors. When a small molecule interacts with nascent receptors to affect their
structural and functional properties, the organelle specific vesicles, in combination with
single-molecule receptors, can provide detailed information about the drug induced
intracellular changes in the assembly of the receptor. In Chapter 3, in collaboration with
another member of Richards’ lab (Dr. Ashley M. Loe), I studied the effects of different
types of nicotinic receptors’ ligands on the assembly and trafficking of α4β2 nicotinic
receptor. We demonstrated that all classes of ligands – agonist, partial agonist, and
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antagonist – can increase the total number of receptors in both the ER and the plasma
membrane and can alter the distribution of the receptors in the ER and the plasma
membrane. The ER and plasma membrane-originated receptors were isolated to study the
stoichiometric assembly in those organelles. The data suggested that the ER has a higher
proportion of the low sensitivity isoform of α4β2 nicotinic receptors than the plasma
membrane. The opposite is true for high sensitivity isoforms. This result suggested that the
high sensitivity isoform trafficked more efficiently from the ER to the plasma membrane
than their counterparts. When nicotine was present, the ratio of a high sensitivity isoform
increases in both the ER and plasma membrane. This result suggested that nicotine helped
the high sensitivity isoform to be assembled more efficiently in the ER and the same
isoform, which was higher in number in the pool due to the presence of nicotine, was
preferentially trafficked to the plasma membrane, increasing the proportion of the isoform
than that of the no nicotine treatment.

The cell-derived vesicles employed in this study are structurally similar to the lipidbased drug carriers used to deliver drug molecules into a targeted location. Some
researchers have employed cell-derived vesicles to deliver therapeutics into tumors of
mice. However, our method of vesicle preparation is faster and can be utilized to load with
drug molecules more efficiently. Hence, my final aim was to explore the applicability of
cell-derived vesicles as a drug delivery system. An ideal drug carrier should possess the
ability to avoid seizure and degradation by body’s immune system, should reach to the
targeted tissue of the body and should penetrate the cellular system to deliver the cargo for
an extended time period (39). A number of approaches has been made to develop an ideal
drug delivery system including liposomes, polymer nanoparticles, micelles, carbon
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nanotubes and gold nanotubes (143-150). Among all these approaches, liposomes have
brought the most excitement by obtaining FDA approval for delivering chemotherapeutics
(252). Liposomes are spherical vesicles consisting of at least one lipid bilayer containing a
hydrophilic aqueous center. Hydrophilic drug molecules can be loaded into the aqueous
center and lipophilic drug molecules can be inserted into the lipid bilayer. Thus, liposomes
can be employed to deliver toxic drug molecule into a targeted location. However,
liposome can elicit an immune response leading to premature degradation of the payload
(274). These vesicles are cleared by the cellular defense system and become degraded
prematurely. Hence, another type of vesicle found in the body fluid called exosomes are
being extensively studied to employ as a drug delivery system (2,255,256). Exosomes are
endogenous vesicles utilized by cells to communicate with cells located at a distance. Since
cells spontaneously produce exosomes, the collection of these vesicles is a very time
consuming, inefficient and expensive process (39).

In Chapter 4, first, we demonstrated that cell derived vesicles can be employed to
deliver genes, proteins and chemotherapeutics into cells by loading these materials inside
the vesicles. We implanted xenografts in immune compromised nude mice with A459
cancer cells and prepared vesicles from the cancer cells as well as RAW 264.7 cells using
nitrogen cavitation. We labeled the vesicles with a lipophilic dye suitable for in vivo
imaging. The dye-labeled vesicles were injected into mice with xenografts, and the mice
were imaged with an IVIS to locate the position of the dye in the body of the mice. The
captured image displayed the presence of a large fluorescent spot on the location of the
xenograft indicating successful delivery of vesicles. This finding validated our hypothesis
that cell-derived vesicles generated by nitrogen cavitation could be utilized to deliver
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therapeutics into a targeted location. We believe that this study can be extended to human
subjects where cancer cells can be extracted from a patient and these cancer cells can be
utilized to prepare vesicles loaded with chemotherapeutics. These vesicles will be injected
back to the patient to deliver chemotherapeutics selectively to the patient’s cancer cells.

5.2 Future Directions
In chapter 2, we demonstrated that different types of transmembrane proteins can
be isolated on cell-derived vesicles to conduct single molecule studies. We believe that
these vesicles can be utilized to isolate all sorts of membrane proteins at the single molecule
level, and thus single molecule studies can be extended to transmembrane proteins which
otherwise could not be studied using traditional approaches. Although our demonstration
of the single molecule studies were limited to step-wise photobleaching and fluorescence
correlation spectroscopy, we believe that our approach can be adopted to conduct studies
with single molecule FRET of freely diffusing molecules or immobilized molecules. We
also believe that single channel kinetics of different ion channels can be studied by isolating
them into cell-derived vesicles.

In chapter 3, we revealed that nicotine and other nicotinic ligands can alter the
assembly and trafficking of α4β2 nicotinic receptors, it would interesting to know if the
endogenous nicotinic receptor ligand, acetylcholine, can also alter assembly and trafficking
of nicotinic receptors. I hypothesis that the endogenous ligand will also alter the assembly
and trafficking of nicotinic receptor to a certain extend. This experiment will help us to
understand if the mechanism of nicotine induced upregulation is any different than that
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observed for endogenous ligands. Additionally, I believe the single molecule studies can
be extended to understand the effect of nicotine and other nicotinic receptor ligands on the
assembly of α4β2 nicotinic receptors derived from brain samples of animal model. In this
work, a transgenic mouse model can be developed to knock-in α4-GFP gene and the brain
from the mouse can be utilized to prepare vesicles isolating single receptors. Similarly,
studies can be conducted with β2-GFP knock-in mouse brains to complement the studies
with α4-GFP knock in mouse brain. We can also isolate receptors from presynaptic and
postsynaptic neurons and study the assembly of different nicotinic receptors in those
regions with and without presence of nicotinic receptor ligands.

In chapter 4, we showed that cell-derived vesicles can be utilized to encapsulate
therapeutics and deliver the therapeutics into a tumor selectively. Still, we need to conduct
a number of experiments to understand the mechanism of delivery and stability of the
vesicles. We can prepare vesicles and store into -80 °C for a given length of time, then the
vesicles can be lyophilized to determine the change in stability of the vesicles over the time
period using a differential scanning calorimetry. We can also determine change in
concentration of vesicles and surface charge or zeta potential over time using FCS and DLS
respectively to study the effect of storage in those parameters.
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Appendix
Outline of GUI: getTimeTraces_byFaruk.fig

Figure S1: Outline of the GUI used to collect time traces from tiff stacks. This GUI was
saved as “getTimeTraces_byFaruk.fig”. The underlying variables (Tag) for components 120 can be found in the Table S1.
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Figure S2: A figure of the GUI shown in Figure S1 without numbering. This figure displays
all texts and default values on the GUI.

Table S1: The essential variables used in the figure for GUI (Figure S1). All other
components were either Static Texts or Panels.
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Number in Type
Figure S1 component

of String

Tag

1

Axes

Not applicable

axes1

2

Slider

Not applicable

sliderChangeFrameInPlot

3

Push Button

Load Movies

loadMovies

4

Check Box

getFirstFrameWithS
potsFromSlider

getFirstFrameWithSpotsFromSl
ider

5

Static Text

Empty

firstFrameWithSpots

6

Edit Text

10

NumOfFramesAddToFindPeak
s

7

Edit Text

10

ImageEdgeSize

8

Edit Text

3

stdInput

9

Push Button

addAPeak

addAPeak

10

Push Button

Find Peaks

findPeaks

11

Push Button

deleteLastPeak

deleteLastPeak

12

Static Text

Empty

numOfSpotsFound

13

Static Text

Empty

currentMovieNumDisp

14

Push Button

nextMovie

nextMovie

15

Push Button

previousMovie

previousMovie

16

Push Button

zoomAPeak

zoomAPeak

17

Edit Text

ROI Length

roiLength

18

Check Box

backgndSubtrctn_rin backgndSubtrctn_ringAroundR
gAroundRoi
oi

19

Check Box

backgndSubtrctn_m
ovingDisk

backgndSubtrctn_movingDisk

20

Push Button

Populate Data

populateData
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Matlab Code in a file called, “getTimeTraces_byFaruk.m”
All Matlab codes were written in Matlab (version 2017a). The following code was
saved on a Matlab file, called, “getTimeTraces_byFaruk.m”.

function varargout = getTimeTraces_byFaruk(varargin)
% Begin initialization code - DO NOT EDIT
gui_Singleton = 1;
gui_State = struct('gui_Name',
mfilename, ...
'gui_Singleton', gui_Singleton, ...
'gui_OpeningFcn', @getTimeTraces_byFaruk_OpeningFcn, ...
'gui_OutputFcn', @getTimeTraces_byFaruk_OutputFcn, ...
'gui_LayoutFcn', [], ...
'gui_Callback', []);
if nargin && ischar(varargin{1})
gui_State.gui_Callback = str2func(varargin{1});
end
if nargout
[varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:});
else
gui_mainfcn(gui_State, varargin{:});
end
% End initialization code - DO NOT EDIT
% --- Executes just before getTimeTraces_byFaruk is made visible.
function getTimeTraces_byFaruk_OpeningFcn(hObject, eventdata, handles, varargin)
% This function has no output args, see OutputFcn.
% hObject handle to figure
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% varargin unrecognized PropertyName/PropertyValue pairs from the
%
command line (see VARARGIN)
% Choose default command line output for getTimeTraces_byFaruk
handles.output = hObject;
set(handles.axes1,'XTickLabel','','YTickLabel','','xtick',[],'ytick',[]);
set(handles.figure1,'Name',mfilename); %set mfilename as GUI name
% Update handles structure
guidata(hObject, handles);
% UIWAIT makes getTimeTraces_byFaruk wait for user response (see UIRESUME)
% uiwait(handles.figure1);
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% --- Outputs from this function are returned to the command line.
function varargout = getTimeTraces_byFaruk_OutputFcn(hObject, eventdata, handles)
% varargout cell array for returning output args (see VARARGOUT);
% hObject handle to figure
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Get default command line output from handles structure
varargout{1} = handles.output;
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
function loadMovies_Callback(hObject, eventdata, handles)
% hObject handle to loadMovies (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
pathMfile = fileparts(mfilename('fullpath'));
addpath(pathMfile);
% addpath(fullfile(pathMfile, 'timeTrace_calls'));
%Open standard dialog box for retrieving files
[fileName,filepath]=uigetfile('*.tif','select the Tiff Movie','MultiSelect','on');
if iscell(fileName) %multiple files were selected
cd(filepath);
initalNumberOfFramesLoaded=getInitalNumOfFramesToLoad();
totalNumMovies=length(fileName);
tempRawData=cell(1,totalNumMovies);
fullFileName=cell(1,totalNumMovies);
hM=waitbar(0,'Reading Movie : 1');
for i=1:totalNumMovies
waitbar(i/totalNumMovies,hM,['Reading
Movie
',num2str(i),'/',num2str(totalNumMovies)]);
fullFileName{i}=fullfile(filepath,fileName{i});
tempRawData{i}=tempLoadAMovie(fullFileName{i},i,initalNumberOfFramesLoaded);
end
elseif fileName~=0 %only one file has been selected
cd(filepath);
initalNumberOfFramesLoaded=getInitalNumOfFramesToLoad();
totalNumMovies=1;
tempRawData=cell(1,1);
fullFileName={fullfile(filepath,fileName)};
hM=waitbar(0,'Reading Movie : 1');
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:

tempRawData{1}=tempLoadAMovie(fullFileName{1},1,initalNumberOfFramesLoaded)
;
elseif fileName==0; %user did not select any movie
return
end
%initiate donor and acceptor peak sets
handles.peakSets=cell(1,totalNumMovies);
handles.roiDiaMats=cell(1,totalNumMovies);
handles.combIm=cell(1,totalNumMovies);
handles.firstFrameWithSpotsMat=cell(1,totalNumMovies);
handles.thresholdValueMat=cell(1,totalNumMovies);
handles.stdInputMat=cell(1,totalNumMovies);
handles.NumOfPeaksManuallySelected=zeros(totalNumMovies,1);
%share data
handles.tempRawData=tempRawData;
handles.fullFileName=fullFileName;
handles.currentMovieNum=1; %count number of movie under analysis
handles.totalNumMovies=totalNumMovies;
%plot data
plotImage(handles.axes1,tempRawData{1}(:,:,1));
%update
sliderMin=1;
sliderMax=size(tempRawData{1},3);
stepSize=[1,1]/(sliderMax-sliderMin);
set(handles.sliderChangeFrameInPlot,'Min',sliderMin,'Max',sliderMax,'Value',5,
'SliderStep', stepSize);
currMovDis=[num2str(handles.currentMovieNum),'/',num2str(handles.totalNumMovies)]
;
set(handles.currentMovieNumDisp,'String',currMovDis);
%if user is analyzing 2nd movie, need to reset the getFirstFrameWithSpotsFromSlider
set(handles.getFirstFrameWithSpotsFromSlider,'Value',1);
set(handles.firstFrameWithSpots,'String','1');
close(hM);
guidata(hObject, handles);
function val=getInitalNumOfFramesToLoad()
prompt = {'Number of frames will be initially loaded ?'};
dlg_title = 'Input';
num_lines = 1;
defaultans = {'50'};
val = inputdlg(prompt,dlg_title,num_lines,defaultans);
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val=round(str2double(val{:}));
function
[tempRawData]=tempLoadAMovie(fullFileName,movieNum,initalNumberOfFramesLoa
ded)
genMessage=['Reading first ', num2str(initalNumberOfFramesLoaded), ' frames of
Movie # '];
hTemp=waitbar(0,[genMessage,num2str(movieNum)]);
MovieInfo = imfinfo(fullFileName);
width=MovieInfo.Width;
height=MovieInfo.Height;
numberOfImages = length(MovieInfo);
if
numberOfImages<initalNumberOfFramesLoaded
%load
only
initalNumberOfFramesLoaded frames
msgbox('There should be at least', num2str(initalNumberOfFramesLoaded), '
frames per movie','Error','error');
end
tempRawData = zeros(height,width,initalNumberOfFramesLoaded,'uint16');
for k = 1:50
updatWaitbar=[{['Reading
first
',genMessage,num2str(movieNum)]};{[num2str(k),'/',num2str(initalNumberOfFramesLo
aded)]}];
waitbar(k/initalNumberOfFramesLoaded,hTemp,updatWaitbar);
tempRawData(:,:,k)=imread(fullFileName, k, 'Info', MovieInfo);
end
close(hTemp);
% --- Executes on slider movement.
function sliderChangeFrameInPlot_Callback(hObject, eventdata, handles)
% hObject handle to sliderChangeFrameInPlot (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'Value') returns position of slider
%
get(hObject,'Min') and get(hObject,'Max') to determine range of slider
val=round(get(hObject,'Value'));
currentMovieNum=handles.currentMovieNum; %count number of movie under
analysis
tempRawData=handles.tempRawData;
%plot
plotImage(handles.axes1,tempRawData{currentMovieNum}(:,:,val));
if get(handles.getFirstFrameWithSpotsFromSlider,'Value');
set(handles.firstFrameWithSpots,'String',num2str(val));
end
guidata(hObject, handles);
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% --- Executes during object creation, after setting all properties.
function sliderChangeFrameInPlot_CreateFcn(hObject, eventdata, handles)
% hObject handle to sliderChangeFrameInPlot (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: slider controls usually have a light gray background.
if isequal(get(hObject,'BackgroundColor'), get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor',[.9 .9 .9]);
end
function firstFrameWithSpots_Callback(hObject, eventdata, handles)
% hObject handle to firstFrameWithSpots (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of firstFrameWithSpots as text
%
str2double(get(hObject,'String')) returns contents of firstFrameWithSpots as a double
input=str2double(get(hObject,'String'));
if input<1
msgbox('Please input a positive number');
return;
end
guidata(hObject,handles);
% --- Executes during object creation, after setting all properties.
function firstFrameWithSpots_CreateFcn(hObject, eventdata, handles)
% hObject handle to firstFrameWithSpots (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in getFirstFrameWithSpotsFromSlider.
function getFirstFrameWithSpotsFromSlider_Callback(hObject, eventdata, handles)
% hObject handle to getFirstFrameWithSpotsFromSlider (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of getFirstFrameWithSpotsFromSlider
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% --- Executes on button press in previousMovie.
function previousMovie_Callback(hObject, eventdata, handles)
% hObject handle to previousMovie (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
%share data
if handles.currentMovieNum>1
tempRawData=handles.tempRawData;
handles.currentMovieNum=handles.currentMovieNum-1;
plotImage(handles.axes1,tempRawData{handles.currentMovieNum}(:,:,1));
%reset sothat firstImageWithSpots will be updated by frameNumSlider
set(handles.getFirstFrameWithSpotsFromSlider,'Value',1);
set(handles.sliderChangeFrameInPlot,'Value',5);
set(handles.firstFrameWithSpots,'String','5');

currMovDis=[num2str(handles.currentMovieNum),'/',num2str(handles.totalNumMovies)]
;
set(handles.currentMovieNumDisp,'String',currMovDis);
guidata(hObject,handles);
end
% --- Executes on button press in nextMovie.
function nextMovie_Callback(hObject, eventdata, handles)
% hObject handle to nextMovie (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)

if handles.currentMovieNum<handles.totalNumMovies
tempRawData=handles.tempRawData;
handles.currentMovieNum=handles.currentMovieNum+1;
%plot
plotImage(handles.axes1,tempRawData{handles.currentMovieNum}(:,:,1));
%share data
%reset sothat firstImageWithSpots will be updated by frameNumSlider
set(handles.getFirstFrameWithSpotsFromSlider,'Value',1);
set(handles.firstFrameWithSpots,'String','5');
set(handles.sliderChangeFrameInPlot,'Value',5);
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currMovDis=[num2str(handles.currentMovieNum),'/',num2str(handles.totalNumMovies)]
;
set(handles.currentMovieNumDisp,'String',currMovDis);
guidata(hObject,handles);
end
% --- Executes on button press in findPeaks.
function findPeaks_Callback(hObject, eventdata, handles)
% hObject handle to findPeaks (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
%find peaks of acceptor channel
set(handles.getFirstFrameWithSpotsFromSlider,'Value',0);
firstFrameWithSpots=str2double(get(handles.firstFrameWithSpots,'String'));
tempRawData=handles.tempRawData;
fullFileName=handles.fullFileName;
currentMovieNum=handles.currentMovieNum; %count number of movie under
analysis
combIm=tempRawData{currentMovieNum}(:,:,firstFrameWithSpots);
% combIm=imtophat(combIm,strel('disk',10));
frams=str2double(get(handles.NumOfFramesAddToFindPeaks,'String'));
for i=firstFrameWithSpots+1:firstFrameWithSpots+frams-1
%
aframe=imtophat(tempRawData{currentMovieNum}(:,:,i),strel('disk',10));
aframe=tempRawData{currentMovieNum}(:,:,i);
combIm=combIm+aframe;
end
%background subtraction from the images
%

combIm=imtophat(combIm,strel('disk',10));
%get peaks from registered image and plot in both channels.
Mean=mean(combIm(:));
STD=std(double(combIm(:)));
stdInput=str2double(get(handles.stdInput,'String'));
threshold=ceil(Mean+STD*stdInput);
imageEdge=str2double(get(handles.ImageEdgeSize,'String'));
[peakSet,roiDiaMat]=getImagePeaks(combIm,threshold,imageEdge);
%
[peakSet,roiDiaMat]=getCentOfMassCoor(combIm,peakSet);
%
figure; hist(roiDiaMat);
%update plot
plotImage(handles.axes1,combIm,peakSet);
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set(handles.numOfSpotsFound,'String',num2str(size(peakSet,1)));
%update the slider
maxThreshold=threshold*5;
minThreshold=1;
stepSize=[25,25]/(maxThreshold-minThreshold);
%
set(handles.sliderCombinedImageThreshold,
'SliderStep',
stepSize,'Min',minThreshold,'Max',maxThreshold,'Value',threshold);
% set(handles.combinedImageThresholdDisplay,'String',num2str(threshold));
%share data
handles.combIm{currentMovieNum}=combIm;
handles.firstFrameWithSpotsMat{currentMovieNum}=firstFrameWithSpots;
handles.peakSets{currentMovieNum}=peakSet;
handles.roiDiaMats{currentMovieNum}=roiDiaMat;
handles.thresholdValueMat{currentMovieNum}=threshold;
handles.stdInputMat{currentMovieNum}=stdInput;
guidata(hObject, handles);
% --- Executes on slider movement.
function sliderCombinedImageThreshold_Callback(hObject, eventdata, handles)
% hObject handle to sliderCombinedImageThreshold (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'Value') returns position of slider
%
get(hObject,'Min') and get(hObject,'Max') to determine range of slider
threshold=ceil(get(hObject,'Value'));
currentMovieNum=handles.currentMovieNum;
halfEdge=num2double(get(handles.ImageEdgeSize,'String'));
[peakSet,roiDiaMat]=getImagePeaks(combIm,threshold,2*halfEdge);
%
[peakSet,roiDiaMat]=getCentOfMassCoor(combIm,peakSet);
handles.roiDiaMats{currentMovieNum}=roiDiaMat;
%plot data and peaks
plotImage(handles.axes1,handles.combIm{currentMovieNum},peakSet);
handles.peakSets{currentMovieNum}=peakSet;
handles.thresholdValueMat{currentMovieNum}=threshold;
set(handles.combinedImageThresholdDisplay,'String',num2str(threshold));
set(handles.numOfSpotsFound,'String',num2str(size(peakSet,1)));
guidata(hObject, handles);
% --- Executes during object creation, after setting all properties.
function sliderCombinedImageThreshold_CreateFcn(hObject, eventdata, handles)
% hObject handle to sliderCombinedImageThreshold (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
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% handles

empty - handles not created until after all CreateFcns called

% Hint: slider controls usually have a light gray background.
if isequal(get(hObject,'BackgroundColor'), get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor',[.9 .9 .9]);
end
function combinedImageThresholdDisplay_Callback(hObject, eventdata, handles)
% hObject handle to combinedImageThresholdDisplay (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of combinedImageThresholdDisplay as text
%
str2double(get(hObject,'String')) returns contents of
combinedImageThresholdDisplay as a double
% hWait=waitbar(0,'Pleas wait');
threshold=round(str2double(get(hObject,'String')));
currentMovieNum=handles.currentMovieNum;
halfEdge=num2double(get(handles.ImageEdgeSize,'String'));
[peakSet,roiDiaMat]=getImagePeaks(combIm,threshold,2*halfEdge);
handles.roiDiaMats{currentMovieNum}=roiDiaMat;
%plot data and peaks
plotImage(handles.axes1,handles.combIm{currentMovieNum},peakSet);
handles.peakSets{currentMovieNum}=peakSet;
handles.thresholdValueMat{currentMovieNum}=threshold;
set(handles.combinedImageThreshold,'Value',threshold);
set(handles.numOfSpotsFound,'String',num2str(size(peakSet,1)));
% close (hWait);
guidata(hObject, handles);
% --- Executes during object creation, after setting all properties.
function combinedImageThresholdDisplay_CreateFcn(hObject, eventdata, handles)
% hObject handle to combinedImageThresholdDisplay (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
function numOfSpotsFound_Callback(hObject, eventdata, handles)
% hObject handle to numOfSpotsFound (see GCBO)
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% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of numOfSpotsFound as text
%
str2double(get(hObject,'String')) returns contents of numOfSpotsFound as a double
% --- Executes on button press in populateData.
function populateData_Callback(hObject, eventdata, handles)
% hObject handle to populateData (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
%
%

message = [{'It will take a while'}; {'Working on file '};{num2str(1)}];
h=waitbar(0,message);
totalNumMovies=handles.totalNumMovies;

for i=1:totalNumMovies
%
message = [{'It will take a while'}; {'Working on file
'};{[num2str(i),'/',num2str(totalNumMovies)]}];
%
waitbar(i/totalNumMovies,h,message)
if ~isempty(handles.peakSets{i}) %if peakset is not empty
populateAMovieData(handles.fullFileName{i},handles.peakSets{i},...
handles.firstFrameWithSpotsMat{i},...
handles.combIm{i},handles,i);
end
end
%
close(h);
guidata(hObject, handles);
function
populateAMovieData(fullFileName,peakSet,firstFrameWithSpots,combIm,handles,curre
ntMovieNum)
%load the movie
stdInput=handles.stdInputMat{currentMovieNum};
MovieInfo = imfinfo(fullFileName);
width=MovieInfo.Width;
height=MovieInfo.Height;
totalFrameNum = length(MovieInfo);
rawData = zeros(height,width,totalFrameNum,'uint16');
hp=waitbar(0,['Reading Movie # ',num2str(currentMovieNum)]);
alreadyLoadedDAta=handles.tempRawData{currentMovieNum};
alreadyLoadedDAtaLength=size(alreadyLoadedDAta,3);
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rawData(:,:,1:alreadyLoadedDAtaLength)=alreadyLoadedDAta;
for k = alreadyLoadedDAtaLength+1:totalFrameNum
updatWaitbar=[{['Reading
Movie
#
',num2str(currentMovieNum)]};
{[num2str(k),'/',num2str(totalFrameNum)]}];
waitbar(k/totalFrameNum,hp,updatWaitbar);
rawData(:,:,k)=imread(fullFileName, k, 'Info', MovieInfo);
end
close(hp);
peakNum=size(peakSet,1);
outputData=zeros(totalFrameNum,peakNum);
Co=
getRoiCoord_variableRois(combIm,
peakSet,str2double(get(handles.roiLength,'String')));%get bright pixels locations as [x1 x2
y1 y2]= [c1 c2 r1 r2], x1=smallest x and x2=highest x
roiLengthArray=
str2double(get(handles.roiLength,'String'))*ones(length(peakSet),1);%for saving data
bCo= getBackgndRoiCord(Co,combIm);
hF=waitbar(0,['Generating Time Traces of Movie # ',num2str(currentMovieNum)]);
if get(handles.backgndSubtrctn_ringAroundRoi,'Value')
for frame =firstFrameWithSpots:totalFrameNum %keep all frames before
molecules appear to be zero
waitbar(frame/totalFrameNum,hF,[{['Generating Time Traces of Movie #
',num2str(currentMovieNum)]};{[num2str(frame),'/',num2str(totalFrameNum)]}]);
for peak=1:peakNum;
Roi=rawData(Co(peak,3):Co(peak,4),Co(peak,1):Co(peak,2),frame);
backRoi=rawData(bCo(peak,3):bCo(peak,4),bCo(peak,1):bCo(peak,2),frame);
backRoi=[backRoi(:,1)',backRoi(:,end)',backRoi(1,2:end1),backRoi(end,2:end-1)]; %only edges are background
backRoi=sort(backRoi(:));
backRoi=mean(backRoi(1:round(0.75*length(backRoi))));
meanRoi=mean(Roi(:))-backRoi;
outputData(frame,peak)=meanRoi;
end
end
else
for frame =firstFrameWithSpots:totalFrameNum %keep all frames before
molecules appear to be zero
waitbar(frame/totalFrameNum,hF,[{['Generating Time Traces of Movie #
',num2str(currentMovieNum)]};{[num2str(frame),'/',num2str(totalFrameNum)]}]);
Im=rawData(:,:,frame);
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Im=imtophat(Im,strel('disk',10));
for peak=1:peakNum;
Roi=Im(Co(peak,3):Co(peak,4),Co(peak,1):Co(peak,2));
meanRoi=mean(Roi(:));
outputData(frame,peak)=meanRoi;
end
end
end

close (hF);
%if any value is negative
for i=1:size(outputData,2)
Min=min(outputData(:,i));
if Min<0 ;
outputData(:,i)=outputData(:,i)+ abs(Min);
end
end
%remove column with junck only
newOutPutData=[];
newPeakSet=[];
newRoiLengthArray=[];
for i=1:size(outputData,2)
mean_1st20 =mean(outputData(firstFrameWithSpots:firstFrameWithSpots+19,i));
mean_last50=mean(outputData(end-49:end,i));
STD_last50=std(outputData(end-49:end,i));
if (mean_1st20-mean_last50)>STD_last50 *3
newOutPutData=[newOutPutData,outputData(:,i)];
newPeakSet=[newPeakSet;peakSet(i,:)];
newRoiLengthArray=[newRoiLengthArray;roiLengthArray(i,:)];
end
end
outputData=newOutPutData;
peakSet=newPeakSet;
roiLengthArray=newRoiLengthArray;
% roiDia matrix
%add an column for frame number
newCol=(1:size(outputData,1))';
outputData=[newCol,outputData];
intiallyTotalPeaksFound=peakNum;
condition2removeGarbage='Garbage removal condition : mean of first 20 frames after
molecule appear on movie - mean of last 50 frames > 3 * std of last 50 frames';
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saveTimeTraces_variableRoi(outputData,fullFileName,peakSet,roiLengthArray);
NumberOfSpotManuallySelected=handles.NumOfPeaksManuallySelected(currentMovie
Num,1);
getLog(handles,fullFileName,peakSet,firstFrameWithSpots,NumberOfSpotManuallySele
cted,stdInput,intiallyTotalPeaksFound,condition2removeGarbage)
function
getLog(handles,fileName,peakSet,firstFrameWithSpots,NumberOfSpotManuallySelected
,stdInput,intiallyTotalPeaksFound,condition2removeGarbage)
hwaitbar=waitbar(0,'Saving Log file');
LogData=cell(15,1);
[~,softwareName,~]=fileparts(mfilename('fullpath'));
d = dir([mfilename('fullpath'),'.m']);
moddate = d.date;
[pathName,fileName,~] = fileparts(fileName) ;
time=['Analysis done on : ',datestr(clock, 0)];
firstFrame=['first frame where molecule appeared : ',num2str(firstFrameWithSpots)];
stdInput=['Condition to find peaks: mean + ',num2str(stdInput),'*STD'];
NumberOfSpotInitiallyFound=['Total
spots
intially
Found
:
',num2str(intiallyTotalPeaksFound)];
NumberOfSpot=['Total spots was kept and saved after garbage removal :
',num2str(size(peakSet,1))];
roiLength=get(handles.roiLength,'String');
roiLength=['Roi lenght : ', roiLength];
if get(handles.backgndSubtrctn_movingDisk,'Value')
backgroundSub=['Background subtraction type :','moving disk with dia of 10
pixel'];
else
backgroundSub=['Background subtraction type :','mean of the ring around (roi
length + 4 pixel diameter)'];
end
frameNumtoCombinedImage=get(handles.NumOfFramesAddToFindPeaks,'String');
NumberOfSpotManuallySelected=['NumberOfSpotManuallySelected',num2str(NumberO
fSpotManuallySelected)];
i=1;
LogData{i}=['Software used : ',softwareName, ' last modified on ',moddate];
i=i+1;
LogData{i}=time;
i=i+1;
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LogData{i}=['Movie name : ',fileName];
i=i+1;
LogData{i}=firstFrame;
i=i+1;
LogData{i}=['Number of frames added to
frameNumtoCombinedImage];
i=i+1;
LogData{i}=stdInput;
i=i+1;
LogData{i}=NumberOfSpotInitiallyFound;
i=i+1;
LogData{i}= NumberOfSpotManuallySelected;
i=i+1;
LogData{i}=NumberOfSpot;
i=i+1;
LogData{i}=roiLength;
i=i+1;
LogData{i}=backgroundSub;
i=i+1;
LogData{i}=condition2removeGarbage;

make

combined

image

fileName=['Log of ',fileName,'.txt'];
newFileName=fullfile(pathName,fileName);
%same the matrix as .txt file remember file name already has an extenstion
%of .txt
fileID = fopen(newFileName, 'wt');
%
fprintf(fileID,'%s \n',LogData.');
[nrows,~] = size(LogData);
for row = 1:nrows
fprintf(fileID,'%s \n',LogData{row,:});
end
fclose(fileID);
% dlmwrite('my_data.out',A, ';')
close(hwaitbar);
function roiLength_Callback(hObject, eventdata, handles)
% hObject handle to roiLength (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of roiLength as text
%
str2double(get(hObject,'String')) returns contents of roiLength as a double
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:

'

% --- Executes during object creation, after setting all properties.
function roiLength_CreateFcn(hObject, eventdata, handles)
% hObject handle to roiLength (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
function NumOfFramesAddToFindPeaks_Callback(hObject, eventdata, handles)
% hObject handle to NumOfFramesAddToFindPeaks (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of NumOfFramesAddToFindPeaks as text
%
str2double(get(hObject,'String')) returns contents of
NumOfFramesAddToFindPeaks as a double
input=str2double(get(hObject,'String')) ;
if input<2
set(hObject,'String','2')
end
guidata(hObject, handles);
function stdInput_Callback(hObject, eventdata, handles)
% hObject handle to stdInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of stdInput as text
%
str2double(get(hObject,'String')) returns contents of stdInput as a double

% --- Executes during object creation, after setting all properties.
function stdInput_CreateFcn(hObject, eventdata, handles)
% hObject handle to stdInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
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if
ispc
&&
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end

isequal(get(hObject,'BackgroundColor'),

% --- Executes on button press in backgndSubtrctn_ringAroundRoi.
function backgndSubtrctn_ringAroundRoi_Callback(hObject, eventdata, handles)
% hObject handle to backgndSubtrctn_ringAroundRoi (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of backgndSubtrctn_ringAroundRoi
if get(hObject,'Value');
set(handles.backgndSubtrctn_movingDisk,'Value',0);
else
set(handles.backgndSubtrctn_movingDisk,'Value',1);
end
guidata(hObject, handles);
% --- Executes on button press in backgndSubtrctn_movingDisk.
function backgndSubtrctn_movingDisk_Callback(hObject, eventdata, handles)
% hObject handle to backgndSubtrctn_movingDisk (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of backgndSubtrctn_movingDisk
if get(hObject,'Value');
mes='This condition will use a "imtophat" function with diameter of 10 pixels. Make
sure you know that this condition meet your requirement';
msgbox(mes,'Warning');
set(handles.backgndSubtrctn_ringAroundRoi,'Value',0);
else
set(handles.backgndSubtrctn_ringAroundRoi,'Value',1);
end
guidata(hObject, handles);
% --- Executes on button press in addAPeak.
function addAPeak_Callback(hObject, eventdata, handles)
% hObject handle to addAPeak (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
[xc,yc] = ginput(1);
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currentMovieNum=handles.currentMovieNum;
framLength=size(handles.combIm{currentMovieNum},1);
framWidth=size(handles.combIm{currentMovieNum},2);
if xc>10 && yc>10 && xc<framWidth-10 && yc<framLength-10
[aPeakCo,~]=getClosestPeakCenter(handles.combIm{currentMovieNum},[xc,yc]);
[aPeakCo,aDia]=getCentOfMassCoor(handles.combIm{currentMovieNum},aPeakCo);
handles.peakSets{currentMovieNum}=[handles.peakSets{currentMovieNum};aPeakCo];
handles.roiDiaMats{currentMovieNum}=[handles.roiDiaMats{currentMovieNum};aDia]
;
plotImage(handles.axes1,
handles.combIm{currentMovieNum},handles.peakSets{currentMovieNum})
%plotImage(axesLoc,d,peakSet)
set(handles.numOfSpotsFound,'String',num2str(size(handles.peakSets{currentMo
vieNum},1)));
handles.NumOfPeaksManuallySelected(currentMovieNum,1)=handles.NumOfPeaksMan
uallySelected(currentMovieNum,1)+1;
else
msgbox('Opps! Looks like your selected peak is out of range. Remember: 10 pixels from
any edge cannot be selected','Error','error');
end
guidata(hObject, handles);
% --- Executes on button press in deleteLastPeak.
function deleteLastPeak_Callback(hObject, eventdata, handles)
% hObject handle to deleteLastPeak (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
currentMovieNum=handles.currentMovieNum;
handles.peakSets{currentMovieNum}(end,:)=[];
handles.roiDiaMats{currentMovieNum}(end,:)=[];
plotImage(handles.axes1,
handles.combIm{currentMovieNum},handles.peakSets{currentMovieNum})
%plotImage(axesLoc,d,peakSet)
set(handles.numOfSpotsFound,'String',num2str(size(handles.peakSets{currentMo
vieNum},1)));
handles.NumOfPeaksManuallySelected(currentMovieNum,1)=handles.NumOfPeaksMan
uallySelected(currentMovieNum,1)-1;
guidata(hObject, handles);

% --- Executes on button press in zoomAPeak.
function zoomAPeak_Callback(hObject, eventdata, handles)
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% hObject handle to zoomAPeak (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
currentMovieNum=handles.currentMovieNum;
[xc,yc] = ginput(1);
clickedAx = gca;
combIm=handles.combIm{currentMovieNum};
if isempty(combIm)
firstFrameWithSpots=str2double(get(handles.firstFrameWithSpots,'String'));
tempRawData=handles.tempRawData;
currentMovieNum=handles.currentMovieNum; %count number of movie under
analysis
combIm=tempRawData{currentMovieNum}(:,:,firstFrameWithSpots);
end
multiplier=round(size(combIm,1)/512); %to roi size selection
roiD=12*multiplier; %if the size of frame is 512, then roi dia is 16, if size if larger roi
dia gets multiplied
framLength=size(combIm,1);
framWidth=size(combIm,2);
if xc>10 && yc>10 && xc<framWidth-10 && yc<framLength-10
%
[aPeakCo,~]=getClosestPeakCenter(combIm,[xc,yc]);
[aPeakCo,~]=getCentOfMassCoor(combIm,[xc,yc]);
[aDia]=CorrespondingDia(handles.peakSets{currentMovieNum},handles.roiDiaMats{cur
rentMovieNum}, aPeakCo);
xRoiEdge=round(aPeakCo(:,1))-roiD/2;
yRoiEdge=round(aPeakCo(:,2))-roiD/2;
aRoi=combIm(yRoiEdge+1:yRoiEdge+roiD,xRoiEdge+1:xRoiEdge+roiD); % roi
figure; bar3(aRoi);
%%
if ~isempty(aDia)
%%
Str=['Recorded diameter was ',num2str(aDia)];
%%
title(Str);
%%%
text(Str);
%%
else
%%
Str='Select the center of an already selected peak to get recorded diameter';
%%
title(Str);
%%
end
% [peakCentOut,diameterOut]=getCentOfMassCoor(combIm,aPeakCo)
else
msgbox('Opps! Looks like your selected peak is out of range. Remember: 10 pixels
from any edge cannot be selected','Error','error');
end
guidata(hObject, handles);
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function [aDia]=CorrespondingDia(allPeaks,allDia, aPeak)
%
temp=abs(allPeaks-[aPeak(1)*ones(size(allPeaks,1),1),
aPeak(2)*ones(size(allPeaks,1),1)]);
col1=allPeaks(:,1);
col2=allPeaks(:,2);
try
temp3=logical((col1==aPeak(1)).*(col2==aPeak(2)));
aDia=allDia(temp3);
catch ME
aDia=[];
end
% aPeaksCoor=[col1(temp3),col2(temp3)];
function ImageEdgeSize_Callback(hObject, eventdata, handles)
% hObject handle to ImageEdgeSize (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of ImageEdgeSize as text
%
str2double(get(hObject,'String')) returns contents of ImageEdgeSize as a double
val=str2double(get(hObject,'String'));
set(hObject,'String',num2str(round(val)));
guidata(hObject, handles);

% --- Executes during object creation, after setting all properties.
function ImageEdgeSize_CreateFcn(hObject, eventdata, handles)
% hObject handle to ImageEdgeSize (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
function [peakSet,peakDiameters]=getImagePeaks(Im,thres,edge)
peakSet=[];
if nargin<3
edge=10;
end
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dx=floor(edge/2);
for c =edge:dx:size(Im,2)-edge-dx
for r=edge:dx:size(Im,1)-edge-dx
aRoi=Im(r+1:r+dx,c+1:c+dx);
if max(max(aRoi))>thres
Max=max(aRoi(:));
[rIdx,cIdx]=find(aRoi==Max);
if length(rIdx)>1 || length(rIdx)>1
cIdx=dx/2;
rIdx=dx/2;
end
aPeak=[c,r]+[cIdx,rIdx];
peakSet=[peakSet;aPeak];
end
end
end
peakSet=double(round(peakSet));
[peakSet,peakDiameters]=getCentOfMassCoor_myfindpeaks(Im,peakSet,edge,thres);
%removes false peaks
if isempty(peakSet)
msgbox('No Peak was found, lowering threshold might help to find some peaks')
return;
end
[peakSet,peakDiameters]=removeClosedPeaks_myfindPeaks(Im,peakSet,dx,peakDiamet
ers); %removes close peaks and avoid putting same peak multiple times
if isempty(peakSet)
msgbox('No Peak was found, lowering threshold might help to find some peaks')
return;
end
peakDiameters=ones(length(peakSet),1);
function
[peakSetOut,peakDiaOut]=removeClosedPeaks_myfindPeaks(Im,peakSet,dx,peakDiaIn)
disThrshold=dx*1.14; %distace =dx*sqrt(2);
peakSetA=peakSet;
peakSetOut=[];
peakDiaOut=[];
%
minDistMat=600*ones(size(peakSet,1),1);
for i=1:size(peakSet,1)
distMat=zeros(size(peakSet,1),1);
for j=1:size(peakSetA,1)
dist=sqrt((peakSet(i,1)-peakSetA(j,1))^2 +(peakSet(i,2)-peakSetA(j,2))^2);
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distMat(j)=dist;
end
if numel(distMat(distMat<disThrshold))==1 %if one peak with lower than threshold
dist, accpt it
peakSetOut=[peakSetOut;peakSet(i,:)];
if nargin==4
peakDiaOut=[peakDiaOut;peakDiaIn(i)];
end
else %otherwise accept one with highest intensity on the image
disputedPeaks=peakSet(distMat<disThrshold,:);
disputedPeaksIndex=find(distMat<disThrshold);
intesityDisputedPeaks=zeros(size(size(disputedPeaks,2),1));
for k=1:size(disputedPeaks,2)
intesityDisputedPeaks(k,1)=Im(disputedPeaks(k,2),disputedPeaks(k,1));
end
[~,Idx]=max(intesityDisputedPeaks);
originalIndex=disputedPeaksIndex(Idx);
if originalIndex==i %avoid putting same peaks multiple times
peakSetOut=[peakSetOut;peakSet(originalIndex,:)];
if nargin==4
peakDiaOut=[peakDiaOut;peakDiaIn(originalIndex)];
end
end
end
end

function
[peakCentOut,diameterOut]=getCentOfMassCoor_myfindpeaks(Im,peakSets,edge,thres)
peakCent=zeros(size(peakSets));
diameterMat=zeros(size(peakSets,1),1);
%

multiplier=round(size(d,1)/512); %to roi size selection
roiD=12; %if the size of frame is 512, then roi dia is 16, if size if larger roi dia gets
multiplied
xRoiEdge=round(peakSets(:,1))-roiD/2;
yRoiEdge=round(peakSets(:,2))-roiD/2;
for i=1:size(peakSets,1)
aRoi=Im(yRoiEdge(i)+1:yRoiEdge(i)+roiD,xRoiEdge(i)+1:xRoiEdge(i)+roiD); %
roi
%%%
[centA,diaA, gof,outputData] = createFit_gaussian2D(double(aRoi));
%%%%
figure; surf(aRoi(:,1:10));
%%%
figure; bar3(aRoi);
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%%%
%%%
%%%
%%%

Str=['Diameter ',num2str(diaA)];
legend(Str);
diameterMat(i,1)=round(diaA);
peakCent(i,:)=[xRoiEdge(i),yRoiEdge(i)]+round(centA);

tempRoi=aRoi(:);
tempMat=sort(tempRoi);
tempMat=tempMat(1:round(0.75*length(tempMat)));
tempThres=mean(tempMat)+3*std(double(tempMat));
if nargin<4
thres=tempThres;
elseif thres>tempThres; %lowest value is the thereshould value
thres=tempThres;
end
dn=aRoi.*uint16(aRoi>thres);
stats = regionprops(logical(dn),dn,'Area','WeightedCentroid');
stats=stats([stats.Area]>2);
cents=[stats.WeightedCentroid]';
cents=[cents(1:2:end),cents(2:2:end)];
if isempty(cents); %no peaks is found
peakCent(i,:)=peakSets(i,:);
diameterMat(i,1)=0;
elseif size(cents,1)==1 %onley one peak is found
Idx=1;
peakCent(i,:)=[xRoiEdge(i),yRoiEdge(i)]+round(cents(Idx,:));
diameterMat(i,1)=round(sqrt(stats(Idx).Area));
%
diameterMat(i,1)=ceil((stats(Idx).MajorAxisLength+stats(Idx).MinorAxisLength)/2);
else %if more than one center is present, select one closest to center of roi
distMat=zeros(size(cents,1),1);
roiCent=[roiD/2,roiD/2];
for j=1:size(cents,1);
dist=sqrt((cents(j,1)-roiCent(1,1))^2 +(cents(j,2)-roiCent(1,2))^2);
distMat(j)=dist;
end
[~,Idx]=min(distMat);
diameterMat(i,1)=round(sqrt(stats(Idx).Area));
peakCent(i,:)=[xRoiEdge(i),yRoiEdge(i)]+round(cents(Idx,:));
%
diameterMat(i,1)=round((stats(Idx).MajorAxisLength+stats(Idx).MinorAxisLength)/2);
end

%

figure; bar3(aRoi);
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%
%

Str=['Diameter ',num2str(diameterMat(i,1))];
legend(Str);
end

%remove peaks with diameter less than 2, wich was recorded as 2
peakCentOut=[];
diameterOut=[];
for i=1:size(diameterMat,1)
%
if diameterMat(i,1)~=0 && peakCent(i,1)>10 && peakCent(i,2)>10 &&
peakCent(i,1)<size(d,2)-10 && peakCent(i,2)<size(d,1)-10
if diameterMat(i,1)>2 && diameterMat(i,1)<length(aRoi) && peakCent(i,1)>edge
&&
peakCent(i,2)>edge
&&
peakCent(i,1)<size(Im,2)-edge
&&
peakCent(i,2)<size(Im,1)-edge
peakCentOut=[peakCentOut;peakCent(i,:)];
diameterOut=[diameterOut;diameterMat(i,1)];
end
end
%%%
peakCentOut=peakCent;
%%%
diameterOut=diameterMat;

function saveTimeTraces_variableRoi(outputData,fullFileName,peakSet,roiLengthArray)
hWaitBar=waitbar(0,'Please wait, saving data as Excell file');
colheaders=cell(1,size(outputData,2));
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%if you dont put anything at colheaders{1}, matlab cannot detect colheaders
%in the structure file
colheaders{1}='Frame Number';
for i=2:size(outputData,2);
colheaders{i}=[num2str(i-1),'
roiDia-',num2str(roiLengthArray(i-1)),'(',
num2str(peakSet(i-1,1)),',',num2str(peakSet(i-1,2)),')'];
end
outputData=num2cell(outputData);
if strcmp(fullFileName(end-3:end),'xlsx')==1;
fullFileName=fullFileName(1:end-5);%remove .xlsx from the file name
else
fullFileName=fullFileName(1:end-4);
end
newFileName=[fullFileName,'.xlsx'];
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%if a file with this name already exist, delete it
if exist(newFileName,'file')==2
delete(newFileName);
end
outputData=[colheaders; outputData];
if ismac()
my_xlwrite(newFileName,outputData,'Sheet1', 'A1')
else
xlswrite(newFileName,outputData);
end
close(hWaitBar);
function plotImage(axesLoc,Im,peakSet)
axes(axesLoc);
% imagesc(imadjust(d), 'parent', axesLoc);
imagesc(Im, 'parent', axesLoc);
if nargin==3 && isempty(peakSet)
msgbox('No Peak to plot', 'Error','error');
elseif nargin==3
hold on
x=peakSet(:,1);
y=peakSet(:,2);
plot(x,y,'ro');
%label the spots as 1,2,3,...
labelOfPoints=(1:size(peakSet,1))';
b = num2str(labelOfPoints);
c = cellstr(b);
dx = 0.1; dy = 0.1; % displacement so the text does not overlay the data poi
text(x+dx, y+dy, c);
hold off
end
% colormap('gray');
set(axesLoc,'XTickLabel','','YTickLabel','','xtick',[],'ytick',[]);
function [peakCentOut,diameterOut]=getClosestPeakCenter(d,peakSets,thres)
%get a 10*10 region to ger roi center and diamters
peakCentOut=zeros(size(peakSets));
diameterOut=zeros(size(peakSets,1),1);
%
xVal=round(peakSets(:,1)); yVal=round(peakSets(:,2));
multiplier=round(size(d,1)/512);
roiD=10*multiplier; %is the size of frame is 512, then roi dia is 10, if size if larger roi
dia gets multiplied
edge_xVal=round(peakSets(:,1))-roiD/2;
edge_yVal=round(peakSets(:,2))-roiD/2;
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for i=1:size(peakSets,1)
aRoi=d(edge_yVal(i)+1:edge_yVal(i)+roiD,edge_xVal(i)+1:edge_xVal(i)+roiD); %
row = y value and col = x val.
if nargin<3
%
thres = multithresh(aRoi);
thres=mean(aRoi(:));
end
dn=aRoi.*uint16(aRoi>thres);
stats
=
regionprops(logical(dn),dn,'Area','WeightedCentroid','MajorAxisLength','MinorAxisLeng
th');
stats=stats([stats.Area]>1);
cents=[stats.WeightedCentroid]';
cents=[cents(1:2:end),cents(2:2:end)];
if isempty(cents); %no peaks is found
peakCentOut(i,:)=peakSets(i,:);
diameterOut(i,1)=2;
elseif size(cents,1)==1 %onley one peak is found
Idx=1;
peakCentOut(i,:)=[edge_xVal(i),edge_yVal(i)]+round(cents(Idx,:));
diameterOut(i,1)=ceil((stats(Idx).MajorAxisLength+stats(Idx).MinorAxisLength)/2);
else %if more than one center is present, select one closest to center of roi
distMat=zeros(size(cents,1),1);
roiCent=[roiD/2,roiD/2];
for j=1:size(cents,1);
dist=sqrt((cents(j,1)-roiCent(1,1))^2 +(cents(j,2)-roiCent(1,2))^2);
distMat(j)=dist;
end
[~,Idx]=min(distMat);
peakCentOut(i,:)=[edge_xVal(i),edge_yVal(i)]+round(cents(Idx,:));
diameterOut(i,1)=ceil((stats(Idx).MajorAxisLength+stats(Idx).MinorAxisLength)/2);
end
end
%check if any peaks values goes beyound the edge of image
for i=1:size(peakSets,1)
if peakCentOut(i,1)<10 && peakCentOut(i,2)<10 && peakCentOut(i,1)>size(d,2)10 && peakCentOut(i,2)>size(d,1)-10
if peakCentOut(i,1)<10
peakCentOut(i,1)=10;
elseif peakCentOut(i,2)<10
peakCentOut(i,2)=10;
elseif peakCentOut(i,1)>size(d,2)-10
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peakCentOut(i,1)=size(d,2)-10;
elseif peakCentOut(i,2)>size(d,1)-10
peakCentOut(i,1)=size(d,1)-10;
end
end
end

function [peakCentOut,diameterOut]=getCentOfMassCoor(d,peakSets,thres)

%

%get a 10*10 region to ger roi center and diamters
peakCent=zeros(size(peakSets));
diameterMat=zeros(size(peakSets,1),1);
xVal=round(peakSets(:,1)); yVal=round(peakSets(:,2));

multiplier=round(size(d,1)/512); %to roi size selection
roiD=12*multiplier; %if the size of frame is 512, then roi dia is 16, if size if larger roi
dia gets multiplied
xRoiEdge=round(peakSets(:,1))-roiD/2;
yRoiEdge=round(peakSets(:,2))-roiD/2;
for i=1:size(peakSets,1)
aRoi=d(yRoiEdge(i)+1:yRoiEdge(i)+roiD,xRoiEdge(i)+1:xRoiEdge(i)+roiD); % roi
%%%
[centA,diaA, gof,outputData] = createFit_gaussian2D(double(aRoi));
%%%%
figure; surf(aRoi(:,1:10));
%%%
figure; bar3(aRoi);
%%%
Str=['Diameter ',num2str(diaA)];
%%%
legend(Str);
%%%
diameterMat(i,1)=round(diaA);
%%%
peakCent(i,:)=[xRoiEdge(i),yRoiEdge(i)]+round(centA);
if nargin<3
tempRoi=aRoi(:);
tempMat=sort(tempRoi);
tempMat=tempMat(1:round(0.80*length(tempMat)));
thres=mean(tempMat)+3*std(double(tempMat));
end
dn=aRoi.*uint16(aRoi>thres);
stats = regionprops(logical(dn),dn,'Area','WeightedCentroid');
stats=stats([stats.Area]>2);
cents=[stats.WeightedCentroid]';
cents=[cents(1:2:end),cents(2:2:end)];
if isempty(cents); %no peaks is found
peakCent(i,:)=peakSets(i,:);
diameterMat(i,1)=0;
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elseif size(cents,1)==1 %onley one peak is found
Idx=1;
peakCent(i,:)=[xRoiEdge(i),yRoiEdge(i)]+round(cents(Idx,:));
diameterMat(i,1)=round(sqrt(stats(Idx).Area));
%
diameterMat(i,1)=ceil((stats(Idx).MajorAxisLength+stats(Idx).MinorAxisLength)/2);
else %if more than one center is present, select one closest to center of roi
distMat=zeros(size(cents,1),1);
roiCent=[roiD/2,roiD/2];
for j=1:size(cents,1);
dist=sqrt((cents(j,1)-roiCent(1,1))^2 +(cents(j,2)-roiCent(1,2))^2);
distMat(j)=dist;
end
[~,Idx]=min(distMat);
diameterMat(i,1)=round(sqrt(stats(Idx).Area));
peakCent(i,:)=[xRoiEdge(i),yRoiEdge(i)]+round(cents(Idx,:));
%
diameterMat(i,1)=round((stats(Idx).MajorAxisLength+stats(Idx).MinorAxisLength)/2);
end

%
%
%

figure; bar3(aRoi);
Str=['Diameter ',num2str(diameterMat(i,1))];
legend(Str);
end

%remove peaks with diameter less than 2, wich was recorded as 2
peakCentOut=[];
diameterOut=[];
for i=1:size(diameterMat,1)
%
if diameterMat(i,1)~=0 && peakCent(i,1)>10 && peakCent(i,2)>10 &&
peakCent(i,1)<size(d,2)-10 && peakCent(i,2)<size(d,1)-10
if diameterMat(i,1)>1 && diameterMat(i,1)<length(aRoi) && peakCent(i,1)>10 &&
peakCent(i,2)>10 && peakCent(i,1)<size(d,2)-10 && peakCent(i,2)<size(d,1)-10
peakCentOut=[peakCentOut;peakCent(i,:)];
diameterOut=[diameterOut;diameterMat(i,1)];
end
end
%%%
peakCentOut=peakCent;
%%%
diameterOut=diameterMat;

function [outputMatrix] = getRoiCoord_variableRois(d, peakSet,roiDiameterArray)
if size(roiDiameterArray,1)==1; %roi size is not variable
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RoiLength=roiDiameterArray;
if RoiLength==1
[outputMatrix] = get1by1RoiCoor(peakSet);
elseif RoiLength==2
[outputMatrix] = get2by2RoiCoor(d, peakSet);
elseif RoiLength==3
[outputMatrix] = get2by2RoiCoor(d, peakSet);
[outputMatrix] = get3by3RoiCoor(d, outputMatrix);
elseif RoiLength==4
[outputMatrix] = get2by2RoiCoor(d, peakSet);
[outputMatrix] = get3by3RoiCoor(d, outputMatrix);
[outputMatrix] = get4by4RoiCoor(d, outputMatrix);
elseif RoiLength==5
[outputMatrix] = get2by2RoiCoor(d, peakSet);
[outputMatrix] = get3by3RoiCoor(d, outputMatrix);
[outputMatrix] = get4by4RoiCoor(d, outputMatrix);
[outputMatrix] = get5by5RoiCoor(d, outputMatrix);
elseif RoiLength==6
[outputMatrix] = get2by2RoiCoor(d, peakSet);
[outputMatrix] = get3by3RoiCoor(d, outputMatrix);
[outputMatrix] = get4by4RoiCoor(d, outputMatrix);
[outputMatrix] = get5by5RoiCoor(d, outputMatrix);
[outputMatrix] = get6by6RoiCoor(d, outputMatrix);
elseif RoiLength>6 && mod(RoiLength,2)==1;%odd 7,9,11...
dx=RoiLength-5; %2,4,6...
[outputMatrix] = get2by2RoiCoor(d, peakSet);
[outputMatrix] = get3by3RoiCoor(d, outputMatrix);
[outputMatrix] = get4by4RoiCoor(d, outputMatrix);
[outputMatrix] = get5by5RoiCoor(d, outputMatrix);
[outputMatrix] = increaseRoiby2Npixels(outputMatrix,dx);
elseif RoiLength>6 && mod(RoiLength,2)==0; %even 8,10,12...
dx=RoiLength-6; %2,4,6...
[outputMatrix] = get2by2RoiCoor(d, peakSet);
[outputMatrix] = get3by3RoiCoor(d, outputMatrix);
[outputMatrix] = get4by4RoiCoor(d, outputMatrix);
[outputMatrix] = get5by5RoiCoor(d, outputMatrix);
[outputMatrix] = get6by6RoiCoor(d, outputMatrix);
[outputMatrix] = increaseRoiby2Npixels(outputMatrix,dx);
end
else
outputMatrix=[];
for i=1:length(roiDiameterArray)
RoiLength= roiDiameterArray(i);
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aPeak=peakSet(i,:);
if RoiLength==1
[tempoutputMatrix] = get1by1RoiCoor(aPeak);
elseif RoiLength==2
[tempoutputMatrix] = get2by2RoiCoor(d, aPeak);
elseif RoiLength==3
[tempoutputMatrix] = get2by2RoiCoor(d, aPeak);
[tempoutputMatrix] = get3by3RoiCoor(d, tempoutputMatrix);
elseif RoiLength==4
[tempoutputMatrix] = get2by2RoiCoor(d, aPeak);
[tempoutputMatrix] = get3by3RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get4by4RoiCoor(d, tempoutputMatrix);
elseif RoiLength==5
[tempoutputMatrix] = get2by2RoiCoor(d, aPeak);
[tempoutputMatrix] = get3by3RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get4by4RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get5by5RoiCoor(d, tempoutputMatrix);
elseif RoiLength==6
[tempoutputMatrix] = get2by2RoiCoor(d, aPeak);
[tempoutputMatrix] = get3by3RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get4by4RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get5by5RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get6by6RoiCoor(d, tempoutputMatrix);
elseif RoiLength>6 && mod(RoiLength,2)==1;%odd 7,9,11...
dx=RoiLength-5; %2,4,6...
[tempoutputMatrix] = get2by2RoiCoor(d, aPeak);
[tempoutputMatrix] = get3by3RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get4by4RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get5by5RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = increaseRoiby2Npixels(tempoutputMatrix,dx);
elseif RoiLength>6 && mod(RoiLength,2)==0; %even 8,10,12...
dx=RoiLength-6; %2,4,6...
[tempoutputMatrix] = get2by2RoiCoor(d, aPeak);
[tempoutputMatrix] = get3by3RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get4by4RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get5by5RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = get6by6RoiCoor(d, tempoutputMatrix);
[tempoutputMatrix] = increaseRoiby2Npixels(tempoutputMatrix,dx);
end
outputMatrix=[outputMatrix;tempoutputMatrix];
end
end
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function [outputMatrix] = increaseRoiby2Npixels(inMat,dx)
outputMatrix=inMat;
outputMatrix(:,1)=inMat(:,1)-dx/2; %new x1=old x1-dx/2
outputMatrix(:,2)=inMat(:,2)+dx/2;%new x2=old x2+dx/2
outputMatrix(:,3)=inMat(:,3)-dx/2;
outputMatrix(:,4)=inMat(:,4)+dx/2;

function [outputMatrix] = get1by1RoiCoor(peakSet)
outputMatrix=zeros(size(peakSet,1),4);
for peak=1:size(peakSet,1)
outputMatrix(peak,:)=[peakSet(peak,1),peakSet(peak,1),peakSet(peak,2),peakSet(peak,2)
];
end

function [outputMatrix] = get2by2RoiCoor(d, peakSet)
outputMatrix=zeros(size(peakSet,1),4);
%store bright pixels locations as [x1 x2 y1 y2] or [c1 c2 r1 r2], x1=smalles x and
x2=highest x
%
RoiLength=round(RoiLength);
%
radius=1+ceil(RoiLength/2);
for peak=1:size(peakSet,1)
xC=peakSet(peak,1);
yC=peakSet(peak,2);
%get a r+1 by r+1 roi
%get the sum of all possible four r+1 by r+1 squares arround the
%center of the peak
sum_1=sum(sum(d(yC-1:yC,xC:xC+1)));
sum_2=sum(sum(d(yC-1:yC,xC-1:xC)));
sum_3=sum(sum(d(yC:yC+1,xC-1:xC)));
sum_4=sum(sum(d(yC:yC+1,xC:xC+1)));
Max_sum=max([sum_1,sum_2,sum_3,sum_4]);
tempMatrix=zeros(1,4);
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if Max_sum==sum_1;
tempMatrix(1,1)=xC;
tempMatrix(1,2)=xC+1;
tempMatrix(1,3)=yC-1;
tempMatrix(1,4)=yC;
elseif Max_sum==sum_2;
tempMatrix(1,1)=xC-1;
tempMatrix(1,2)=xC;
tempMatrix(1,3)=yC-1;
tempMatrix(1,4)=yC;
elseif Max_sum==sum_3;
tempMatrix(1,1)=xC-1;
tempMatrix(1,2)=xC;
tempMatrix(1,3)=yC;
tempMatrix(1,4)=yC+1;
elseif Max_sum==sum_4;
tempMatrix(1,1)=xC;
tempMatrix(1,2)=xC+1;
tempMatrix(1,3)=yC;
tempMatrix(1,4)=yC+1;
end
outputMatrix(peak,:)=tempMatrix;
end

function [outputMatrix] = get3by3RoiCoor(d, inMat)
%inMat is the output of get2by2RoiCoor=[x1,x2,y1,y2]
outputMatrix=zeros(size(inMat,1),4);
%store bright pixels locations as [x1 x2 y1 y2] or [c1 c2 r1 r2], x1=smalles x and
x2=highest x
%strategy, make a 3 by 3 square centering each pixels obtained from
%2by2 matrix

for peak=1:size(inMat,1)
x1=inMat(peak,1); x2=inMat(peak,2);
y1=inMat(peak,3); y2=inMat(peak,4);
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%make add one half parimeter with one pixel higher length and width centering each
corner of previous roi
sum_1=sum(sum(d(y1-1:y2,x1-1:x2)));
sum_2=sum(sum(d(y1-1:y2,x1:x2+1)));
sum_3=sum(sum(d(y1:y2+1,x1-1:x2)));
sum_4=sum(sum(d(y1:y2+1,x1:x2+1)));

Max_sum=max([sum_1,sum_2,sum_3,sum_4]);
tempMatrix=zeros(1,4);
if Max_sum==sum_1;
tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_2;
tempMatrix(1,1)=x1;
tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_3;
tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
elseif Max_sum==sum_4;
tempMatrix(1,1)=x1;
tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
end
outputMatrix(peak,:)=tempMatrix;
end

function [outputMatrix] = get4by4RoiCoor(d, inMat)
outputMatrix=zeros(size(inMat,1),4);
%store bright pixels locations as [x1 x2 y1 y2] or [c1 c2 r1 r2], x1=smalles x and
x2=highest x
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%strategy, add

for peak=1:size(inMat,1)
x1=inMat(peak,1); x2=inMat(peak,2);
y1=inMat(peak,3); y2=inMat(peak,4);
%make add one half parimeter centering each corner of previous roi
sum_1=sum(sum(d(y1-1:y2,x1-1:x2)));
sum_2=sum(sum(d(y1-1:y2,x1:x2+1)));
sum_3=sum(sum(d(y1:y2+1,x1-1:x2)));
sum_4=sum(sum(d(y1:y2+1,x1:x2+1)));

Max_sum=max([sum_1,sum_2,sum_3,sum_4]);
tempMatrix=zeros(1,4);
if Max_sum==sum_1;
tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_2;
tempMatrix(1,1)=x1;
tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_3;
tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
elseif Max_sum==sum_4;
tempMatrix(1,1)=x1;
tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
end
outputMatrix(peak,:)=tempMatrix;
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end
function [outputMatrix] = get5by5RoiCoor(d, inMat)
outputMatrix=zeros(size(inMat,1),4);
%store bright pixels locations as [x1 x2 y1 y2] or [c1 c2 r1 r2], x1=smalles x and
x2=highest x
%strategy, add

for peak=1:size(inMat,1)
x1=inMat(peak,1); x2=inMat(peak,2);
y1=inMat(peak,3); y2=inMat(peak,4);
%make add one half parimeter centering each corner of previous roi
sum_1=sum(sum(d(y1-1:y2,x1-1:x2)));
sum_2=sum(sum(d(y1-1:y2,x1:x2+1)));
sum_3=sum(sum(d(y1:y2+1,x1-1:x2)));
sum_4=sum(sum(d(y1:y2+1,x1:x2+1)));

Max_sum=max([sum_1,sum_2,sum_3,sum_4]);
tempMatrix=zeros(1,4);
if Max_sum==sum_1;
tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_2;
tempMatrix(1,1)=x1;
tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_3;
tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
elseif Max_sum==sum_4;
tempMatrix(1,1)=x1;
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tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
end
outputMatrix(peak,:)=tempMatrix;
end

function [outputMatrix] = get6by6RoiCoor(d, inMat)
outputMatrix=zeros(size(inMat,1),4);
%store bright pixels locations as [x1 x2 y1 y2] or [c1 c2 r1 r2], x1=smalles x and
x2=highest x
%strategy, add

for peak=1:size(inMat,1)
x1=inMat(peak,1); x2=inMat(peak,2);
y1=inMat(peak,3); y2=inMat(peak,4);
%make add one half parimeter centering each corner of previous roi
sum_1=sum(sum(d(y1-1:y2,x1-1:x2)));
sum_2=sum(sum(d(y1-1:y2,x1:x2+1)));
sum_3=sum(sum(d(y1:y2+1,x1-1:x2)));
sum_4=sum(sum(d(y1:y2+1,x1:x2+1)));

Max_sum=max([sum_1,sum_2,sum_3,sum_4]);
tempMatrix=zeros(1,4);
if Max_sum==sum_1;
tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_2;
tempMatrix(1,1)=x1;
tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1-1;
tempMatrix(1,4)=y2;
elseif Max_sum==sum_3;
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tempMatrix(1,1)=x1-1;
tempMatrix(1,2)=x2;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
elseif Max_sum==sum_4;
tempMatrix(1,1)=x1;
tempMatrix(1,2)=x2+1;
tempMatrix(1,3)=y1;
tempMatrix(1,4)=y2+1;
end
outputMatrix(peak,:)=tempMatrix;
end
function [backRoiCoordinates] = getBackgndRoiCord(RoiCoordinates,Im)
backRoiCoordinates=zeros(size(RoiCoordinates));
for peak=1:size(RoiCoordinates,1)
bx=2;
x1= RoiCoordinates(peak,1)-bx; x2=RoiCoordinates(peak,2)+bx;
y1=RoiCoordinates(peak,3)-bx; y2=RoiCoordinates(peak,4)+bx;
%if roi dimenstion exceeds the limits
if x1<1 || y1<1 || x2>size(Im,2)|| y2>size(Im,1)
if x1<1
x1=1;
end
if y1<1
y1=1;
end
if x2>size(Im,2);
x2=size(Im,2);
end
if y2>size(Im,1)
y2=size(Im,1);
end
end
backRoiCoordinates(peak,:)=[x1, x2, y1, y2];
backRoi=rawData(y1:y2,x1:x2,frame);
back=[backRoi(:,1)',backRoi(:,end)',backRoi(1,2:end-1),backRoi(end,2:end-

%
%
1)];
%

meanBack=mean(back(:));
end
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Outline of the GUI: simpleGraph_byFaruk.fig

Figure S3: Outline of the GUI used to plot time traces collected using
getTimeTraces_byFaruk.fig and getTimeTraces_byFaruk.m. This GUI was saved as
“simpleGraph_byFaruk.fig”. The underlying variables (Tag) for components 1-42 can be
found in the Table S2.
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Figure S4: A figure of the GUI shown in Figure S3 without numbering. This figure displays
all texts and default values on the GUI.
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Table S2: The essential variables used in the figure for GUI (Figure S3). All other
components were either Static Texts or Panels.
Number Type
of String
in
component
Figure
S1

Tag

1

Static Text

File Name

fileName

2

Panel

Not applicable

uipanel_DisplayOldResults

3a

Static Text

0 (red)

tb_dispOldStepNum

3b

Static Text

0 (green)

tb_oldBinSize

4

Axes

Not applicable

axes1

5

Push Button

Load Data Files

loadDataFiles

6

Check Box

hideFileName

hideFileName

7

Check Box

displayOldResult

displayOldResult

8

Check Box

CompareWithOldRes
ults

cb_CompareWithOldResults

9

Push Button

load all 1st Results

pb_load_1st_Results

10

Push Button

load all 2nd Results

pb_load_2nd_Results

11

Push Button

load all 3rd Results

pb_load_3rd_Results

12

Check Box

plotOnlyBleachStep =

plotOnlyBleachStepOption

13

Check Box

plotBleachStep >=

plotBleachStepOption_greaterTh
an

14

Check Box

plotGraphWithDiffSte
pNum

cb_plotGraphWithDiffStepNum

15

Edit Text

1

plotOnlyBleachStepInput

16

Edit Text

0

plotOnlyBleachStepOption_great
erThanInput

17

Edit Text

500

plotOpt_frameNum
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18

Push Button

+100

increaseBy100

19

Push Button

-100

decreaseBy100

20

Pop-up Manu

1;2;3;4;5;6;7;8;9;10
(;=enter)

NumPontsAddToPlot

21

Check Box

keyPressMode

keyPressMode

22

Check Box

NextGraph:
points

23

Check Box

verticalLine on

verticalLine

24

Edit Text

10

verticalLineInput

25

Edit Text

Empty

displayCurrentDataFileNum

26

Edit Text

1

roiNum

27

Edit Text

Empty

stepNum

28

Edit Text

Empty

tb_totalGraph

29

Push Button

+

increaseStepNum

30

Push Button

-

decreaseStepNum

31

Push Button

Next

nextRoi

31b

Push Button

Previous

previousRoi

32

Push Button

Display Vetical Lines displayVeticalLinesforMeanAnd
for Finding Mean And STD
STD

33

Edit Text

0

avg_1

34

Edit Text

0

avg_2

35

Edit Text

0

avgDif

36

Edit Text

0

std_1

37

Edit Text

0

std_2

38

Edit Text

0

ratio_1

Add
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2 NextGraphPlotAddTwoFrames

39

Edit Text

0

ratio_2

40

Edit Text

calculate

calculate

41

Push Button

SaveThisGraph

saveThisGraph

42

Push Button

Save Results

saveResults
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Matlab Code in a file called, “simpleGraph_byFaruk.m”
The following code was saved on a Matlab file, called, “simpleGraph_byFaruk.m”.

function varargout = simpleGraph_byFaruk(varargin)
% SIMPLEGRAPH_BYFARUK MATLAB code for simpleGraph_byFaruk.fig
% Begin initialization code - DO NOT EDIT
gui_Singleton = 1;
gui_State = struct('gui_Name',
mfilename, ...
'gui_Singleton', gui_Singleton, ...
'gui_OpeningFcn', @simpleGraph_byFaruk_OpeningFcn, ...
'gui_OutputFcn', @simpleGraph_byFaruk_OutputFcn, ...
'gui_LayoutFcn', [] , ...
'gui_Callback', []);
if nargin && ischar(varargin{1})
gui_State.gui_Callback = str2func(varargin{1});
end
if nargout
[varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:});
else
gui_mainfcn(gui_State, varargin{:});
end
% End initialization code - DO NOT EDIT

% --- Executes just before simpleGraph_byFaruk is made visible.
function simpleGraph_byFaruk_OpeningFcn(hObject, eventdata, handles, varargin)
% This function has no output args, see OutputFcn.
% hObject handle to figure
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% varargin command line arguments to simpleGraph_byFaruk (see VARARGIN)
% Choose default command line output for simpleGraph_byFaruk
handles.output = hObject;
%update some presets
set(hObject,
'WindowButtonUpFcn',
@(hObject,eventdata)simpleGraph_byFaruk('stopDragFcn',hObject,eventdata,guidata(hO
bject)));
set(handles.axes1,'XTickLabel','','YTickLabel','','xtick',[],'ytick',[]);
% set(handles.axes2,'XTickLabel','','YTickLabel','','xtick',[],'ytick',[]);
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% set(handles.plotOpt_frameNum,'String','1000');
% set(handles.cb_CompareWithOldResults,'Value',0);
% set(handles.cb_CompareWithOldResults,'Visible','off');
%
set(handles.uipanel_DisplayOldResults,'Visible','off');
% set(handles.pb_load_2nd_Results,'Visible','off');
% set(handles.pb_load_3rd_Results,'Visible','off');
% set(handles.cb_plotGraphWithDiffStepNum,'Visible','off');
% set(handles.cb_plotGraphWithDiffStepNum,'Value',0)
% set(handles.plotBleachStepOption_greaterThan,'Visible','off');
% set(handles.plotBleachStepOption_greaterThan,'Value',0);
%
%%
% % set(get(handles.uipanel_findMeanAndStd,'Children'), 'Enable','off');
% % set(handles.plotOpt_frameNum,'Enable','off');
% % set(handles.roiNum,'Enable','off');
% % set(handles.stepNum,'Enable','off');
% % set(handles.verticalLineInput,'Enable','off');
% % set(handles.plotOnlyBleachStepInput,'Enable','off');
% % set(handles.plotOnlyBleachStepOption_greaterThanInput,'Enable','off');

%

set(get(handles.uipanel_plotOpt_Limits,'Children'), 'Enable','off');

%set the name of GUI
set(handles.figure1,'Name',mfilename);
% Update handles structure
guidata(hObject, handles);
% UIWAIT makes simpleGraph_byFaruk wait for user response (see UIRESUME)
% uiwait(handles.figure1);

% --- Outputs from this function are returned to the command line.
function varargout = simpleGraph_byFaruk_OutputFcn(hObject, eventdata, handles)
% varargout cell array for returning output args (see VARARGOUT);
% hObject handle to figure
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Get default command line output from handles structure
varargout{1} = handles.output;
function figure1_WindowKeyPressFcn(hObject, eventdata, handles)
% hObject handle to figure1 (see GCBO)
% eventdata structure with the following fields (see FIGURE)
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%
Key: name of the key that was pressed, in lower case
%
Character: character interpretation of the key(s) that was pressed
%
Modifier: name(s) of the modifier key(s) (i.e., control, shift) pressed
% handles structure with handles and user data (see GUIDATA)
%keypressed=get(handles.figure1,'CurrentCharacter');
keypressed=eventdata.Character;
% Determine whether Enter was pressed to request new crosshairs
keypressMode=get(handles.keyPressMode,'Value');
if keypressMode==1;
switch keypressed

%
%

% for next images
case 119 %119 is the ascii value for w
nextRoi_Callback(hObject, eventdata, handles)
case 30 %30 is the ascii value for upwards arrow
nextRoi_Callback(hObject, eventdata, handles)
case 29 %29 is the ascii value for rightwards arrow
nextRoi_Callback(hObject, eventdata, handles)

% for previous images
% case 100 %100 is the ascii value for w
%
previousRoi_Callback(hObject, eventdata, handles)
%
case 31 %31 is the ascii value for downwards arrow
previousRoi_Callback(hObject, eventdata, handles)
case 28 %28 is the ascii value for leftwards arrow
previousRoi_Callback(hObject, eventdata, handles)
%number in inputs
case 13 %press enter
noSteps_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 101 %press e
noSteps_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 48
zero_Callback(hObject, eventdata, handles)

194

nextRoi_Callback(hObject, eventdata, handles)
case 96 %key `
zero_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 49
one_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 50
two_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 51
three_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 52
four_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 53
five_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 54
six_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 55
seven_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 56
eight_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 57
nine_Callback(hObject, eventdata, handles)
nextRoi_Callback(hObject, eventdata, handles)
case 43 %+ key
if get(handles.NumPontsAddToPlot,'Value')==1
set(handles.NumPontsAddToPlot,'Value',2)
else
set(handles.NumPontsAddToPlot,'Value',1)
end
handles=plotSimpleGraph_newApproach(handles) ;

case 45 % - key
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if get(handles.NumPontsAddToPlot,'Value')==1
set(handles.NumPontsAddToPlot,'Value',2)
else
set(handles.NumPontsAddToPlot,'Value',1)
end
handles=plotSimpleGraph_newApproach(handles) ;
end
end

% --- Executes on button press in loadDataFiles.
function loadDataFiles_Callback(hObject, eventdata, handles)
% hObject handle to loadDataFiles (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)

pathMfile = fileparts(mfilename('fullpath'));
addpath(pathMfile);
%
addpath(fullfile(pathMfile, 'simpleGraph_calls'));
%addpath([pathMfile, '\vbFRET']);
%open a dialoge box to get a file
[fileNames,pathName]=uigetfile('*.xlsx','Please select all the files you want to
analyze','MultiSelect','on');

%check if user did not select a file
if iscell(fileNames)
handles. fileNames=fileNames;
elseif fileNames==0
return
else
afile={};
afile{1}=fileNames;
handles.fileNames=afile;
end
handles.curFileNum=1;
set(handles.displayCurrentDataFileNum,'String',[num2str(handles.curFileNum),'/',num2st
r(length(handles.fileNames))]);
handles.pathName=pathName;
handles=
LoadADataFile(handles,handles.fileNames{handles.curFileNum},handles.pathName);
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set(handles.cb_CompareWithOldResults,'Visible','on','Value',0);
%
set(handles.displayOldResult,'Visible','on','Value',0);
set(handles.pb_load_1st_Results,'Visible','off');
set(handles.pb_load_2nd_Results,'Visible','off');
set(handles.pb_load_3rd_Results,'Visible','off');
set(handles.cb_plotGraphWithDiffStepNum,'Visible','off');
%
set(handles.cb_plotGraphWithDiffStepNum,'Value',0)
set(handles.plotBleachStepOption_greaterThan,'Visible','off');
%
set(handles.plotBleachStepOption_greaterThan,'Value',0)
set(handles.plotOnlyBleachStepOption,'Visible','off');
set(handles.plotOnlyBleachStepInput,'Visible','off');
set(handles.tb_dispOldStepNum,'String','');
set(handles.tb_oldBinSize,'String','');
%for calculating mean and std
handles.calculate_1Data=[];
handles.calculate_2Data=[];
handles.calculate_3Data=[];
set(handles.NumPontsAddToPlot,'Value',2)
guidata(hObject, handles)

% --- Executes on button press in saveThisGraph.
function saveThisGraph_Callback(hObject, eventdata, handles)
% hObject handle to saveThisGraph (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% structure with handles and user data (see GUIDATA)
h = waitbar(0,'Please wait...'); %open a waitbar so that user can see that matlab has done
something upon pressin this button

currentRoi=get(handles.roiNum,'String'); %get the graph number which is actually ROI
number
stepNum=get(handles.stepNum,'String'); %get the number number
path=handles.datafilePathname; %same as filename
fileName=handles.fileNames{handles.curFileNum};
if strcmp(fileName(end-3:end),'xlsx')==1;
fileName=fileName(1:end-5);%remove .xlsx from the file name
else
fileName=fileName(1:end-4);
end
% concatinate ROI number with ROIs and step number with Step to add these
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% into the final file name of the graph
ROI=['- ROI- ',currentRoi];
step=[' Step-',stepNum];
fileName=strcat(fileName,ROI,step); %concatinate all to make final file name
fileName=['Data of-',fileName,'.xlsx'];
dataFileName=fullfile(path,fileName);%add path infront of file name
figHand = findobj(handles.axes1,'Type','line');
plottedData=num2cell(handles.plottedData);
headings=['Num of points added', num2str(get(handles.NumPontsAddToPlot,'Value'))];
plottedData=[headings;plottedData];

%
% %if user did not check the checkbox 'plot residual data', then we will not
% %have last two label on the plottedDataHeading
% plotOpt_residualData=get(handles.plotOpt_residualData,'Value');
% if plotOpt_residualData==0
% dataHeading=handles.plottedDataHeaing(1:end-2);
% else
% dataHeading=handles.plottedDataHeaing;
% end
% plottedData=vertcat(dataHeading, plottedData);
if ismac()
my_xlwrite(dataFileName,plottedData,'sheet', 'A1')
else
xlswrite(dataFileName,plottedData);
end
% %save the graph
% F=getframe(handles.axes1); %Capture the figuref from GUI as movie frame
close(h) ;% closing my waitbar as I can not close it after this lines :(
% h=figure(); %new figure
% image(F.cdata); %F is a structure with the frame and cdata contains the captured image
data. and make a new image with that cdata
h=figure();
% plotSimpleGraph(gca,handles.plottedData)
plot(handles.plottedData)
saveas(gca, [fileName(1:end-5),'.fig'], 'fig'); %save current figure handles as assinged file
name and format
close(h); %and close it

% --- Executes on button press in saveResults.
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function saveResults_Callback(hObject, eventdata, handles)
% hObject handle to saveResults (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
h=waitbar(0,'Please wait! saving the result');
outputData=handles.outputData;
path=handles.datafilePathname; %same as filename
fileName=handles.fileNames{handles.curFileNum};
if strcmp(fileName(end-3:end),'xlsx')==1;
fileName=fileName(1:end-5);%remove .xlsx from the file name
else
fileName=fileName(1:end-4);
end
%make a new file name adding a part infront of it
fileAddfront='Result of- ';
fileAtEnd='.txt';
fileName=strcat(fileAddfront,fileName,fileAtEnd);
%mane the file name with path in it
fileName=fullfile(path,fileName);
if exist(fileName,'file')==2
delete(fileName);
end
% xlswrite(fileName,num2cell(outputData))

fileID = fopen(fileName, 'wt');
fprintf(fileID,'ROIs #\tStep #\tBinSize\txAxisSize\n'); %add heading in each column as
ROI and step #
% fprintf(fileID,'%g\t%g\n',outputData.');
fprintf(fileID,'%g\t%g\t%g\t%g\n',outputData.');
fclose(fileID);
% end
close(h) ;

% --- Executes on button press in nextRoi.
function nextRoi_Callback(hObject, eventdata, handles)
% hObject handle to nextRoi (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
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% set(handles.CKFiltering,'Value',0);
%with currect ROI
currentRoi=str2double(get(handles.roiNum,'String'));
%record results
binSize=get(handles.NumPontsAddToPlot,'Value');
lim = axis;
xLim=lim(2);
%under key press fnc, input this value.
currentStep=str2double(get(handles.stepNum,'String'));
handles.outputData(currentRoi,:)=[currentRoi,currentStep,binSize,xLim];
%plot next graph
nextRoi=currentRoi+1;
%for comparing with old results and automatically plot next graph
%with different stepNum,
if get(handles.plotOnlyBleachStepOption,'Value')
aVal=str2double(get(handles.plotOnlyBleachStepInput,'String'));
if isfield(handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
nextRoi=getNextRoi_aValue(aVal,currentRoi,handles.old_1st_Results,handles.old_2nd_
Results,handles.old_3rd_Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_3rd_Results(currentRoi+1:nextRoi-1,:);
end
elseif isfield(handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
nextRoi=getNextRoi_aValue(aVal,currentRoi,handles.old_1st_Results,handles.old_2nd_
Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_2nd_Results(currentRoi+1:nextRoi-1,:);
end
elseif isfield(handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
nextRoi=getNextRoi_aValue(aVal,currentRoi,handles.old_1st_Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_1st_Results(currentRoi+1:nextRoi-1,:);
end
end
elseif get(handles.cb_plotGraphWithDiffStepNum,'Value')
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if isfield(handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
nextRoi=getNextRoi_differntStepNum(currentRoi,handles.old_1st_Results,handles.old_
2nd_Results,handles.old_3rd_Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_3rd_Results(currentRoi+1:nextRoi-1,:);
end
elseif isfield(handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
nextRoi=getNextRoi_differntStepNum(currentRoi,handles.old_1st_Results,handles.old_
2nd_Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_2nd_Results(currentRoi+1:nextRoi-1,:);
end
elseif isfield(handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
nextRoi=getNextRoi_differntStepNum(currentRoi,handles.old_1st_Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_1st_Results(currentRoi+1:nextRoi-1,:);
end
end
elseif get(handles.plotBleachStepOption_greaterThan,'Value')
aVal=str2double(get(handles.plotOnlyBleachStepOption_greaterThanInput,'String'));
if isfield(handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
nextRoi=getNextRoi_greaterThan(aVal,currentRoi,handles.old_1st_Results,handles.old_
2nd_Results,handles.old_3rd_Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_3rd_Results(currentRoi+1:nextRoi-1,:);
end
elseif isfield(handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
nextRoi=getNextRoi_greaterThan(aVal,currentRoi,handles.old_1st_Results,handles.old_
2nd_Results);
if nextRoi-currentRoi>1; %next roi is not selected
handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_2nd_Results(currentRoi+1:nextRoi-1,:);
end
elseif isfield(handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
nextRoi=getNextRoi_greaterThan(aVal,currentRoi,handles.old_1st_Results);
if nextRoi-currentRoi>1; %next roi is not selected
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handles.outputData(currentRoi+1:nextRoi1,:)=handles.old_1st_Results(currentRoi+1:nextRoi-1,:);
end
end
end
%plot next graph
if nextRoi<=size(handles.rawData,2) %for all the ROIs
set(handles.roiNum,'String',num2str(nextRoi));
if get(handles.NextGraphPlotAddTwoFrames,'Value')
set(handles.NumPontsAddToPlot,'Value',2);
end

%plot next graph
handles=plotSimpleGraph_newApproach(handles) ;

if get(handles.cb_CompareWithOldResults,'Value')
if isfield (handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
handles=plot_3rdResult(handles); %will plot 2nd and 1st as well
elseif isfield (handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
handles=plot_2ndResult(handles); %will pot 1st as well
elseif isfield (handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
handles=plot_1stResult(handles);
end
end
else
%for previous graphNum share maxRoi
handles.totalRoisLastDataFile=nextRoi-1;
handles.lastDataOutputData=handles.outputData;
%save it
saveResults_Callback(hObject, eventdata, handles);
%plot next files
if handles.curFileNum<length(handles.fileNames)
handles.curFileNum= handles.curFileNum+1;
handles=
LoadADataFile(handles,handles.fileNames{handles.curFileNum},handles.pathName);
set(handles.displayCurrentDataFileNum,'String',[num2str(handles.curFileNum),'/',num2st
r(length(handles.fileNames))]);
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handles=load_1stResultFile(handles);
handles=load_2ndResultFile(handles);
handles=load_3rdResultFile(handles);
else
msgbox([{'All selected files have been analyzed!!!'};{'Its time to get a Beer!!!'}]);
end
end
%for calculating mean and std
handles.calculate_1Data=[];
handles.calculate_2Data=[];
handles.calculate_3Data=[];
guidata(hObject,handles);
% --- Executes on button press in previousRoi.
function previousRoi_Callback(hObject, eventdata, handles)
% hObject handle to previousRoi (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
%
set(handles.CKFiltering,'Value',0);
%with currect ROI
currentRoi=str2double(get(handles.roiNum,'String'));
%for 1st ROI you cannot go to previous
if currentRoi>1
%for prvious ROI
previousRoi=currentRoi-1;
%for comparing with old results and automatically plot next graph
%with different stepNum,
if get(handles.plotOnlyBleachStepOption,'Value')
aVal=str2double(get(handles.plotOnlyBleachStepInput,'String'));
if isfield(handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
previousRoi=getPreviousRoi_aValue(aVal,currentRoi,handles.old_1st_Results,handles.ol
d_2nd_Results,handles.old_3rd_Results);
elseif isfield(handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
previousRoi=getPreviousRoi_aValue(aVal,currentRoi,handles.old_1st_Results,handles.ol
d_2nd_Results);
elseif isfield(handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
previousRoi=getPreviousRoi_aValue(aVal,currentRoi,handles.old_1st_Results);
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end
elseif get(handles.cb_plotGraphWithDiffStepNum,'Value')
if isfield(handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
previousRoi=getPreviousRoi_differntStepNum(currentRoi,handles.old_1st_Results,handl
es.old_2nd_Results,handles.old_3rd_Results);
elseif isfield(handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
previousRoi=getPreviousRoi_differntStepNum(currentRoi,handles.old_1st_Results,handl
es.old_2nd_Results);
elseif isfield(handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
previousRoi=getPreviousRoi_differntStepNum(currentRoi,handles.old_1st_Results);
end
elseif get(handles.plotBleachStepOption_greaterThan,'Value')
aVal=str2double(get(handles.plotOnlyBleachStepOption_greaterThanInput,'String'));
if isfield(handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
previousRoi=getPreviousRoi_greaterThan(aVal,currentRoi,handles.old_1st_Results,hand
les.old_2nd_Results,handles.old_3rd_Results);
elseif isfield(handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
previousRoi=getPreviousRoi_greaterThan(aVal,currentRoi,handles.old_1st_Results,hand
les.old_2nd_Results);
elseif isfield(handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
previousRoi=getPreviousRoi_greaterThan(aVal,currentRoi,handles.old_1st_Results);
end
end

set(handles.roiNum,'String',num2str(previousRoi));
%plot previous graph
if get(handles.NextGraphPlotAddTwoFrames,'Value')
set(handles.NumPontsAddToPlot,'Value',2);
end

%plot next graph
handles=plotSimpleGraph_newApproach(handles) ;
%show old results if exist
if get(handles.cb_CompareWithOldResults,'Value')
if isfield (handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
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handles=plot_3rdResult(handles);
elseif isfield (handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
handles=plot_2ndResult(handles);
elseif isfield (handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
handles=plot_1stResult(handles);
end
end
elseif currentRoi==1 && handles.curFileNum>1
uiwait(msgbox('Sorry!! This version does not allow to go prvious movie data'));
% handles.curFileNum= handles.curFileNum-1;
%
set(handles.displayCurrentDataFileNum,'String',[num2str(handles.curFileNum),'/',num2st
r(length(handles.fileNames))]);
%
handles=
LoadADataFile(handles,handles.fileNames{handles.curFileNum},handles.pathName,han
dles.totalRoisLastDataFile);
% handles=load_1stResultFile(handles);
% handles=load_2ndResultFile(handles);
% handles=load_3rdResultFile(handles);
end
guidata(hObject,handles);
function roiNum_Callback(hObject, eventdata, handles)
% hObject handle to roiNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of roiNum as text
%
str2double(get(hObject,'String')) returns contents of roiNum as a double
handles=plotSimpleGraph_newApproach(handles) ;
guidata(hObject,handles);

% --- Executes during object creation, after setting all properties.
function roiNum_CreateFcn(hObject, eventdata, handles)
% hObject handle to roiNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
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end
function stepNum_Callback(hObject, eventdata, handles)
% hObject handle to stepNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of stepNum as text
%
str2double(get(hObject,'String')) returns contents of stepNum as a double
% --- Executes during object creation, after setting all properties.
function stepNum_CreateFcn(hObject, eventdata, handles)
% hObject handle to stepNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end

% --- Executes on button press in keyPressMode.
function keyPressMode_Callback(hObject, eventdata, handles)
% hObject handle to keyPressMode (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of keyPressMode
if get(hObject,'Value')
set(handles.plotOnlyBleachStepInput,'Enable','off');
set(handles.plotOnlyBleachStepOption_greaterThanInput,'Enable','off');
set(handles.plotOpt_frameNum,'Enable','off');
set(handles.verticalLineInput,'Enable','off');
set(handles.roiNum,'Enable','off');
set(handles.stepNum,'Enable','off');
else
set(handles.plotOnlyBleachStepInput,'Enable','on');
set(handles.plotOnlyBleachStepOption_greaterThanInput,'Enable','on');
set(handles.plotOpt_frameNum,'Enable','on');
set(handles.verticalLineInput,'Enable','on');
set(handles.roiNum,'Enable','on');
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set(handles.stepNum,'Enable','on');
end
guidata(hObject, handles);
function plotOpt_frameNum_Callback(hObject, eventdata, handles)
% hObject handle to plotOpt_frameNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of plotOpt_frameNum as text
%
str2double(get(hObject,'String')) returns contents of plotOpt_frameNum as a double
input=str2double(get(handles.plotOpt_frameNum,'String'));
if input<50
set(hObject,'String','50')
end
handles=plotSimpleGraph_newApproach(handles) ;
guidata(hObject,handles);
% --- Executes during object creation, after setting all properties.
function plotOpt_frameNum_CreateFcn(hObject, eventdata, handles)
% hObject handle to plotOpt_frameNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in increaseBy100.
function increaseBy100_Callback(hObject, eventdata, handles)
% hObject handle to increaseBy100 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
input=str2double(get(handles.plotOpt_frameNum,'String'));
set(handles.plotOpt_frameNum,'String',num2str(input+100));
handles=plotSimpleGraph_newApproach(handles) ;
guidata(hObject,handles);
% --- Executes on button press in decreaseBy100.
function decreaseBy100_Callback(hObject, eventdata, handles)
% hObject handle to decreaseBy100 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
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input=str2double(get(handles.plotOpt_frameNum,'String'));
if input-100>50
set(handles.plotOpt_frameNum,'String',num2str(input-100));
else
set(handles.plotOpt_frameNum,'String','50');
end
handles=plotSimpleGraph_newApproach(handles) ;
guidata(hObject,handles);

% --- Executes on button press in increaseStepNum.
function increaseStepNum_Callback(hObject, eventdata, handles)
% hObject handle to increaseStepNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
stepNum=str2double(get(handles.stepNum,'String'));
val=stepNum+1;
if isnan(stepNum);
set(handles.stepNum,'String','0');
else
set(handles.stepNum,'String',num2str(val));
end
guidata(hObject, handles);

% --- Executes on button press in decreaseStepNum.
function decreaseStepNum_Callback(hObject, eventdata, handles)
% hObject handle to decreaseStepNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
stepNum=str2double(get(handles.stepNum,'String'));
val=stepNum-1;
if stepNum==0
set(handles.stepNum,'String','');%empty
elseif stepNum>0
set(handles.stepNum,'String',num2str(val));
end
guidata(hObject, handles);

% --- Executes on button press in cb_CompareWithOldResults.
function cb_CompareWithOldResults_Callback(hObject, eventdata, handles)
% hObject handle to cb_CompareWithOldResults (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
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% Hint: get(hObject,'Value') returns toggle state of cb_CompareWithOldResults
if get(hObject,'Value');
set(handles.pb_load_1st_Results,'Visible','on');
set(handles.plotBleachStepOption_greaterThan,'Visible','on');
set(handles.plotOnlyBleachStepOption,'Visible','on');
set(handles.plotOnlyBleachStepInput,'Visible','on');
set(handles.plotOnlyBleachStepOption_greaterThanInput,'Visible','on');
set(handles.displayOldResult,'Visible','on','Value',0);
else
set(handles.pb_load_1st_Results,'Visible','off');
set(handles.pb_load_2nd_Results,'Visible','off');
set(handles.pb_load_3rd_Results,'Visible','off');
set(handles.plotBleachStepOption_greaterThan,'Visible','off','Value',0);
set(handles.plotOnlyBleachStepOption,'Visible','off');
set(handles.plotOnlyBleachStepInput,'Visible','off');
set(handles.plotOnlyBleachStepOption_greaterThanInput,'Visible','off');
set(handles.displayOldResult,'Visible','off','Value',0);
end
% handles= load_1stResultFile(handles);
if get(handles.displayOldResult,'Value')
set(handles.uipanel_DisplayOldResults,'Visible','on');
else
set(handles.uipanel_DisplayOldResults,'Visible','off');
end
guidata(hObject, handles);
% function handles=load_anyResultsFile(handles, resultFileName,PathName)

%display off ylabel
% --- Executes on button press in pb_load_1st_Results.
function pb_load_1st_Results_Callback(hObject, eventdata, handles)
% hObject handle to pb_load_1st_Results (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.pb_load_2nd_Results,'Visible','on');
[resultFileNames,pathName]=uigetfile('*.txt','Please select all the files you want to
analyze','MultiSelect','on');

%check if user did not select a file
if iscell(resultFileNames)
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handles. old_1st_resultFileNames=resultFileNames;
elseif resultFileNames==0
return
else
afile={};
afile{1}=resultFileNames;
handles.old_1st_resultFileNames=afile;
end
handles.old_1st_resultpathName=pathName;
handles=load_1stResultFile(handles);
guidata(hObject, handles);

function handles=load_1stResultFile(handles)
if ~isfield(handles,'old_1st_resultpathName');
return;
end
curDir=cd;
if isfield(handles,'path_load_1nd_Results')
cd(handles.old_1st_resultpathName);
end
%change the directory again
cd(curDir)
pathName=handles.old_1st_resultpathName;
curDataFileName=handles.fileNames{handles.curFileNum};
resultFileNameCorspndToDataFileName=getCorFileName(curDataFileName,handles.old
_1st_resultFileNames);
if ~isempty(resultFileNameCorspndToDataFileName)
fileName=resultFileNameCorspndToDataFileName;
fullFileName=fullfile(pathName,fileName);
handles.path_CompareWithOldResults=pathName;
[data,~]=importdata(fullFileName);
oldResults=data.data;
handles.old_1st_Results=oldResults;
else
handles.old_1st_Results=[];
end
handles=plot_1stResult(handles);
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% --- Executes on button press in pb_load_2nd_Results.
function pb_load_2nd_Results_Callback(hObject, eventdata, handles)
% hObject handle to pb_load_2nd_Results (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.pb_load_3rd_Results,'Visible','on');
[resultFileNames,pathName]=uigetfile('*.txt','Please select all the files you want to
analyze','MultiSelect','on');

%check if user did not select a file
if iscell(resultFileNames)
handles. old_2nd_resultFileNames=resultFileNames;
elseif resultFileNames==0
return
else
afile={};
afile{1}=resultFileNames;
handles.old_2nd_resultFileNames=afile;
end
handles.old_2nd_resultpathName=pathName;
handles=load_2ndResultFile(handles);
guidata(hObject, handles);
function handles=load_2ndResultFile(handles)
if ~isfield(handles,'old_2nd_resultpathName');
return;
end
curDir=cd;
if isfield(handles,'path_load_2nd_Results')
cd(handles.old_2nd_resultpathName);
end
%change the directory again
cd(curDir);
pathName=handles.old_2nd_resultpathName;
curDataFileName=handles.fileNames{handles.curFileNum};
resultFileNameCorspndToDataFileName=getCorFileName(curDataFileName,handles.old
_2nd_resultFileNames);
if ~isempty(resultFileNameCorspndToDataFileName)
fileName=resultFileNameCorspndToDataFileName;
fullFileName=fullfile(pathName,fileName);
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[data,~]=importdata(fullFileName);
oldResults=data.data;
handles.old_2nd_Results=oldResults;
else
handles.old_2nd_Results=[];
end
handles=plot_2ndResult(handles);
set(handles.cb_plotGraphWithDiffStepNum,'Visible','on');
% --- Executes on button press in pb_load_3rd_Results.
function pb_load_3rd_Results_Callback(hObject, eventdata, handles)
% hObject handle to pb_load_3rd_Results (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
[resultFileNames,pathName]=uigetfile('*.txt','Please select all the files you want to
analyze','MultiSelect','on');

%check if user did not select a file
if iscell(resultFileNames)
handles. old_3rd_resultFileNames=resultFileNames;
elseif resultFileNames==0
return
else
afile={};
afile{1}=resultFileNames;
handles.old_3rd_resultFileNames=afile;
end
handles.old_3rd_resultpathName=pathName;
handles=load_3rdResultFile(handles) ;
guidata(hObject, handles);
function handles=load_3rdResultFile(handles)
if ~isfield(handles,'old_3rd_resultpathName');
return;
end
curDir=cd;
if isfield(handles,'path_load_3rd_Results')
cd(handles.old_3rd_resultpathName);
end
%change the directory again
cd(curDir);
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pathName=handles.old_3rd_resultpathName;
curDataFileName=handles.fileNames{handles.curFileNum};
resultFileNameCorspndToDataFileName=getCorFileName(curDataFileName,handles.old
_3rd_resultFileNames);
if ~isempty(resultFileNameCorspndToDataFileName)
fileName=resultFileNameCorspndToDataFileName;
fullFileName=fullfile(pathName,fileName);
[data,~]=importdata(fullFileName);
oldResults=data.data;
handles.old_3rd_Results=oldResults;
else
handles.old_3rd_Results=[];
end
handles=plot_3rdResult(handles);
function handles=plot_1stResult(handles)
if get(handles.displayOldResult,'Value')==0
return
end
%for displaying old results
if ~isempty(handles.roiNum)
currentRoi=str2double(get(handles.roiNum,'String'));
else
currentRoi=1;
end
oldStepNum=num2str(handles.old_1st_Results(currentRoi,2));
set(handles.tb_dispOldStepNum,'String',oldStepNum);
%
%

set(handles.cb_plotGraphWithDiffStepNum,'Value',1);
set(handles.plotBleachStepOption_greaterThan,'Value',0);
if size(handles.old_1st_Results,2)>2 %not previous version's analysis data
oldBin=num2str(handles.old_1st_Results(currentRoi,3));
set(handles.tb_oldBinSize,'String',oldBin);
end

function handles=plot_2ndResult(handles)
if get(handles.displayOldResult,'Value')==0
return
end
%for displaying old results
if ~isempty(handles.roiNum)
currentRoi=str2double(get(handles.roiNum,'String'));
else
currentRoi=1;
end

213

oldStepNum=[num2str(handles.old_1st_Results(currentRoi,2)),'-',...
num2str(handles.old_2nd_Results(currentRoi,2))];
set(handles.tb_dispOldStepNum,'String',oldStepNum);
%
%
%

set(handles.cb_plotGraphWithDiffStepNum,'Value',1);
set(handles.plotBleachStepOption_greaterThan,'Value',0);
if size(handles.old_1st_Results,2)>2 %not previous version's analysis data
oldBin=[num2str(handles.old_1st_Results(currentRoi,3)),'-',...
num2str(handles.old_2nd_Results(currentRoi,3))];
set(handles.tb_oldBinSize,'String',oldBin);
end

%for displaying old results

function handles=plot_3rdResult(handles)
if get(handles.displayOldResult,'Value')==0
return
end
%for displaying old results
if ~isempty(handles.roiNum)
currentRoi=str2double(get(handles.roiNum,'String'));
else
currentRoi=1;
end

oldStepNum=[num2str(handles.old_1st_Results(currentRoi,2)),'-',...
num2str(handles.old_2nd_Results(currentRoi,2)),'-',...
num2str(handles.old_3rd_Results(currentRoi,2))];
set(handles.tb_dispOldStepNum,'String',oldStepNum);
%
%

set(handles.cb_plotGraphWithDiffStepNum,'Value',1);
set(handles.plotBleachStepOption_greaterThan,'Value',0);
if size(handles.old_1st_Results,2)>2 %not previous version's analysis data
oldBin=[num2str(handles.old_1st_Results(currentRoi,3)),'-',...
num2str(handles.old_2nd_Results(currentRoi,3)),'-',...
num2str(handles.old_3rd_Results(currentRoi,3))];
set(handles.tb_oldBinSize,'String',oldBin);
end

% --- Executes on button press in plotBleachStepOption_greaterThan.
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function plotBleachStepOption_greaterThan_Callback(hObject, eventdata, handles)
% hObject handle to plotBleachStepOption_greaterThan (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of plotBleachStepOption_greaterThan
if get(hObject,'Value')
set(handles.plotOnlyBleachStepOption,'Value',0);
set(handles.cb_plotGraphWithDiffStepNum,'Value',0);
else
set(handles.plotOnlyBleachStepOption,'Value',1);
end
guidata(hObject, handles);

% --- Executes on button press in cb_plotGraphWithDiffStepNum.
function cb_plotGraphWithDiffStepNum_Callback(hObject, eventdata, handles)
% hObject handle to cb_plotGraphWithDiffStepNum (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of cb_plotGraphWithDiffStepNum
if get(hObject,'Value')
set(handles.plotOnlyBleachStepOption,'Value',0);
set(handles.plotBleachStepOption_greaterThan,'Value',0);
else
set(handles.plotOnlyBleachStepOption,'Value',1);
end
guidata(hObject, handles);

% --- Executes on button press in NextGraphPlotAddTwoFrames.
function NextGraphPlotAddTwoFrames_Callback(hObject, eventdata, handles)
% hObject handle to NextGraphPlotAddTwoFrames (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of NextGraphPlotAddTwoFrames

% --- Executes on button press in plotOnlyBleachStepOption.
function plotOnlyBleachStepOption_Callback(hObject, eventdata, handles)
% hObject handle to plotOnlyBleachStepOption (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
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% Hint: get(hObject,'Value') returns toggle state of plotOnlyBleachStepOption
if get(hObject,'Value')
set(handles.plotBleachStepOption_greaterThan,'Value',0);
set(handles.cb_plotGraphWithDiffStepNum,'Value',0);
else
set(handles.plotBleachStepOption_greaterThan,'Value',1);
end
guidata(hObject, handles);

function plotOnlyBleachStepInput_Callback(hObject, eventdata, handles)
% hObject handle to plotOnlyBleachStepInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of plotOnlyBleachStepInput as text
%
str2double(get(hObject,'String')) returns contents of plotOnlyBleachStepInput as a
double

% --- Executes during object creation, after setting all properties.
function plotOnlyBleachStepInput_CreateFcn(hObject, eventdata, handles)
% hObject handle to plotOnlyBleachStepInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in verticalLine.
function verticalLine_Callback(hObject, eventdata, handles)
% hObject handle to verticalLine (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of verticalLine
function verticalLineInput_Callback(hObject, eventdata, handles)
% hObject handle to verticalLineInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
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% Hints: get(hObject,'String') returns contents of verticalLineInput as text
%
str2double(get(hObject,'String')) returns contents of verticalLineInput as a double

% --- Executes during object creation, after setting all properties.
function verticalLineInput_CreateFcn(hObject, eventdata, handles)
% hObject handle to verticalLineInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in filterTimeTrace.
function filterTimeTrace_Callback(hObject, eventdata, handles)
% hObject handle to filterTimeTrace (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of filterTimeTrace
if ~get(hObject,'Value')
data=handles.plottedData;
plotSimpleGraph2(handles, data);
else
plotSimpleGraph2(handles);
end
guidata(hObject, handles);
function handles= LoadADataFile(handles,fileName,path,inputRoiNum)
if get(handles.hideFileName,'Value')==0
set(handles.fileName,'String',fileName);
else
set(handles.fileName,'String','');
end
cd(path); %make the folder my current directory so that it will dircet you here later
hWaitbar = waitbar(0,'Populating raw data');
%update fileNum1 to use in saving data
%get data from the file
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fullFileName=fullfile(path,fileName); % Make a new file name with path name in
front of the file name.
[data,~]=importdata(fullFileName); %get the file
%remove frameNum, mean and average data column from raw data table
if(strcmp(data.colheaders{1, 2},'Average'))==1 %strcmp does not give any error if
two string are of different size
rawData=data.data(:,4:end);
elseif (strcmp(data.colheaders{1, end-1},'Average'))==1
rawData=data.data(:,2:end-2);
else
rawData=data.data(:,2:end);
end
%
handles.actualRawData=rawData;
numFrameBeforeCameraSutterOpened=0;
for i=2:size(rawData,1)
if rawData(i,1)==rawData(1,1)
numFrameBeforeCameraSutterOpened=numFrameBeforeCameraSutterOpened+5;
else
break;
end
end
rawData=rawData(numFrameBeforeCameraSutterOpened+1:end,:);
handles.datafilePathname=path; %same as filename
handles.rawData=rawData;
%following statement for "previous graph"
if nargin==3
currentRoi=1;
handles.outputData=500*ones(size(rawData,2),4);%to get ROInum and stepNum
else
currentRoi=inputRoiNum;
handles.outputData=handles.lastDataOutputData;
end
set(handles.roiNum,'String',num2str(currentRoi));
handles=plotSimpleGraph_newApproach(handles) ;
%display on
handles.old_1st_Results=[]; %sothat data from previous analysis does not show
handles.old_2nd_Results=[]; %sothat data from previous analysis does not show
handles.old_3rd_Results=[];
%display total graph num
set(handles.tb_totalGraph,'String',num2str(size(rawData,2)));
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close(hWaitbar);
function
resultFileNameCorspndToDataFileName=getCorFileName(dataFileName,allResultFileN
ames)
dataFileName=dataFileName(1:end-5); %remove .xlsx
for i=1:length(allResultFileNames)
aResultFileName=allResultFileNames{i};
aResultFileName=aResultFileName(11:end-4); %remove "Result of- " from file
name and ".txt"
if strcmp(dataFileName,aResultFileName)
resultFileNameCorspndToDataFileName=allResultFileNames{i};
break;
elseif i==length(allResultFileNames)
resultFileNameCorspndToDataFileName={};
end
end
% --- Executes on button press in fit_timeTrace.
function fit_timeTrace_Callback(hObject, eventdata, handles)
% hObject handle to fit_timeTrace (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of fit_timeTrace
plotSimpleGraph2(handles,handles.plottedData);
guidata(hObject, handles);
function plotOnlyBleachStepOption_greaterThanInput_Callback(hObject, eventdata,
handles)
% hObject handle to plotOnlyBleachStepOption_greaterThanInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
%
Hints:
get(hObject,'String')
returns
plotOnlyBleachStepOption_greaterThanInput as text
%
str2double(get(hObject,'String'))
plotOnlyBleachStepOption_greaterThanInput as a double

contents
returns

contents

% --- Executes during object creation, after setting all properties.
function plotOnlyBleachStepOption_greaterThanInput_CreateFcn(hObject, ~, handles)
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of
of

% hObject handle to plotOnlyBleachStepOption_greaterThanInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end

% --- Executes on button press in displayOldResult.
function displayOldResult_Callback(hObject, eventdata, handles)
% hObject handle to displayOldResult (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of displayOldResult
if get(hObject,'Value')
set(handles.uipanel_DisplayOldResults,'Visible','on')
set(get(handles.uipanel_DisplayOldResults,'Children'), 'Visible','on')
if isfield (handles,'old_3rd_Results') && ~isempty(handles.old_3rd_Results);
handles=plot_3rdResult(handles); %will plot 2nd and 1st as well
elseif isfield (handles,'old_2nd_Results') && ~isempty(handles.old_2nd_Results);
handles=plot_2ndResult(handles); %will pot 1st as well
elseif isfield (handles,'old_1st_Results') && ~isempty(handles.old_1st_Results);
handles=plot_1stResult(handles);
end
else
set(handles.uipanel_DisplayOldResults,'Visible','off')
set(get(handles.uipanel_DisplayOldResults,'Children'), 'Visible','off')
end
guidata(hObject, handles);
function calculate1_Callback(hObject, eventdata, handles)
% hObject handle to calculate1 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of calculate1 as text
%
str2double(get(hObject,'String')) returns contents of calculate1 as a double
input=get(hObject,'String');
[x1, x2]=getValues(input);
%get the data
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data=handles.plottedData;
tempData=data(x1:x2,1);
mean1=round(mean(tempData));
std1=round(std(tempData));
set(handles.mean1,'String',num2str(mean1));
set(handles.std1,'String',num2str(std1));
calculate_1Data=[(x1:x2)',mean1*ones(size(tempData))];
%for calculating mean and std, romove ealir data

%plot options
%only this has data
if ~isempty(handles.calculate_2Data)==0 && ~isempty(handles.calculate_3Data)==0
plotIt(handles,data,calculate_1Data);
elseif ~isempty(handles.calculate_2Data)==1 && ~isempty(handles.calculate_3Data)==0
plotIt(handles,data,calculate_1Data,handles.calculate_2Data);
mean2=str2double(get(handles.mean2,'String'));
set(handles.meanDiff1,'String',num2str(abs(mean1-mean2)));
elseif ~isempty(handles.calculate_2Data)==0 && ~isempty(handles.calculate_3Data)==1
plotIt(handles,data,calculate_1Data,handles.calculate_3Data);
mean3=str2double(get(handles.mean3,'String'));
set(handles.meanDiff3,'String',num2str(abs(mean1-mean3)));
else
plotIt(handles,data,calculate_1Data,handles.calculate_2Data,handles.calculate_3Data);
mean2=str2double(get(handles.mean2,'String'));
set(handles.meanDiff1,'String',num2str(abs(mean1-mean2)));
mean3=str2double(get(handles.mean3,'String'));
set(handles.meanDiff3,'String',num2str(abs(mean1-mean3)));
end
handles.calculate_1Data=calculate_1Data;
guidata(hObject,handles);

% --- Executes during object creation, after setting all properties.
function calculate1_CreateFcn(hObject, eventdata, handles)
% hObject handle to calculate1 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
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set(hObject,'BackgroundColor','white');
end

function calculate2_Callback(hObject, eventdata, handles)
% hObject handle to calculate2 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of calculate2 as text
%
str2double(get(hObject,'String')) returns contents of calculate2 as a double
input=get(hObject,'String');
[x1, x2]=getValues(input);
%get the data
data=handles.plottedData;
tempData=data(x1:x2,1);
mean2=round(mean(tempData));
std2=round(std(tempData));
set(handles.mean2,'String',num2str(mean2));
set(handles.std2,'String',num2str(std2));
calculate_2Data=[(x1:x2)',mean2*ones(size(tempData))];
%plot option
if ~isempty(handles.calculate_1Data)==0 && ~isempty(handles.calculate_3Data)==0
plotIt(handles,data,calculate_2Data);
elseif ~isempty(handles.calculate_1Data)==1 && ~isempty(handles.calculate_3Data)==0
plotIt(handles,data,handles.calculate_1Data,calculate_2Data);
mean1=str2double(get(handles.mean1,'String'));
set(handles.meanDiff1,'String',num2str(abs(mean2-mean1)));
elseif ~isempty(handles.calculate_1Data)==0 && ~isempty(handles.calculate_3Data)==1
plotIt(handles,data,calculate_2Data,handles.calculate_3Data);
mean3=str2double(get(handles.mean3,'String'));
set(handles.meanDiff2,'String',num2str(abs(mean2-mean3)));
else
plotIt(handles,data,handles.calculate_1Data,calculate_2Data,handles.calculate_3Data);
mean1=str2double(get(handles.mean1,'String'));
set(handles.meanDiff1,'String',num2str(abs(mean2-mean1)));
mean3=str2double(get(handles.mean3,'String'));
set(handles.meanDiff2,'String',num2str(abs(mean2-mean3)));
end
%set(handles.meanDiff1,'String',num2str(abs(mean1-handles.mean2)));
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handles.calculate_2Data=calculate_2Data;
guidata(hObject,handles);
% --- Executes during object creation, after setting all properties.
function calculate2_CreateFcn(hObject, eventdata, handles)
% hObject handle to calculate2 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
function calculate3_Callback(hObject, eventdata, handles)
% hObject handle to calculate3 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of calculate3 as text
%
str2double(get(hObject,'String')) returns contents of calculate3 as a double
input=get(hObject,'String');
[x1, x2]=getValues(input);
%get the data
data=handles.plottedData;
tempData=data(x1:x2,1);
mean3=round(mean(tempData));
std3=round(std(tempData));
set(handles.mean3,'String',num2str(mean3));
set(handles.std3,'String',num2str(std3));
calculate_3Data=[(x1:x2)',mean3*ones(size(tempData))];
%plot option
if ~isempty(handles.calculate_1Data)==0 && ~isempty(handles.calculate_2Data)==0
plotIt(handles,data,calculate_3Data);
elseif ~isempty(handles.calculate_1Data)==1 && ~isempty(handles.calculate_2Data)==0
plotIt(handles,data,handles.calculate_1Data,calculate_3Data);
mean1=str2double(get(handles.mean1,'String'));
set(handles.meanDiff3,'String',num2str(abs(mean3-mean1)));
elseif ~isempty(handles.calculate_1Data)==0 && ~isempty(handles.calculate_2Data)==1
plotIt(handles,data,handles.calculate_2Data,calculate_3Data);
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mean2=str2double(get(handles.mean2,'String'));
set(handles.meanDiff2,'String',num2str(abs(mean3-mean2)));
else
plotIt(handles,data,handles.calculate_1Data,handles.calculate_2Data,calculate_3Data);
mean1=str2double(get(handles.mean1,'String'));
set(handles.meanDiff3,'String',num2str(abs(mean3-mean1)));
mean2=str2double(get(handles.mean2,'String'));
set(handles.meanDiff2,'String',num2str(abs(mean3-mean2)));
end
handles.calculate_3Data=calculate_3Data;
guidata(hObject,handles);
% --- Executes during object creation, after setting all properties.
function calculate3_CreateFcn(hObject, eventdata, handles)
% hObject handle to calculate3 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end

function [x1, x2]=getValues(input)
%seperate the numbers from input
if (strcmp(input(1,2),'-'))==1;
x1=str2double(input(1,1));
x2=str2double(input(1,3:end));
elseif (strcmp(input(1,3),'-'))==1;
x1=str2double(input(1,1:2));
x2=str2double(input(1,4:end));
elseif (strcmp(input(1,4),'-'))==1;
x1=str2double(input(1,1:3));
x2=str2double(input(1,5:end));
else
uiwait(msgbox('Remember you need to put two numbers separated by a
hipen','Error','error'));
return;
end
%check if x1 or x2 bigger
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if x1>x2
a1=x2;
a2=x1;
x1=a1;
x2=a2;
end
% --- Executes on selection change in NumPontsAddToPlot.
function NumPontsAddToPlot_Callback(hObject, eventdata, handles)
% hObject handle to NumPontsAddToPlot (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: contents = cellstr(get(hObject,'String')) returns NumPontsAddToPlot contents as
cell array
%
contents{get(hObject,'Value')} returns selected item from NumPontsAddToPlot
% set(handles.NumPontsAddToPlot,'Value',2)
handles=plotSimpleGraph_newApproach(handles) ;
guidata(hObject,handles);

% --- Executes during object creation, after setting all properties.
function NumPontsAddToPlot_CreateFcn(hObject, eventdata, handles)
% hObject handle to NumPontsAddToPlot (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: popupmenu controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end

% --- Executes on button press in displayVeticalLinesforMeanAndSTD.
function displayVeticalLinesforMeanAndSTD_Callback(hObject, eventdata, handles)
% hObject handle to displayVeticalLinesforMeanAndSTD (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
handles=plotSimpleGraph_newApproach(handles); % necessary to avoid multiple plots of
lines on the same graphs
handles=plotLines(handles);
guidata(hObject,handles);
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function handles=plotLines(handles,line_1,line_2,line_3)
% Hint: get(hObject,'Value') returns toggle state of displayVeticalLinesforMeanAndSTD
if nargin<2
handles.edge=5;
handles.secondFromRihgtLineDist=10;
line_1=handles.edge;
xLimit=xlim(handles.axes1);
line_2=floor(xLimit(2)/4*3);
line_3=floor(xLimit(2)-handles.secondFromRihgtLineDist);
% line_4=floor(xLimit(2)-handles.edge);
end
yLimit=ylim(handles.axes1);
% --- Executes on button press in calculate.
function calculate_Callback(hObject, eventdata, handles)
% hObject handle to calculate (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% replotLines(hObject, eventdata, handles)
handles=plotSimpleGraph_newApproach(handles) ;
guidata(hObject,handles);
function handles=plotSimpleGraph_newApproach(handles)
currentRoi=str2double(get(handles.roiNum,'String')); %get the graph number which
is actually ROI number
data=handles.rawData(:,currentRoi);
%conts = get(handles.NumPontsAddToPlot,'String');
NumPontsAddToPlot_input = get(handles.NumPontsAddToPlot,'Value');
combinedData=zeros(floor(size(data,1)/NumPontsAddToPlot_input),1);
for r =1:size(combinedData,1)
combinedData(r,1)=mean(data(NumPontsAddToPlot_input*(r1)+1:r*NumPontsAddToPlot_input));
end
%to plot a base line, plot mean of last 20 frames
if size(combinedData,1)>25
baseData=mean(combinedData(end-20:end,1))*ones(size(combinedData,1),1);
else
uiwait(msgbox({'"How Many Frames to plot?" need to be greater than 30'}),1);
return
end
%
cla reset;
if get(handles.verticalLine,'Value')
xVal=str2double(get(handles.verticalLineInput,'String'));
xVal=round(xVal/NumPontsAddToPlot_input);
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else
xVal=0;
end
temp=round(min(combinedData(:,1))):round(max(combinedData(:,1)));
%since when we plot any graph handles assocated with lines
%(h_k_line, h_g_line, etc) disappeared, we are collecting those
%numbers here
if get(handles.calculate,'Value')==0
axes(handles.axes1)
cla reset;
xAxisLimit=str2double(get(handles.plotOpt_frameNum,'String'));
plot(1:size(combinedData(:,1),1),combinedData(:,1),'b','LineWidth',1);
hold on
plot(1:size(combinedData(:,1),1),combinedData(:,1),'b',...
1:size(baseData(:,1),1),baseData(:,1),'--r',...
xVal*ones(length(temp),1),temp,'--k','LineWidth',1);
hold off
%display x limit values
if size(combinedData,1)<xAxisLimit
xAxisLimit=size(combinedData,1);
end
xlim([0 xAxisLimit]);
%
handles.plottedData=data;
xlabel('Number of Frames'); ylabel('Average Intensity');
%display vertical lines for finding mean and std
%when calculate button was clicked
else
%get line's x coordinates limits
line_1 =round(get(handles.h_k_line, 'XData'));
line_2=round(get(handles.h_r_line, 'XData'));
line_3=round(get(handles.h_g_line, 'XData'));
%
line_4=round(get(handles.h_m_line, 'XData'));
%get one values form the cooridate limits
line_1=line_1(1);
line_2=line_2(1);
line_3=line_3(1);
xLimit=xlim(handles.axes1);
xAxisLimit =xLimit(2);
if line_1<1 || line_2<1 || line_3<1
if line_1<1
line_1=1;
elseif line_2<1
line_2=1;
else
line_3=1;
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end

elseif line_1>xAxisLimit || line_2>xAxisLimit || line_3>xAxisLimit
if line_1>xAxisLimit
line_1=xAxisLimit;
elseif line_2>xAxisLimit
line_2=xAxisLimit;
else
line_3=xAxisLimit;
end
end
%
line_4=line_4(1);
%sort the x coordinates
xValues=sort([line_1,line_2,line_3]);
line_1=xValues(1);
line_2=xValues(2);
line_3=xValues(3);
%
line_4=xValues(4);
xLimitVal=xlim(handles.axes1);
xLimitVal=xLimitVal(2);
plotedData=combinedData(1:xLimitVal,1);
%plot graphs agains
axes(handles.axes1)
cla reset;
xAxisLimit=str2double(get(handles.plotOpt_frameNum,'String'));
plot(1:size(combinedData(:,1),1),combinedData(:,1),'b','LineWidth',1);
hold on
plot(1:size(combinedData(:,1),1),combinedData(:,1),'b',...
1:size(baseData(:,1),1),baseData(:,1),'--r',...
xVal*ones(length(temp),1),temp,'--k','LineWidth',1);
hold off
%display x limit values
if size(combinedData,1)<xAxisLimit
xAxisLimit=size(combinedData,1);
end
xlim([0 xAxisLimit]);
%
handles.plottedData=data;
xlabel('Number of Frames'); ylabel('Average Intensity');
handles=plotLines(handles,line_1,line_2,line_3);
%get mean Intensity and Bleaching time of first interval
data_12=plotedData(line_1:line_2);
data_23=plotedData(line_2:line_3);
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mean_12=round(mean(data_12));
mean_23=round(mean(data_23));
std_12=round(std(data_12));
std_23=round(std(data_23));
hold on
axes(handles.axes1)
plot(line_1:line_2,mean_12*(ones(1, size(data_12,1))),'m',...
line_2:line_3,mean_23*(ones(1, size(data_23,1))), 'm', 'LineWidth', 4)
hold off
%set values
set(handles.avg_1,'String',num2str(mean_12));
set(handles.avg_2,'String',num2str(mean_23));
set(handles.avgDif,'String',num2str(round((abs(mean_12-mean_23)))));
set(handles.std_1,'String',num2str(std_12));
set(handles.std_2,'String',num2str(std_23));
set(handles.ratio_1,'String',num2str(round(abs(mean_12-mean_23)/std_12,2)));
set(handles.ratio_2,'String',num2str(round(abs(mean_12-mean_23)/std_23,2)));
end
handles.plottedData =combinedData;
function
nextRoi=getNextRoi_greaterThan(stepNum,currentRoi,old_1st_Results,old_2nd_Results
,old_3rd_Results)
if nargin<4
for i=currentRoi+1:size(old_1st_Results,1)
if old_1st_Results(i,2)>=stepNum
break;
end
end
elseif nargin<5
for i=currentRoi+1:size(old_1st_Results,1)
if old_1st_Results(i,2)>=stepNum || old_2nd_Results(i,2)>=stepNum; %al least one
is greater than the value
break;
end
end
else
for i=currentRoi+1:size(old_1st_Results,1)
if
old_1st_Results(i,2)>=stepNum
||old_2nd_Results(i,2)>=stepNum
||
old_3rd_Results(i,2)>=stepNum
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break;
end
end
end
nextRoi=i;

function
perviousRoi=getPreviousRoi_greaterThan(stepNum,currentRoi,old_1st_Results,old_2nd
_Results,old_3rd_Results)
if nargin<4
for i=currentRoi-1:-1:1
if old_1st_Results(i,2)>=stepNum
break;
end
end
elseif nargin<5
for i=currentRoi-1:-1:1
if old_1st_Results(i,2)>=stepNum || old_2nd_Results(i,2)>=stepNum; %al least one
is greater than the value
break;
end
end
else
for i=currentRoi-1:-1:1
if
old_1st_Results(i,2)>=stepNum
||old_2nd_Results(i,2)>=stepNum
||
old_3rd_Results(i,2)>=stepNum
break;
end
end
end
perviousRoi=i;

function
nextRoi=getNextRoi_aValue(aVal,
currentRoi,old_1st_Results,old_2nd_Results,old_3rd_Results)
if nargin<4
for i=currentRoi+1:size(old_1st_Results,1)
if old_1st_Results(i,2)==aVal
break;
end
end
elseif nargin<5
for i=currentRoi+1:size(old_1st_Results,1)
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if old_1st_Results(i,2)==aVal || old_2nd_Results(i,2)==aVal;
break;
end
end
else
for i=currentRoi+1:size(old_1st_Results,1)
if
old_1st_Results(i,2)==aVal
||
old_2nd_Results(i,2)==aVal
old_3rd_Results(i,2)==aVal;
break;
end
end
end
nextRoi=i;

||

function
nextRoi=getPreviousRoi_aValue(aVal,
currentRoi,old_1st_Results,old_2nd_Results,old_3rd_Results)

if nargin<4
for i=currentRoi-1:-1:1
if old_1st_Results(i,2)==aVal
break;
end
end
elseif nargin<5
for i=currentRoi-1:-1:1
%
nextRoi=i;
%
if
~isequal(old_1st_Results(i,2),old_2nd_Results(i,2)) &&
any([old_1st_Results(i,2),old_2nd_Results(i,2)]); %if not equal and has atleast one
nonezero value
if old_1st_Results(i,2)==aVal || old_2nd_Results(i,2)==aVal;
break;
end
end
else
for i=currentRoi-1:-1:1
if
old_1st_Results(i,2)==aVal
old_3rd_Results(i,2)==aVal;
%
nextRoi=i;
break;
end
end

||
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old_2nd_Results(i,2)==aVal

||

end
nextRoi=i;
function
nextRoi=getNextRoi_differntStepNum(currentRoi,old_1st_Results,old_2nd_Results,old_
3rd_Results)

if nargin<3
for i=currentRoi+1:size(old_1st_Results,1)
if old_1st_Results(i,2)>0
break;
end
end

elseif nargin<4
for i=currentRoi+1:size(old_1st_Results,1)
%
nextRoi=i;
if
~isequal(old_1st_Results(i,2),old_2nd_Results(i,2))
&&
any([old_1st_Results(i,2),old_2nd_Results(i,2)]); %if not equal and has atleast one
nonezero value
break;
end
end
else
for i=currentRoi+1:size(old_1st_Results,1)
if ~isequal(old_1st_Results(i,2),old_2nd_Results(i,2),old_3rd_Results(i,2))
any([old_1st_Results(i,2),old_2nd_Results(i,2),old_3rd_Results(i,2)]);
%
nextRoi=i;
break;
end
end

&&

end
nextRoi=i;
function
perviousRoi=getPreviousRoi_differntStepNum(currentRoi,old_1st_Results,old_2nd_Res
ults,old_3rd_Results)
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if nargin<3
for i=currentRoi-1:-1:1
if old_1st_Results(i,2)>0
break;
end
end

elseif nargin<4
for i=currentRoi-1:-1:1
if
~isequal(old_1st_Results(i,2),old_2nd_Results(i,2))
&&
any([old_1st_Results(i,2),old_2nd_Results(i,2)]); %if not equal and has atleast one
nonezero value
break;
end
end
else
for i=currentRoi-1:-1:1
if ~isequal(old_1st_Results(i,2),old_2nd_Results(i,2),old_3rd_Results(i,2))
any([old_1st_Results(i,2),old_2nd_Results(i,2),old_3rd_Results(i,2)]);
break;
end
end
end
perviousRoi=i;
% --- Executes on button press in noSteps.
function noSteps_Callback(hObject, eventdata, handles)
% hObject handle to noSteps (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','');
guidata(hObject, handles);
% --- Executes on button press in zero.
function zero_Callback(hObject, eventdata, handles)
% hObject handle to zero (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
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&&

set(handles.stepNum,'String','0');
guidata(hObject, handles);

% --- Executes on button press in one.
function one_Callback(hObject, eventdata, handles)
% hObject handle to one (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','1');
guidata(hObject, handles);

% --- Executes on button press in two.
function two_Callback(hObject, eventdata, handles)
% hObject handle to two (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','2');
guidata(hObject, handles);
% --- Executes on button press in three.
function three_Callback(hObject, eventdata, handles)
% hObject handle to three (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','3');
guidata(hObject, handles);
% --- Executes on button press in five.
function five_Callback(hObject, eventdata, handles)
% hObject handle to five (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','5');
guidata(hObject, handles);
% --- Executes on button press in six.
function six_Callback(hObject, eventdata, handles)
% hObject handle to six (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','6');
guidata(hObject, handles);
% --- Executes on button press in four.
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function four_Callback(hObject, eventdata, handles)
% hObject handle to four (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','4');
guidata(hObject, handles);

% --- Executes on button press in seven.
function seven_Callback(hObject, eventdata, handles)
% hObject handle to seven (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','7');
guidata(hObject, handles);
function eight_Callback(hObject, eventdata, handles)
% hObject handle to seven (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','8');
guidata(hObject, handles);
function nine_Callback(hObject, eventdata, handles)
% hObject handle to seven (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
set(handles.stepNum,'String','9');
guidata(hObject, handles);

% --- Executes on button press in hideFileName.
function hideFileName_Callback(hObject, eventdata, handles)
% hObject handle to hideFileName (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
if get(handles.hideFileName,'Value')==1
set(handles.fileName,'String','');
else
set(handles.fileName,'String',handles.fileNames{handles.curFileNum});
end
guidata(hObject, handles);
% Hint: get(hObject,'Value') returns toggle state of hideFileName
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%% this block of code was modified and directy adpoted from following copyright
sources
%https://www.mathworks.com/matlabcentral/fileexchange/42284-drag-line-in-gui
% % Copyright (c) 2013, Gero Nootz
% % All rights reserved.
%%
% % Redistribution and use in source and binary forms, with or without
% % modification, are permitted provided that the following conditions are
% % met:
%%
% % * Redistributions of source code must retain the above copyright
%%
notice, this list of conditions and the following disclaimer.
% % * Redistributions in binary form must reproduce the above copyright
%%
notice, this list of conditions and the following disclaimer in
%%
the documentation and/or other materials provided with the distribution
% % THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND
CONTRIBUTORS "AS IS"
% % AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT
LIMITED TO, THE
% % IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A
PARTICULAR PURPOSE
% % ARE DISCLAIMED. IN NO EVENT SHALL THE COPYRIGHT OWNER OR
CONTRIBUTORS BE
% % LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL,
EXEMPLARY, OR
% % CONSEQUENTIAL DAMAGES (INCLUDING, BUT NOT LIMITED TO,
PROCUREMENT OF
% % SUBSTITUTE GOODS OR SERVICES; LOSS OF USE, DATA, OR PROFITS; OR
BUSINESS
% % INTERRUPTION) HOWEVER CAUSED AND ON ANY THEORY OF
LIABILITY, WHETHER IN
% % CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR
OTHERWISE)
% % ARISING IN ANY WAY OUT OF THE USE OF THIS SOFTWARE, EVEN IF
ADVISED OF THE
% % POSSIBILITY OF SUCH DAMAGE.
% Plot lines
handles.h_k_line = line([line_1 line_1], [yLimit(1) yLimit(2)],...
'LineWidth',
2,
'Color',
'k',
'ButtonDownFcn',
@(hObject,eventdata)simpleGraph_byFaruk('startDragK_Fcn',hObject,eventdata,guidata(
hObject)));
handles.h_r_line = line([line_2 line_2], [yLimit(1) yLimit(2)],...
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'LineWidth',
2,
'Color',
'r',
'ButtonDownFcn',
@(hObject,eventdata)simpleGraph_byFaruk('startDragR_Fcn',hObject,eventdata,guidata(
hObject)));
handles.h_g_line = line([line_3 line_3], [yLimit(1) yLimit(2)],...
'LineWidth',
2,
'Color',
'g',
'ButtonDownFcn',
@(hObject,eventdata)simpleGraph_byFaruk('startDragG_Fcn',hObject,eventdata,guidata(
hObject)));
% % handles.h_m_line = line([line_4 line_4], [yLimit(1) yLimit(2)],...
% %
'LineWidth', 2, 'Color', 'm', 'ButtonDownFcn',
@(hObject,eventdata)simpleGraph_byFaruk('startDragM_Fcn',hObject,eventdata,guidata
(hObject)));
% % %%

function startDragK_Fcn(hObject, eventdata, handles)
set(handles.figure1,
'WindowButtonMotionFcn',
@(hObject,eventdata)simpleGraph_byFaruk('draggingK_Fcn',hObject,eventdata,guidata(
hObject)));

function draggingK_Fcn(hObject, eventdata, handles)
pt = get(handles.axes1, 'CurrentPoint');
set(handles.h_k_line, 'XData', pt(1)*[1 1]);

function startDragR_Fcn(hObject, eventdata, handles)
set(handles.figure1,
'WindowButtonMotionFcn',
@(hObject,eventdata)simpleGraph_byFaruk('draggingR_Fcn',hObject,eventdata,guidata(
hObject)));
function draggingR_Fcn(hObject, eventdata, handles)
pt = get(handles.axes1, 'CurrentPoint');
set(handles.h_r_line, 'XData', pt(1)*[1 1]);

function startDragG_Fcn(hObject, eventdata, handles)
set(handles.figure1,
'WindowButtonMotionFcn',
@(hObject,eventdata)simpleGraph_byFaruk('draggingG_Fcn',hObject,eventdata,guidata(
hObject)));
function draggingG_Fcn(hObject, eventdata, handles)
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pt = get(handles.axes1, 'CurrentPoint');
set(handles.h_g_line, 'XData', pt(1)*[1 1]);

function startDragM_Fcn(hObject, eventdata, handles)
set(handles.figure1,
'WindowButtonMotionFcn',
@(hObject,eventdata)simpleGraph_byFaruk('draggingM_Fcn',hObject,eventdata,guidata(
hObject)));
function draggingM_Fcn(hObject, eventdata, handles)
pt = get(handles.axes1, 'CurrentPoint');
set(handles.h_m_line, 'XData', pt(1)*[1 1]);

function stopDragFcn(hObject, eventdata, handles)
set(handles.figure1, 'WindowButtonMotionFcn', '');

238

Outline of the GUI: StiochiometryFitting_byFaruk.fig

Figure S5: Outline of the GUI used to fit photobleaching distribution to obtain proportion
of two and three labeled subunits. This GUI was saved as
“StiochiometryFitting_byFaruk.fig”. The underlying variables (Tag) for components 1-13
can be found in the Table S3.
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Table S3: The essential variables used in the figure for GUI (Figure S5). All other
components were either Static Texts or Panels.

Numbe Type of String
r
in compone
Figure nt
S1

Tag

1

Edit Text

80

num_1steps

2

Edit Text

30

num_2steps

3

Edit Text

10

num_3steps

4

Edit Text

0.90

probability

5

Check
Box

Don't Save Results

donotSaveResults

6

Check
Box

AutoGenerateFileName

AutoGenerateFileName

7

Check
Box

Save File As

saveAs

8

Check
Box

showMeDirectoryAfterCalcula
tion

showMeDirectoryAfterCalcula
tion

9

Check
Box

displayResults

displayResults

10

Push
Button

setFolder

setFolder1

11

Edit Text

fileNameInput

fileNameInput

12

Push
Button

setFolder

setFolder2

13

Push
Button

Calculate

calculate
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Matlab Code in a file called, “StiochiometryFitting_byFaruk.m”

function varargout = StiochiometryFitting_byFaruk(varargin)
% Begin initialization code - DO NOT EDIT
gui_Singleton = 1;
gui_State = struct('gui_Name',
mfilename, ...
'gui_Singleton', gui_Singleton, ...
'gui_OpeningFcn', @StiochiometryFitting_byFaruk_OpeningFcn, ...
'gui_OutputFcn', @StiochiometryFitting_byFaruk_OutputFcn, ...
'gui_LayoutFcn', [] , ...
'gui_Callback', []);
if nargin && ischar(varargin{1})
gui_State.gui_Callback = str2func(varargin{1});
end
if nargout
[varargout{1:nargout}] = gui_mainfcn(gui_State, varargin{:});
else
gui_mainfcn(gui_State, varargin{:});
end
% End initialization code - DO NOT EDIT
% --- Executes just before StiochiometryFitting_byFaruk is made visible.
function StiochiometryFitting_byFaruk_OpeningFcn(hObject, eventdata, handles,
varargin)
% This function has no output args, see OutputFcn.
% hObject handle to figure
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% varargin command line arguments to StiochiometryFitting_byFaruk (see VARARGIN)
% Choose default command line output for StiochiometryFitting_byFaruk
handles.output = hObject;
% Update handles structure
guidata(hObject, handles);
% UIWAIT makes StiochiometryFitting_byFaruk wait for user response (see
UIRESUME)
% uiwait(handles.figure1);

% --- Outputs from this function are returned to the command line.
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function varargout = StiochiometryFitting_byFaruk_OutputFcn(hObject, eventdata,
handles)
% varargout cell array for returning output args (see VARARGOUT);
% hObject handle to figure
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Get default command line output from handles structure
varargout{1} = handles.output;

function num_1steps_Callback(hObject, eventdata, handles)
% hObject handle to num_1steps (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of num_1steps as text
%
str2double(get(hObject,'String')) returns contents of num_1steps as a double
% contents = cellstr(get(handles.popupmenu1,'String')) ;
% cond=contents{get(handles.popupmenu1,'Value')} ;
% if strcmp(cond, 'Fit 1 and 2 labeled xFP')
% num_1steps=str2double(get(hObject,'String'));
% set(handles.num_2steps,'String',num2str(100-num_1steps));
% end
% guidata(hObject, handles);
% --- Executes during object creation, after setting all properties.
function num_1steps_CreateFcn(hObject, eventdata, handles)
% hObject handle to num_1steps (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end

function num_2steps_Callback(hObject, eventdata, handles)
% hObject handle to num_2steps (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
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% Hints: get(hObject,'String') returns contents of num_2steps as text
%
str2double(get(hObject,'String')) returns contents of num_2steps as a double
% --- Executes during object creation, after setting all properties.
function num_2steps_CreateFcn(hObject, eventdata, handles)
% hObject handle to num_2steps (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
function num_3steps_Callback(hObject, eventdata, handles)
% hObject handle to num_3steps (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of num_3steps as text
%
str2double(get(hObject,'String')) returns contents of num_3steps as a double
% --- Executes during object creation, after setting all properties.
function num_3steps_CreateFcn(hObject, eventdata, handles)
% hObject handle to num_3steps (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in calculate.
function calculate_Callback(hObject, eventdata, handles)
% hObject handle to calculate (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
hb=waitbar(0,'Please wait...');
fit_2_3_stoiochiometry (handles)
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close(hb);
guidata(hObject, handles);
function fit_2_3_stoiochiometry (handles)
num_1steps = str2double(get(handles.num_1steps,'String'));
num_2steps = str2double(get(handles.num_2steps,'String'));
num_3steps = str2double(get(handles.num_3steps,'String'));
prob = str2double(get(handles.probability,'String'));
%get the ratio of the number of steps
obsDist=[num_1steps, num_2steps, num_3steps]; %an arry of the number of steps
totalSteps=sum(obsDist);
obsDistRatio=obsDist/totalSteps; %observed distribution array
errorInObsDistRatio=sqrt(obsDist)/totalSteps; %an array of error in the observed
distribution.
%get bionomal distributions
x=[1 2 3];
distFrom_2LabeledSub=binopdf(x,2,prob);
distFrom_3LabeledSub=binopdf(x,3,prob);
%normailize as there is a possiblity to observe 0 steps
normDistFrom_2LabeledSub=distFrom_2LabeledSub/sum(distFrom_2LabeledSub);
normDistFrom_3LabeledSub=distFrom_3LabeledSub/sum(distFrom_3LabeledSub);
%make a matrix to weight the binomal distribution and get a final
%distribution
a1 =(0:100)';
a2=100-a1;
weightMat=[a1,a2]/100; % the weight matrix with 0,1; 0.1, .99,.....
%apply the weight to the binomial and get the an array of p-values
p1=zeros(1,length(a1));
outDis=[];
for i=1:length(a1)
expectedDist
=(normDistFrom_2LabeledSub*weightMat(i,1)+
normDistFrom_3LabeledSub*weightMat(i,2))*totalSteps;
%expected distribution, a1*P([1 2 3],2,p)+a2*P([1 2 3],3,p) is a probability,
% %which needs to multiply by the total number of bleaching steps, as chi square does
not work with ratio
chi2stat = sum((obsDist-expectedDist).^2 ./ expectedDist); %get chi squares statistics,
manually
%
[~,p] = chi2gof([1 2 3],'freq',obsDist,'expected',expDist,'ctrs',[1 2 3],'nparams',1);
p1(1,i)=1-chi2cdf(chi2stat,1) ;%get p value manually
%
outDis=[outDis;[weightMat(i,:)*100,expectedDist/totalSteps]];
end
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%find the maxima and the index of the maxima. This maxima is the height fit
%possibles
[~,In]=max(p1); %as we want to get maximum silimality
%get the distribution for the height p values
combDist
=normDistFrom_2LabeledSub*weightMat(In,1)+
normDistFrom_3LabeledSub*weightMat(In,2);
%final expected ratio, it will be save as a results
expectedDist=combDist*totalSteps; %out of total steps, need to get chi square statistics
chi2stat = sum((obsDist-expectedDist).^2 ./ expectedDist);
%%%%%%%%%%%%%%%%%%%%%%-----------------make the excel sheet to output
results -------------fittingDecision=[{'Chi2GOF decision'};{['p_Value= ',num2str(p1(In)),'
chi2stat =
',num2str(chi2stat),' degree of freedom =2']}];
% percent of the each subunits
perentageOfSubunits=(weightMat(In,:)*100);
str=[{'% 2 Subunits'}, {'% 3 Subunits'}];
perentageOfSubunits=[str;num2cell(perentageOfSubunits)];
%make a header and arry to print results to plot with origin
header=[{'From 2 labeled subunits'},{'From 3 labeled subunits'},{'Expected
Ratio'},{'Observed Ratio'},{'Error in Observed Ratio'}];
finalDist=round([(normDistFrom_2LabeledSub*weightMat(In,1))',
(normDistFrom_3LabeledSub*weightMat(In,2))',combDist',...
obsDistRatio',errorInObsDistRatio'],3);
finalDist=[header;num2cell(finalDist)];
column=[{''};{'1 step bleaching'};{'2 steps bleaching'};{'3 steps bleaching'}];
finalDist=[column,finalDist];

% Make a matrix to print the chi square statistics, decision
% of the hypothesis test
chi2TestResults=[{'Calclulated Chi Square value'};num2cell(chi2stat)];
resultsAndFitDecision=[perentageOfSubunits,[{''};{''}],[{''};{''}],chi2TestResults,fitting
Decision];
%make a matrix to print space
spacing=[[{''};{''}],[{''};{''}],[{''};{''}],[{''};{''}],[{''};{''}],[{''};{''}]];
%the final output matrix with r
Results=[spacing; resultsAndFitDecision;spacing;finalDist];
%make an matrix to print input data
inputDataHeader=[{'# 1 step'},{'# 2 step'},{'# 3 step'},{'probability'},{''},{''}];
inputData=[obsDist,prob];
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inputData=[inputDataHeader;[num2cell(inputData),{''},{''}]];
%the final output matrix
outputExcel=[inputData;spacing;Results];
%get the saving file name and directory
if get(handles.saveAs,'Value')
fileName=[get(handles.fileNameInput,'String'),'.xlsx'];
filepath=pwd;
elseif get(handles.AutoGenerateFileName,'Value');
fileName=['Stoicheometry fit with ', num2str(num_1steps), '-',num2str(num_2steps), '',num2str(num_3steps),'.xlsx'];
filepath=pwd;
elseif get(handles.showMeDirectoryAfterCalculation,'Value');
[fileName,filepath] = uiputfile('*.xlsx','Write a filename to save the data');
if fileName==0
return;
end
end
if get(handles.displayResults,'Value')
figure;
% c = categorical({'one steps';'two steps';'three steps'});
y = [obsDist',expectedDist'];
bar(y)
legend('Observed','Expected','Location','northwest','Orientation','horizontal');
msgbox([{['Two labeled FP = ',num2str(perentageOfSubunits{2,1}),'% Three labeled
FP = ',...
num2str(perentageOfSubunits{2,2}),'%']};{['p_Value= ',num2str(p1(In)),' chi2stat =
',...
num2str(chi2stat),' degree of freedom =2']}]);
end
if get(handles.donotSaveResults,'Value')==0
fullFileName=fullfile(filepath,fileName);
xlswrite(fullFileName,outputExcel);
end
function probability_Callback(hObject, eventdata, handles)
% hObject handle to probability (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of probability as text
%
str2double(get(hObject,'String')) returns contents of probability as a double
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% --- Executes during object creation, after setting all properties.
function probability_CreateFcn(hObject, eventdata, handles)
% hObject handle to probability (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in saveAs.
function saveAs_Callback(hObject, eventdata, handles)
% hObject handle to saveAs (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of saveAs
if get(hObject,'Value')
set(handles.showMeDirectoryAfterCalculation,'Value',0);
set(handles.donotSaveResults,'Value',0);
set(handles.fileNameInput,'Enable','on');
set(handles.setFolder2,'Enable','on');
set(handles.AutoGenerateFileName,'Value',0);
set(handles.setFolder1,'Enable','off');
else
set(handles.showMeDirectoryAfterCalculation,'Value',1);
set(handles.setFolder1,'Enable','off');
set(handles.saveAs,'Value',0);
set(handles.fileNameInput,'Enable','off');
set(handles.setFolder2,'Enable','off');
end
guidata(hObject, handles);
function fileNameInput_Callback(hObject, eventdata, handles)
% hObject handle to fileNameInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: get(hObject,'String') returns contents of fileNameInput as text
%
str2double(get(hObject,'String')) returns contents of fileNameInput as a double
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% --- Executes during object creation, after setting all properties.
function fileNameInput_CreateFcn(hObject, eventdata, handles)
% hObject handle to fileNameInput (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: edit controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in AutoGenerateFileName.
function AutoGenerateFileName_Callback(hObject, eventdata, handles)
% hObject handle to AutoGenerateFileName (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of AutoGenerateFileName
if get(hObject,'Value')
set(handles.setFolder2,'Enable','on');
set(handles.showMeDirectoryAfterCalculation,'Value',0);
set(handles.donotSaveResults,'Value',0);
set(handles.saveAs,'Value',0);
set(handles.fileNameInput,'Enable','off');
set(handles.setFolder2,'Enable','off');
set(handles.setFolder1,'Enable','on');
else
set(handles.showMeDirectoryAfterCalculation,'Value',1);
set(handles.setFolder1,'Enable','off');
end
guidata(hObject, handles);
% --- Executes on button press in showMeDirectoryAfterCalculation.
function showMeDirectoryAfterCalculation_Callback(hObject, eventdata, handles)
% hObject handle to showMeDirectoryAfterCalculation (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of showMeDirectoryAfterCalculation
if get(hObject,'Value')
set(handles.donotSaveResults,'Value',0);
set(handles.saveAs,'Value',0);
set(handles.fileNameInput,'Enable','off');
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set(handles.setFolder2,'Enable','off');
set(handles.AutoGenerateFileName,'Value',0);
set(handles.setFolder1,'Enable','off');
else
set(handles.saveAs,'Value',1);
set(handles.fileNameInput,'Enable','on');
set(handles.setFolder2,'Enable','on');
end
guidata(hObject, handles);
% --- Executes on button press in donotSaveResults.
function donotSaveResults_Callback(hObject, eventdata, handles)
% hObject handle to donotSaveResults (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hint: get(hObject,'Value') returns toggle state of donotSaveResults
if get(hObject,'Value')
set(handles.showMeDirectoryAfterCalculation,'Value',0);
set(handles.saveAs,'Value',0);
set(handles.fileNameInput,'Enable','off');
set(handles.setFolder2,'Enable','off');
set(handles.AutoGenerateFileName,'Value',0);
set(handles.setFolder1,'Enable','off');
else
set(handles.saveAs,'Value',1);
set(handles.fileNameInput,'Enable','on');
set(handles.setFolder2,'Enable','on');
end
guidata(hObject, handles);
% --- Executes on button press in setFolder2.
function setFolder2_Callback(hObject, eventdata, handles)
% hObject handle to setFolder2 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
currFolder=pwd;
addpath(currFolder)
folder_name = uigetdir;
cd(folder_name);
% --- Executes on button press in setFolder1.
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function setFolder1_Callback(hObject, eventdata, handles)
% hObject handle to setFolder1 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
currFolder=pwd;
addpath(currFolder)
folder_name = uigetdir;
cd(folder_name);
% --- Executes on selection change in popupmenu1.
function popupmenu1_Callback(hObject, eventdata, handles)
% hObject handle to popupmenu1 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles structure with handles and user data (see GUIDATA)
% Hints: contents = cellstr(get(hObject,'String')) returns popupmenu1 contents as cell array
%
contents{get(hObject,'Value')} returns selected item from popupmenu1
contents = cellstr(get(handles.popupmenu1,'String')) ;
cond=contents{get(handles.popupmenu1,'Value')} ;
switch cond
case 'Fit 2 and 3 labeled xFP'
set(handles.num_3steps,'Visible','on');
set(handles.text4,'Visible','on');
case 'Fit 1 and 2 labeled xFP'
set(handles.num_3steps,'Visible','off');
set(handles.text4,'Visible','off');
end

guidata(hObject, handles);
% --- Executes during object creation, after setting all properties.
function popupmenu1_CreateFcn(hObject, eventdata, handles)
% hObject handle to popupmenu1 (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
% handles empty - handles not created until after all CreateFcns called
% Hint: popupmenu controls usually have a white background on Windows.
%
See ISPC and COMPUTER.
if
ispc
&&
isequal(get(hObject,'BackgroundColor'),
get(0,'defaultUicontrolBackgroundColor'))
set(hObject,'BackgroundColor','white');
end
% --- Executes on button press in displayResults.
function displayResults_Callback(hObject, eventdata, handles)
% hObject handle to displayResults (see GCBO)
% eventdata reserved - to be defined in a future version of MATLAB
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% handles

structure with handles and user data (see GUIDATA)

% Hint: get(hObject,'Value') returns toggle state of displayResults
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